Nanotechnology synergized immunoengineering for cancer
[Display omitted] Novel strategies modulating the immune system yielded enhanced anticancer responses and improved cancer survival. Nevertheless, the success rate of immunotherapy in cancer treatment has been below expectation(s) due to unpredictable efficacy and off-target effects from systemic dos...
Saved in:
| Published in | European journal of pharmaceutics and biopharmaceutics Vol. 163; pp. 72 - 101 |
|---|---|
| Main Authors | , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Netherlands
Elsevier B.V
01.06.2021
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | [Display omitted]
Novel strategies modulating the immune system yielded enhanced anticancer responses and improved cancer survival. Nevertheless, the success rate of immunotherapy in cancer treatment has been below expectation(s) due to unpredictable efficacy and off-target effects from systemic dosing of immunotherapeutic(s). As a result, there is an unmet clinical need for improving conventional immunotherapy. Nanotechnology offers several new strategies, multimodality, and multiplex biological targeting advantage to overcome many of these challenges. These efforts enable programming the pharmacodynamics, pharmacokinetics, and delivery of immunomodulatory agents/co-delivery of compounds to prime at the tumor sites for improved therapeutic benefits. This review provides an overview of the design and clinical principles of biomaterials driven nanotechnology and their potential use in personalized nanomedicines, vaccines, localized tumor modulation, and delivery strategies for cancer immunotherapy. In this review, we also summarize the latest highlights and recent advances in combinatorial therapies availed in the treatment of cold and complicated tumors. It also presents key steps and parameters implemented for clinical success. Finally, we analyse, discuss, and provide clinical perspectives on the integrated opportunities of nanotechnology and immunology to achieve synergistic and durable responses in cancer treatment. |
|---|---|
| AbstractList | [Display omitted]
Novel strategies modulating the immune system yielded enhanced anticancer responses and improved cancer survival. Nevertheless, the success rate of immunotherapy in cancer treatment has been below expectation(s) due to unpredictable efficacy and off-target effects from systemic dosing of immunotherapeutic(s). As a result, there is an unmet clinical need for improving conventional immunotherapy. Nanotechnology offers several new strategies, multimodality, and multiplex biological targeting advantage to overcome many of these challenges. These efforts enable programming the pharmacodynamics, pharmacokinetics, and delivery of immunomodulatory agents/co-delivery of compounds to prime at the tumor sites for improved therapeutic benefits. This review provides an overview of the design and clinical principles of biomaterials driven nanotechnology and their potential use in personalized nanomedicines, vaccines, localized tumor modulation, and delivery strategies for cancer immunotherapy. In this review, we also summarize the latest highlights and recent advances in combinatorial therapies availed in the treatment of cold and complicated tumors. It also presents key steps and parameters implemented for clinical success. Finally, we analyse, discuss, and provide clinical perspectives on the integrated opportunities of nanotechnology and immunology to achieve synergistic and durable responses in cancer treatment. Novel strategies modulating the immune system yielded enhanced anticancer responses and improved cancer survival. Nevertheless, the success rate of immunotherapy in cancer treatment has been below expectation(s) due to unpredictable efficacy and off-target effects from systemic dosing of immunotherapeutic(s). As a result, there is an unmet clinical need for improving conventional immunotherapy. Nanotechnology offers several new strategies, multimodality, and multiplex biological targeting advantage to overcome many of these challenges. These efforts enable programming the pharmacodynamics, pharmacokinetics, and delivery of immunomodulatory agents/co-delivery of compounds to prime at the tumor sites for improved therapeutic benefits. This review provides an overview of the design and clinical principles of biomaterials driven nanotechnology and their potential use in personalized nanomedicines, vaccines, localized tumor modulation, and delivery strategies for cancer immunotherapy. In this review, we also summarize the latest highlights and recent advances in combinatorial therapies availed in the treatment of cold and complicated tumors. It also presents key steps and parameters implemented for clinical success. Finally, we analyse, discuss, and provide clinical perspectives on the integrated opportunities of nanotechnology and immunology to achieve synergistic and durable responses in cancer treatment. |
| Author | Jaggi, Meena Srivastava, Rohit Laskar, Partha Jain, Nishant K. Chauhan, Subhash C. Chauhan, Deepak S. Yallapu, Murali M. Prasad, Rajendra Dhasmana, Anupam |
| Author_xml | – sequence: 1 givenname: Deepak S. surname: Chauhan fullname: Chauhan, Deepak S. organization: Department of Immunology and Microbiology, School of Medicine, University of Texas Rio Grande Valley, McAllen, TX 78504, USA – sequence: 2 givenname: Anupam surname: Dhasmana fullname: Dhasmana, Anupam organization: Department of Immunology and Microbiology, School of Medicine, University of Texas Rio Grande Valley, McAllen, TX 78504, USA – sequence: 3 givenname: Partha surname: Laskar fullname: Laskar, Partha organization: Department of Immunology and Microbiology, School of Medicine, University of Texas Rio Grande Valley, McAllen, TX 78504, USA – sequence: 4 givenname: Rajendra surname: Prasad fullname: Prasad, Rajendra organization: Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Powai, Mumbai 400076, India – sequence: 5 givenname: Nishant K. surname: Jain fullname: Jain, Nishant K. organization: Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Powai, Mumbai 400076, India – sequence: 6 givenname: Rohit surname: Srivastava fullname: Srivastava, Rohit organization: Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Powai, Mumbai 400076, India – sequence: 7 givenname: Meena surname: Jaggi fullname: Jaggi, Meena organization: Department of Immunology and Microbiology, School of Medicine, University of Texas Rio Grande Valley, McAllen, TX 78504, USA – sequence: 8 givenname: Subhash C. surname: Chauhan fullname: Chauhan, Subhash C. organization: Department of Immunology and Microbiology, School of Medicine, University of Texas Rio Grande Valley, McAllen, TX 78504, USA – sequence: 9 givenname: Murali M. surname: Yallapu fullname: Yallapu, Murali M. email: murali.yallapu@utrgv.edu organization: Department of Immunology and Microbiology, School of Medicine, University of Texas Rio Grande Valley, McAllen, TX 78504, USA |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33774162$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kMtOwzAQRS0Eog_4ARYoP5AwY7uxK7FBFS-pgg2srcSeBkeNXTktUvl6UhVYsprFfWjumbDTEAMxdoVQIGB50xbUbuqCA8cCRAEIJ2yMWolcSImnbAxzMc9LiThik75vAUCqmT5nIyGUkljyMStfqhC3ZD9CXMdmn_X7QKnxX-Qy33W7ECk0PhAlH5psFVNmq2ApXbCzVbXu6fLnTtn7w_3b4ilfvj4-L-6WuZUA27ziTnC0yJ1WmssapZ65mgMRVGqmpHaccxg0J0iXNScUSmhXzbFUZT3nYsr4sdem2PeJVmaTfFelvUEwBwimNQcI5gDBgDADhCF0fQxtdnVH7i_yu3ow3B4NNLz-6SmZ3noadjmfyG6Ni_6__m9cMm6a |
| CitedBy_id | crossref_primary_10_3390_pharmaceutics14030611 crossref_primary_10_1007_s42452_024_05845_x crossref_primary_10_3390_pharmaceutics15051326 crossref_primary_10_1080_08982104_2023_2204372 crossref_primary_10_1039_D4NJ00077C crossref_primary_10_1016_j_ejpb_2022_09_006 crossref_primary_10_1016_j_jconrel_2023_12_007 crossref_primary_10_1002_SMMD_20230035 crossref_primary_10_3389_fimmu_2023_1237764 |
| Cites_doi | 10.1126/scitranslmed.aan3682 10.1177/1533033819831068 10.1038/nbt.3071 10.1021/acs.molpharmaceut.7b00015 10.1021/nl500618u 10.1038/nmat4822 10.1038/nri.2017.89 10.1021/acs.nanolett.7b03186 10.1038/nnano.2017.54 10.1038/nbt1332 10.1038/s41467-017-01830-8 10.1038/nmat1390 10.1371/journal.pone.0061825 10.1021/mp100067u 10.1038/s41598-017-04912-1 10.7150/ijbs.7.651 10.1038/nnano.2016.168 10.1038/ncomms8556 10.1126/scitranslmed.aal3604 10.3389/fphar.2017.00561 10.1038/s41467-017-02251-3 10.1038/s41467-017-01460-0 10.1073/pnas.1505405112 10.1016/j.cell.2015.03.030 10.1189/jlb.1106699 10.3727/096504014X13890370410285 10.1038/nnano.2011.149 10.1056/NEJMra1703481 10.1093/annonc/mdv623 10.1038/cmi.2015.84 10.1038/s41467-017-00965-y 10.1200/JCO.2016.66.9861 10.1186/s40425-017-0222-9 10.1002/eji.201243119 10.1182/blood-2017-07-741025 10.1126/sciadv.aao1736 10.1097/RLI.0b013e31827994e5 10.1016/j.canlet.2015.01.029 10.1016/j.biomaterials.2012.04.041 10.1182/blood-2017-06-741041 10.1016/j.cell.2009.10.014 10.1038/nri.2016.107 10.1039/c0pp00343c 10.1371/journal.pone.0156626 10.1126/science.aaa4971 10.1016/j.jconrel.2011.05.025 10.1016/j.biomaterials.2014.10.053 10.1016/j.critrevonc.2017.06.001 10.1038/nnano.2017.57 10.1038/ncomms13193 10.1016/j.nano.2014.01.011 10.1111/j.1365-2249.2009.03912.x 10.1007/s11095-010-0258-8 10.1155/2014/149185 10.1038/s12276-018-0191-1 10.1038/mt.2015.60 10.1172/JCI31537 10.1038/s41563-018-0028-2 10.1007/s10103-013-1270-0 10.1056/NEJMoa1709866 10.1038/nri1148 10.1021/acs.jpcc.5b11232 10.1158/1078-0432.CCR-17-1243 10.1016/j.biomaterials.2014.04.073 10.1002/ijc.31246 10.1016/j.molimm.2014.10.020 10.1038/sj.cdd.4402237 10.1016/j.biomaterials.2015.04.043 10.1002/adfm.201203859 10.1002/adfm.201707249 10.1200/JCO.2016.68.2005 10.1155/2019/4508794 10.1002/adfm.201501031 10.1016/j.biomaterials.2008.05.033 10.1002/mrm.1910300513 10.1126/scitranslmed.3006034 10.1056/NEJMp1711886 10.1097/01.rli.0000101027.57021.28 10.1021/acsnano.8b04338 10.1073/pnas.1606050113 10.1016/j.biomaterials.2017.09.014 10.1016/j.ccell.2015.03.015 10.1084/jem.20130579 10.1038/nri2567 10.1166/jbn.2016.2216 10.1016/j.biomaterials.2015.07.053 10.1038/nrd.2016.201 10.1038/ncomms12499 10.1016/j.biomaterials.2015.10.021 10.1038/nrc3239 10.1002/wnan.1449 10.1200/JCO.2005.01.128 10.1182/blood-2013-03-490565 10.1016/j.biomaterials.2013.10.009 10.1016/S0140-6736(18)32409-7 10.1038/nrc.2016.97 10.1021/jacs.5b04069 10.1371/journal.pone.0069073 10.1056/NEJMoa1707447 10.1038/nri3423 10.1016/j.coi.2015.10.009 10.1016/j.biomaterials.2014.10.050 10.1016/S0264-410X(03)00178-6 10.1158/1078-0432.CCR-10-2888 10.1016/j.ymthe.2004.02.011 10.1158/0008-5472.CAN-13-0777 10.1021/acsnano.5b01042 10.1200/JCO.2006.10.1386 10.3390/cancers3043856 10.1093/annonc/mdz394.075 10.1007/s00262-012-1206-8 10.1016/j.nantod.2009.07.001 10.1016/j.immuni.2014.10.019 10.1038/nri888 10.1007/s11095-010-0205-8 10.1021/ja304180y 10.1021/acsomega.8b00227 10.1038/nm.4051 10.1038/nri2506 10.1016/j.biomaterials.2014.05.076 10.1038/s41467-018-03915-4 10.1056/NEJMoa1801005 10.1158/1078-0432.CCR-15-0515 10.1016/j.ijrobp.2003.09.012 10.1016/j.biomaterials.2011.12.029 10.1016/j.addr.2017.05.011 10.1016/j.ccell.2018.02.010 10.1038/nri3843 10.1158/1078-0432.CCR-16-1272 10.1016/j.it.2010.04.002 10.1038/nature23003 10.1038/nrd.2017.243 10.1002/anie.201203193 10.1038/nmat3780 10.1038/nature12978 10.1002/adma.201704408 10.1021/nn900918w 10.1371/journal.pone.0004942 10.1002/adma.201802244 10.1016/j.ymthe.2017.10.020 10.1021/nl080141f 10.1038/nrc.2016.2 10.1161/CIRCULATIONAHA.109.891804 10.1126/scitranslmed.3003761 10.1021/acs.molpharmaceut.8b00564 10.1021/nn5002112 10.1002/adma.201506312 10.1016/j.coi.2013.12.005 10.7150/thno.19987 10.1016/j.cellimm.2010.03.001 10.1016/j.ijpharm.2013.01.045 10.1021/jp990183f 10.1016/j.aquaculture.2020.735829 10.1016/j.jconrel.2012.03.020 10.1021/acsnano.8b00967 10.1371/journal.pone.0011995 10.18632/oncotarget.22853 10.1056/NEJMoa1810865 10.1038/nmat3355 10.1093/annonc/mdr628 10.1016/j.jconrel.2014.07.040 10.1016/j.addr.2017.04.003 10.1016/j.micinf.2007.07.002 10.1007/s10544-007-9081-3 10.1016/j.jconrel.2011.06.021 10.1200/JCO.2014.59.4358 10.1039/C8BM01219A 10.1126/scitranslmed.aan0401 10.1039/c2ib20093g 10.1158/2326-6066.CIR-14-0186 10.1016/j.it.2011.01.004 10.1001/archotol.131.12.1079 10.1155/2015/794528 10.1021/acsnano.7b04736 10.4161/rna.22269 10.1038/nmeth.3929 10.1021/jacs.6b09538 10.1093/carcin/bgn056 10.1158/1078-0432.CCR-07-1881 10.1016/j.cell.2017.01.016 10.1038/nrd.2016.248 10.1158/1078-0432.CCR-17-2871 10.1021/nn500216y 10.7150/ntno.26389 10.1038/s41591-018-0201-9 10.1016/j.jconrel.2015.12.032 10.1146/annurev-bioeng-071910-124709 10.1038/s41551-019-0436-x 10.1002/adfm.201501283 10.1038/s41598-018-34898-3 10.1016/j.addr.2017.06.008 10.1002/ijc.24375 10.1038/nbt.3104 10.1016/S1521-6926(02)00084-1 10.1002/jgm.2605 10.1021/acsnano.7b00078 10.1021/acs.nanolett.5b05030 10.1021/mp060096p 10.1016/j.bj.2019.09.002 10.1016/j.biomaterials.2013.11.044 10.1016/j.jconrel.2013.05.037 10.1016/j.cllc.2017.02.001 10.1016/j.jconrel.2010.12.016 10.1002/ijc.20757 10.1016/j.cell.2017.01.017 10.1002/adma.201402996 10.2217/imt-2016-0141 10.1371/journal.pone.0128910 10.1056/NEJMoa1809615 10.1039/C4RA05209A 10.1146/annurev-immunol-031210-101324 10.1021/acs.nanolett.6b01994 10.1158/1078-0432.CCR-14-3145 10.1593/neo.05352 10.1038/s41598-017-09116-1 10.1038/s41422-018-0011-0 10.1186/1479-5876-3-9 10.1111/cei.12816 10.1016/j.vaccine.2008.04.069 10.1038/mt.2013.135 10.1038/nnano.2015.292 10.1002/ijc.27710 10.1038/nmat2357 10.1021/acsnano.7b09112 10.1126/science.342.6165.1432 10.7150/thno.19826 10.1002/adhm.201500089 10.1016/S0140-6736(15)01281-7 10.2217/nnm.14.115 10.1158/1078-0432.CCR-04-2140 10.1208/s12248-014-9676-6 10.1146/annurev-immunol-032712-100008 10.1200/JCO.2010.28.9793 10.1016/j.addr.2010.04.009 10.1080/14712598.2018.1518422 10.1038/nm.2198 10.1158/1078-0432.728.11.2 10.1038/s41551-018-0236-8 10.2741/e414 10.1038/nri3191 10.21037/atm.2019.05.58 10.4161/21645515.2014.980686 10.1016/j.omtm.2016.12.006 10.1097/CCM.0000000000002053 10.1038/sj.bjc.6604059 10.1038/nm.3105 10.1093/cvr/cvv154 10.1126/scitranslmed.aaf6843 10.1172/JCI67313 10.1016/j.addr.2016.03.002 10.1056/NEJMoa1708566 10.1038/s41573-018-0006-z 10.1038/nnano.2007.387 10.1021/acs.molpharmaceut.6b00982 10.1021/acs.langmuir.8b03460 10.1016/j.biomaterials.2012.03.041 10.1039/C8CS00473K 10.1073/pnas.1720948115 10.1148/radiol.2522081484 10.1038/s41467-018-03473-9 10.1142/S1793545816300019 10.1038/nature18300 10.1016/j.biopha.2020.109821 10.1039/C9NH00514E 10.1186/s11671-016-1468-8 10.1021/acsnano.7b00715 10.1016/j.biomaterials.2012.03.047 10.1038/nrc.2015.3 10.1038/nrc2734 10.1056/NEJMoa1001294 10.1093/annonc/mdx681 10.1016/j.ijrobp.2010.09.034 10.1039/C4CS00173G 10.1038/nm1096 10.1016/j.it.2017.05.006 10.1007/s11095-013-1021-8 10.1126/scitranslmed.aac5415 10.1364/BOE.1.000278 10.3402/nano.v1i0.5358 10.1021/acsnano.5b02014 10.1016/j.pharmthera.2019.107456 10.1021/acs.chemrev.6b00073 10.1016/j.molmed.2013.09.002 10.3389/fimmu.2017.00304 10.1021/acs.nanolett.7b03218 10.1007/s00330-008-0984-z 10.1038/nature22991 10.3389/fonc.2015.00015 10.1016/S0022-3476(05)80287-2 10.1186/1748-717X-9-180 10.1084/jem.20152021 |
| ContentType | Journal Article |
| Copyright | 2021 Elsevier B.V. Copyright © 2021 Elsevier B.V. All rights reserved. |
| Copyright_xml | – notice: 2021 Elsevier B.V. – notice: Copyright © 2021 Elsevier B.V. All rights reserved. |
| DBID | NPM AAYXX CITATION |
| DOI | 10.1016/j.ejpb.2021.03.010 |
| DatabaseName | PubMed CrossRef |
| DatabaseTitle | PubMed CrossRef |
| DatabaseTitleList | PubMed |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Pharmacy, Therapeutics, & Pharmacology |
| EISSN | 1873-3441 |
| EndPage | 101 |
| ExternalDocumentID | 10_1016_j_ejpb_2021_03_010 33774162 S0939641121000771 |
| Genre | Journal Article |
| GroupedDBID | --- --K --M .~1 0R~ 1B1 1RT 1~. 1~5 29G 4.4 457 4G. 53G 5GY 5VS 7-5 71M 8P~ AABNK AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AATCM AAXUO AAYOK ABFNM ABFRF ABGSF ABJNI ABMAC ABUDA ABXDB ABYKQ ABZDS ACDAQ ACGFO ACIUM ACRLP ADBBV ADEZE ADMUD ADUVX AEBSH AEFWE AEHWI AEKER AENEX AFKWA AFTJW AFXIZ AGHFR AGRDE AGUBO AGYEJ AIEXJ AIKHN AITUG AJBFU AJOXV ALCLG ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC C45 CS3 DOVZS DU5 EBS EFJIC EFLBG EJD EO8 EO9 EP2 EP3 FDB FEDTE FGOYB FIRID FNPLU FYGXN G-Q GBLVA HVGLF HZ~ IHE J1W KOM M41 MO0 N9A O-L O9- OAUVE OGGZJ OVD OZT P-8 P-9 P2P PC. Q38 R2- RIG ROL RPZ SDF SDG SES SEW SPCBC SSP SSU SSZ T5K TEORI UNMZH ~G- AKRWK NPM AAXKI AAYXX CITATION |
| ID | FETCH-LOGICAL-c400t-a2d321c12d87824b1485db20ee0a75748d2220878d3e86b2e13738da91676b923 |
| IEDL.DBID | .~1 |
| ISSN | 0939-6411 |
| IngestDate | Thu Sep 12 17:38:10 EDT 2024 Thu May 23 23:39:00 EDT 2024 Fri Feb 23 02:45:20 EST 2024 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | Nanoparticles Cancer treatment Immunotherapy Imaging Theranostic Adjuvants Tumor Vaccines Biomaterials |
| Language | English |
| License | Copyright © 2021 Elsevier B.V. All rights reserved. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c400t-a2d321c12d87824b1485db20ee0a75748d2220878d3e86b2e13738da91676b923 |
| OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170847 |
| PMID | 33774162 |
| PageCount | 30 |
| ParticipantIDs | crossref_primary_10_1016_j_ejpb_2021_03_010 pubmed_primary_33774162 elsevier_sciencedirect_doi_10_1016_j_ejpb_2021_03_010 |
| PublicationCentury | 2000 |
| PublicationDate | June 2021 2021-Jun 2021-06-00 |
| PublicationDateYYYYMMDD | 2021-06-01 |
| PublicationDate_xml | – month: 06 year: 2021 text: June 2021 |
| PublicationDecade | 2020 |
| PublicationPlace | Netherlands |
| PublicationPlace_xml | – name: Netherlands |
| PublicationTitle | European journal of pharmaceutics and biopharmaceutics |
| PublicationTitleAlternate | Eur J Pharm Biopharm |
| PublicationYear | 2021 |
| Publisher | Elsevier B.V |
| Publisher_xml | – name: Elsevier B.V |
| References | Galluzzi, Buqué, Kepp, Zitvogel, Kroemer (b0695) 2017; 17 Yin, Hu, Xu, Qiao, Qin, Song, Peng, Zhao, Zhang (b0780) 2018; 15 Tannock (b0005) 1998; 351 Bhargava, Bunkar, Khare, Mishra, Mishra (b0455) 2014; 9 Xie, Gong, Zhu, Yong, Gu, Zhao (b1080) 2019; 31 Reddy, van der Vlies, Simeoni, Angeli, Randolph, O'Neil, Lee, Swartz, Hubbell (b1460) 2007; 25 Pollard, De Koker, Saelens, Vanham, Grooten (b0515) 2013; 19 Li, Yang, Song, Zeng, He, Wang, Yu, Yin, Liu, Wei, Wu, Wei, Yang, Gong (b0930) 2018; 8 Kroemer, Galluzzi, Kepp, Zitvogel (b0700) 2013; 31 Li, Goedegebuure, Gillanders (b0345) 2017; 28 Deng, Liang, Xu, Yang, Burnette, Arina, Li, Mauceri, Beckett, Darga, Huang, Gajewski, Chen, Fu, Weichselbaum (b1040) 2014; 41 Ostberg, Dayanc, Yuan, Oflazoglu, Repasky (b0910) 2007; 82 Zhang, Zhang, Shi, Song, Shi, Zhang, Huang, Wang, Wang, Wang, Kong, Li (b1205) 2017; 14 Abadeer, Murphy (b0825) 2016; 120 Tang, Weng, Jia, Luo, Xu, Li, Zhang (b0555) 2019; 7 Chauhan, Bukhari, Ravichandran, Gupta, George, Poojari, Ingle, Rengan, Shanavas, Srivastava, De (b1465) 2018; 8 Fang, Hu, Luk, Gao, Copp, Tai, O'Connor, Zhang (b1515) 2014; 14 Peggs, Quezada, Allison (b0255) 2009; 157 Liu, Maccarini, Palmer, Etienne, Zhao, Lee, Ma, Inman, Vo-Dinh (b0820) 2017; 7 Sigovan, Boussel, Sulaiman, Sappey-Marinier, Alsaid, Desbleds-Mansard, Ibarrola, Gamondès, Corot, Lancelot, Raynaud, Vives, Laclédère, Violas, Douek, Canet-Soulas (b1325) 2009; 252 Pardi, Hogan, Porter, Weissman (b0320) 2018; 17 Buchan, Rogel, Al-Shamkhani (b0265) 2018; 131 Tan, Li, Zhu (b0020) 2020; 124 Fesnak, June, Levine (b0180) 2016; 16 Study of Nivolumab in Combination With Ipilimumab or Standard of Care Chemotherapy Compared to the Standard of Care Chemotherapy Alone in Treatment of Participants With Untreated Inoperable or Metastatic Urothelial Cancer (CheckMate901). Patel, Czapar, Fiering, Oleinick, Steinmetz (b1060) 2018; 3 Frigault, Lee, Basil, Carpenito, Motohashi, Scholler, Kawalekar, Guedan, McGettigan, Posey, Ang, Cooper, Platt, Johnson, Paulos, Zhao, Kalos, Milone, June (b0210) 2015; 3 Du, Tang, Liu, Su, Zhang, Wu, Devenport, Lazarski, Zhang, Wang, Ye, Wang, Hwang, Zhu, Xu, Zheng, Liu (b0130) 2018; 28 Kleinovink, van Driel, Snoeks, Prokopi, Fransen, Cruz, Mezzanotte, Chan, Löwik, Ossendorp (b0435) 2016; 22 Cameron, Gerry, Dukes, Harper, Kannan, Bianchi, Grand, Brewer, Gupta, Plesa, Bossi, Vuidepot, Powlesland, Legg, Adams, Bennett, Pumphrey, Williams, Binder-Scholl, Kulikovskaya, Levine, Riley, Varela-Rohena, Stadtmauer, Rapoport, Linette, June, Hassan, Kalos, Jakobsen (b0240) 2013; 5 Basto, Badenes, Almeida, Martins, Duarte, Santos, Leitão (b0470) 2015; 64 Huang, Chang (b0035) 2019; 42 Zhao, Huo, Xu, Wang, Huang (b0680) 2015; 68 Beauvillain, Ruiz, Guiton, Bout, Dimier-Poisson (b1555) 2007; 9 Sun, Barz, De Geest, Diken, Hennink, Kiessling, Lammers, Shi (b0525) 2019; 48 SoRelle, Yecies, Liba, Bennett, Graef, Dutta, Mitra, Joubert, Cheshier, Grant, de la Zerda (b1410) 2017 Kantoff, Higano, Shore, Berger, Small, Penson, Redfern, Ferrari, Dreicer, Sims, Xu, Frohlich, Schellhammer (b0310) 2010; 363 Wang, Wang, Yu, Feng, Zhou, Zhang, Zhou, Jiao, Li (b0895) 2018; 9 Darvin, Toor, Sasidharan Nair, Elkord (b0120) 2018; 50 Scheetz, Park, Li, Lowenstein, Castro, Schwendeman, Moon (b0405) 2019; 3 Teo, Yang, Whilding, Parente-Pereira, Maher, George, Hedrick, Yang, Ghaem-Maghami (b0605) 2015; 4 Kranz, Diken, Haas, Kreiter, Loquai, Reuter, Meng, Fritz, Vascotto, Hefesha, Grunwitz, Vormehr, Hüsemann, Selmi, Kuhn, Buck, Derhovanessian, Rae, Attig, Diekmann, Jabulowsky, Heesch, Hassel, Langguth, Grabbe, Huber, Türeci, Sahin (b0520) 2016; 534 Couzin-Frankel (b0565) 2013; 342 Simpson, Li, Montalvo-Ortiz, Sepulveda, Bergerhoff, Arce, Roddie, Henry, Yagita, Wolchok, Peggs, Ravetch, Allison, Quezada (b0135) 2013; 210 Fransen, Sluijter, Morreau, Arens, Melief (b1180) 2011; 17 Ghassemi, van Steenbergen, Talsma, van Nostrum, Crommelin, Hennink (b0590) 2010; 27 Porter, Hwang, Frey, Lacey, Shaw, Loren, Bagg, Marcucci, Shen, Gonzalez, Ambrose, Grupp, Chew, Zheng, Milone, Levine, Melenhorst, June (b0190) 2015; 7 Zhang, Li, Suh, Irvine (b0295) 2018; 9 Gu, Mooney (b1200) 2016; 16 Busato, Bonafede, Bontempi, Scambi, Schiaffino, Benati, Malatesta, Sbarbati, Marzola, Mariotti (b1360) 2016; 11 Study of Atezolizumab as Monotherapy and in Combination With Platinum-Based Chemotherapy in Participants With Untreated Locally Advanced or Metastatic Urothelial Carcinoma (IMvigor130). Rodell, Arlauckas, Cuccarese, Garris, Li, Ahmed, Kohler, Pittet, Weissleder (b0655) 2018; 2 Pollock, Krischer, Vietti (b0010) 1991; 119 Sambi, Bagheri, Szewczuk (b0390) 2019; 2019 Tang, van Panhuys, Kastenmüller, Germain (b1415) 2013; 43 André, Chaput, Schartz, Flament, Aubert, Bernard, Lemonnier, Raposo, Escudier, Hsu, Tursz, Amigorena, Angevin, Zitvogel (b1560) 1950; 172 Kim, Erpelding, Jankovic, Pashley, Wang (b1435) 2010; 1 Tolcher, Sznol, Hu-Lieskovan, Papadopoulos, Patnaik, Rasco, Di Gravio, Huang, Gambhire, Chen, Thall, Pathan, Schmidt, Chow (b0285) 2017; 23 Link, Mohamed, El-Sayed (b0865) 1999; 103 Wu, Duan, Kong, Tu, Wang, Guo, Ye (b0070) 2021; 531 Guo, Yan, Yang, Li, Wang, Zalewski, Yan, Lu (b0815) 2014; 8 El-Dakdouki, El-Boubbou, Kamat, Huang, Abela, Kiupel, Zhu, Huang (b1335) 2014; 31 Zhou, Wu, Song, Chen, Resasco, Xing (b0935) 2012; 33 Bhatnagar, Li, Choi, Guo, Li, Lee, Figliola, Huls, Lee, Zal, Li, Cooper (b1430) 2013; 5 Garg, Coulie, Van den Eynde, Agostinis (b0305) 2017; 38 R.S. Herbst, P. Baas, D.W. Kim, E. Felip, J.L. Pérez-Gracia, J.Y. Han, J. Molina, J.H. Kim, C.D. Arvis, M.J. Ahn, M. Majem, M.J. Fidler, G. de Castro, Jr., M. Garrido, G.M. Lubiniecki, Y. Shentu, E. Im, M. Dolled-Filhart, E.B. Garon, Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial, Lancet 387 (2016) 1540–1550. Shim, Kim, Kim, Park, Oh (b1160) 2017; 115 Bhatt, Daemen (b0315) 2020; 8 Eigl, Eggener, Baybik, Ettinger, Chi, Nelson, Wang, Gleave (b1155) 2005; 11 Deng, Liang, Burnette, Beckett, Darga, Weichselbaum, Fu (b1070) 2014; 124 McNamara, Nair, Holl (b0330) 2015; 2015 Demento, Cui, Criscione, Stern, Tulipan, Kaech, Fahmy (b0495) 2012; 33 Rosenbaum (b0530) 2017; 377 Fodor (b1170) 2006; 147 Zheng, Koropatnick, Chen, Velenosi, Ling, Zhang, Jiang, Navarro, Ichim, Urquhart, Min (b1095) 2013; 132 Cox, Harrington, Zajac (b0065) 2011; 32 Gorbet, Ranjan (b0490) 2020; 207 Chantarasrivong, Ueki, Ohyama, Unga, Nakamura, Nakanishi, Higuchi, Kawakami, Ando, Imamura, Ishida, Yamashita, Kiso, Hashida (b1355) 2017; 14 Munn, Bronte (b0115) 2016; 39 Innovent Receives an Approval from the US FDA to Initiate Clinical Trials for its Anti-OX40 Monoclonal Antibody IBI101. Arlauckas, Garris, Kohler, Kitaoka, Cuccarese, Yang, Miller, Carlson, Freeman, Anthony, Weissleder, Pittet (b0630) 2017; 9 Restifo, Smyth, Snyder (b0170) 2016; 16 Song, Yin, Shang, Wu, Zhang, Kong, Zhao, He, Tan, Guo, Zhang (b0775) 2017; 17 Schlake, Thess, Fotin-Mleczek, Kallen (b0335) 2012; 9 Weber, Beard, Bohndiek (b1440) 2016; 13 Stephan, Taber, Jileaeva, Pegues, Sentman, Stephan (b1215) 2015; 33 Ghaznavi, Hosseini-Nami, Kamrava, Irajirad, Maleki, Shakeri-Zadeh, Montazerabadi (b0855) 2018; 46 Landskron, De la Fuente, Thuwajit, Thuwajit, Hermoso (b0365) 2014; 2014 Lauss, Donia, Harbst, Andersen, Mitra, Rosengren, Salim, Vallon-Christersson, Törngren, Kvist, Ringnér, Svane, Jönsson (b0350) 2017; 8 Zhou, Li, Naylor, Hode, Nordquist, Alleruzzo, Raker, Lam, Du, Shi, Wang, Chen (b0810) 2015; 359 Croft (b0275) 2003; 3 Shen, Li, Liu, Song, Zhang, Tiruthani, Hu, Das, Goodwin, Liu, Huang (b1125) 2018; 12 Xian, Yang, Lin, Liu (b1130) 2005; 131 Ruella, Xu, Barrett, Fraietta, Reich, Ambrose, Klichinsky, Shestova, Patel, Kulikovskaya, Nazimuddin, Bhoj, Orlando, Fry, Bitter, Maude, Levine, Nobles, Bushman, Young, Scholler, Gill, June, Grupp, Lacey, Melenhorst (b0540) 2018; 24 Smith, Heverhagen, Knopp, Schmalbrock, Shapiro, Shiomi, Moldovan, Ferrari, Lee (b1340) 2007; 9 Chen, Singhal, Liu, Nordquist (b0805) 2001; 61 Gupta, Probst, Vuong, Landshammer, Muth, Yagita, Schwendener, Pruschy, Knuth, van den Broek (b1035) 1950; 189 Monette, Ceccaldi, Assaad, Lerouge, Lapointe (b1275) 2016; 75 Temchura, Tenbusch, Nchinda, Nabi, Tippler, Zelenyuk, Wildner, Uberla, Kuate (b1550) 2008; 26 Chapuis, Lee, Thompson, Roberts, Margolin, Bhatia, Sloan, Lai, Wagener, Shibuya, Cao, Wolchok, Greenberg, Yee (b0095) 2016; 213 Hasan, Selvakumar, Shabrova, Liu, Afridi, Heller, Riviere, Sadelain, Dupont, O'Reilly (b0090) 2016; 186 Kuai, Ochyl, Bahjat, Schwendeman, Moon (b1520) 2017; 16 Kircher, Allport, Graves, Love, Josephson, Lichtman, Weissleder (b1320) 2003; 63 Nakatsuji, Kawabata Galbraith, Kurisu, Imahori, Murakami, Kengaku (b0840) 2017; 7 Lim, June (b0175) 2017; 168 Ali, Verbeke, Johnson, Sands, Lewin, White, Doherty, Dranoff, Mooney (b1225) 2014; 74 Restifo, Dudley, Rosenberg (b0690) 2012; 12 Gabrilovich, Nagaraj (b0370) 2009; 9 Liao, Li, Bonini, Nair, Gilboa, Greenberg, Yee (b0510) 2004; 9 Sutton, Henning, Pichler, Bremer, Daldrup-Link (b1375) 2008; 18 Wang, Sun, Wright, Wang, Gu (b0600) 2016; 28 Yu, Zhang, Ye, DiSanto, Sun, Ranson, Ligler, Buse, Gu (b1285) 2015; 112 Guo, Wang, Song, Wu, Zhuang, Bao, Kong, Qi, Tan, Zhang (b1510) 2015; 9 Crielaard, Lammers, Rivella (b0640) 2017; 16 He, Duan, Guo, Chan, Poon, Weichselbaum, Lin (b0995) 2016; 7 Kachikwu, Iwamoto, Liao, DeMarco, Agazaryan, Economou, McBride, Schaue (b1050) 2011; 81 Peters, Ramalingam, Paz-Ares, Bernabe Caro, Zurawski, Kim, Alexandru, Lupinacci, de la Mora Jimenez, Sakai, Albert, Vergnenegre, Reck, Borghaei, Brahmer, O’Byrne, Geese, Bhagavatheeswaran, Nathan, Hellmann (b0420) 2019; 30 Hailemichael, Dai, Jaffarzad, Ye, Medina, Huang, Dorta-Estremera, Greeley, Nitti, Peng, Liu, Lou, Wang, Ma, Rabinovich, Sowell, Schluns, Davis, Hwu, Overwijk (b0505) 2013; 19 Yang, Zhang, Xia, Zhang, Qian, Zhi, Yue, Sun, Cheng, Fang, Jin, Yang, Cui (b1445) 2016; 11 Nathan, Cunningham-Bussel (b1270) 2013; 13 Wang, Ye, Hochu, Sadeghifar, Gu (b1280) 2016; 16 Cubillos-Ruiz, Engle, Scarlett, Martinez, Barber, Elgue Tang (10.1016/j.ejpb.2021.03.010_b1415) 2013; 43 Sieniawski (10.1016/j.ejpb.2021.03.010_b0015) 2007; 25 Xia (10.1016/j.ejpb.2021.03.010_b1255) 2009; 3 Wu (10.1016/j.ejpb.2021.03.010_b0070) 2021; 531 Fang (10.1016/j.ejpb.2021.03.010_b1515) 2014; 14 Zhang (10.1016/j.ejpb.2021.03.010_b0295) 2018; 9 Lee (10.1016/j.ejpb.2021.03.010_b0735) 2011; 155 Gorbet (10.1016/j.ejpb.2021.03.010_b0490) 2020; 207 Levine (10.1016/j.ejpb.2021.03.010_b0220) 2017; 4 Dai (10.1016/j.ejpb.2021.03.010_b1005) 2018; 28 Seyednejad (10.1016/j.ejpb.2021.03.010_b0585) 2011; 152 Xue (10.1016/j.ejpb.2021.03.010_b0970) 2017; 12 Fesnak (10.1016/j.ejpb.2021.03.010_b0180) 2016; 16 Korbelik (10.1016/j.ejpb.2021.03.010_b0960) 2007; 97 Müller (10.1016/j.ejpb.2021.03.010_b0060) 2017; 8 Hasan (10.1016/j.ejpb.2021.03.010_b0090) 2016; 186 Hossain (10.1016/j.ejpb.2021.03.010_b1110) 2015; 21 Sharma (10.1016/j.ejpb.2021.03.010_b0030) 2015; 161 Arce Vargas (10.1016/j.ejpb.2021.03.010_b0125) 2018; 33 Sambi (10.1016/j.ejpb.2021.03.010_b0390) 2019; 2019 He (10.1016/j.ejpb.2021.03.010_b0995) 2016; 7 Ristorcelli (10.1016/j.ejpb.2021.03.010_b1545) 2009; 125 Peggs (10.1016/j.ejpb.2021.03.010_b0255) 2009; 157 Selt (10.1016/j.ejpb.2021.03.010_b1300) 2016; 11 Garg (10.1016/j.ejpb.2021.03.010_b0305) 2017; 38 Scholler (10.1016/j.ejpb.2021.03.010_b0185) 2012; 4 Nishikawa (10.1016/j.ejpb.2021.03.010_b0900) 2014; 27 Evans (10.1016/j.ejpb.2021.03.010_b0925) 2015; 15 Fitzgerald (10.1016/j.ejpb.2021.03.010_b0215) 2017; 45 Liu (10.1016/j.ejpb.2021.03.010_b0820) 2017; 7 Chapuis (10.1016/j.ejpb.2021.03.010_b0095) 2016; 213 Barenholz (10.1016/j.ejpb.2021.03.010_b0415) 2012; 160 Segal (10.1016/j.ejpb.2021.03.010_b0290) 2017; 23 Park (10.1016/j.ejpb.2021.03.010_b0615) 2012; 11 McNamara (10.1016/j.ejpb.2021.03.010_b0330) 2015; 2015 10.1016/j.ejpb.2021.03.010_b0445 Shahid (10.1016/j.ejpb.2021.03.010_b0040) 2019; 7 Cubillos-Ruiz (10.1016/j.ejpb.2021.03.010_b1475) 2009; 119 Beauvillain (10.1016/j.ejpb.2021.03.010_b1555) 2007; 9 Iliopoulos (10.1016/j.ejpb.2021.03.010_b0385) 2009; 139 Shim (10.1016/j.ejpb.2021.03.010_b1160) 2017; 115 Galluzzi (10.1016/j.ejpb.2021.03.010_b0695) 2017; 17 Zheng (10.1016/j.ejpb.2021.03.010_b0945) 2013; 28 Xian (10.1016/j.ejpb.2021.03.010_b1130) 2005; 131 Smith (10.1016/j.ejpb.2021.03.010_b1385) 2017; 117 Lu (10.1016/j.ejpb.2021.03.010_b1030) 2015; 137 Morse (10.1016/j.ejpb.2021.03.010_b1575) 2005; 3 Ellis (10.1016/j.ejpb.2021.03.010_b0140) 2017; 18 Brody (10.1016/j.ejpb.2021.03.010_b1075) 2010; 28 Singh (10.1016/j.ejpb.2021.03.010_b1370) 2010; 1 Croft (10.1016/j.ejpb.2021.03.010_b0275) 2003; 3 Wang (10.1016/j.ejpb.2021.03.010_b0895) 2018; 9 Yeung (10.1016/j.ejpb.2021.03.010_b0940) 2017; 14 Hailemichael (10.1016/j.ejpb.2021.03.010_b0505) 2013; 19 Paz-Ares (10.1016/j.ejpb.2021.03.010_b0425) 2018; 379 Nam (10.1016/j.ejpb.2021.03.010_b0830) 2018; 9 Kuai (10.1016/j.ejpb.2021.03.010_b1520) 2017; 16 Gandhi (10.1016/j.ejpb.2021.03.010_b0430) 2018; 378 Postow (10.1016/j.ejpb.2021.03.010_b0150) 2018; 378 Sato (10.1016/j.ejpb.2021.03.010_b0620) 2016; 8 Wang (10.1016/j.ejpb.2021.03.010_b0600) 2016; 28 Chauhan (10.1016/j.ejpb.2021.03.010_b0850) 2019; 35 Jang (10.1016/j.ejpb.2021.03.010_b1315) 2012; 33 Riley (10.1016/j.ejpb.2021.03.010_b0570) 2019; 18 Mok (10.1016/j.ejpb.2021.03.010_b0450) 2019; 393 Scheetz (10.1016/j.ejpb.2021.03.010_b0405) 2019; 3 Fotin-Mleczek (10.1016/j.ejpb.2021.03.010_b1145) 2014; 9 Korbelik (10.1016/j.ejpb.2021.03.010_b0975) 2011; 10 Graham (10.1016/j.ejpb.2021.03.010_b1185) 2010; 5 Ali (10.1016/j.ejpb.2021.03.010_b1220) 2013; 23 Busato (10.1016/j.ejpb.2021.03.010_b1360) 2016; 11 Byun (10.1016/j.ejpb.2021.03.010_b0160) 2017; 13 Eigl (10.1016/j.ejpb.2021.03.010_b1155) 2005; 11 Yan (10.1016/j.ejpb.2021.03.010_b0075) 2017; 9 Postow (10.1016/j.ejpb.2021.03.010_b0100) 2015; 33 Guo (10.1016/j.ejpb.2021.03.010_b1510) 2015; 9 El-Dakdouki (10.1016/j.ejpb.2021.03.010_b1335) 2014; 31 Gupta (10.1016/j.ejpb.2021.03.010_b1035) 1950; 189 Rahimian (10.1016/j.ejpb.2021.03.010_b0595) 2015; 61 Bhatt (10.1016/j.ejpb.2021.03.010_b0315) 2020; 8 Kuai (10.1016/j.ejpb.2021.03.010_b0705) 2018; 4 Zamarron (10.1016/j.ejpb.2021.03.010_b0360) 2011; 7 Wang (10.1016/j.ejpb.2021.03.010_b1265) 2018; 10 Monette (10.1016/j.ejpb.2021.03.010_b1275) 2016; 75 Cho (10.1016/j.ejpb.2021.03.010_b1540) 2005; 114 Temchura (10.1016/j.ejpb.2021.03.010_b1550) 2008; 26 Huang (10.1016/j.ejpb.2021.03.010_b0035) 2019; 42 Fan (10.1016/j.ejpb.2021.03.010_b0765) 2017; 17 Li (10.1016/j.ejpb.2021.03.010_b1345) 2018; 2 Maude (10.1016/j.ejpb.2021.03.010_b0205) 2018; 378 Song (10.1016/j.ejpb.2021.03.010_b0775) 2017; 17 Moy (10.1016/j.ejpb.2021.03.010_b0915) 2017; 114 Fotin-Mleczek (10.1016/j.ejpb.2021.03.010_b1140) 2012; 14 Wang (10.1016/j.ejpb.2021.03.010_b0440) 2014; 26 Schmid (10.1016/j.ejpb.2021.03.010_b0560) 2017; 8 Couzin-Frankel (10.1016/j.ejpb.2021.03.010_b0565) 2013; 342 Fox (10.1016/j.ejpb.2021.03.010_b0880) 1957; 32 Darvin (10.1016/j.ejpb.2021.03.010_b0120) 2018; 50 Ali (10.1016/j.ejpb.2021.03.010_b1225) 2014; 74 Mullard (10.1016/j.ejpb.2021.03.010_b0300) 2016; 15 Landskron (10.1016/j.ejpb.2021.03.010_b0365) 2014; 2014 Machiels (10.1016/j.ejpb.2021.03.010_b0745) 2001; 61 Alshamsan (10.1016/j.ejpb.2021.03.010_b1105) 2010; 7 Toraya-Brown (10.1016/j.ejpb.2021.03.010_b0800) 2014; 10 Yata (10.1016/j.ejpb.2021.03.010_b0835) 2017; 146 Bencherif (10.1016/j.ejpb.2021.03.010_b1245) 2015; 6 Li (10.1016/j.ejpb.2021.03.010_b0345) 2017; 28 Yang (10.1016/j.ejpb.2021.03.010_b1445) 2016; 11 Weiden (10.1016/j.ejpb.2021.03.010_b1210) 2018; 18 Sigovan (10.1016/j.ejpb.2021.03.010_b1325) 2009; 252 Linette (10.1016/j.ejpb.2021.03.010_b0250) 2013; 122 Vesely (10.1016/j.ejpb.2021.03.010_b0025) 2011; 29 Lizotte (10.1016/j.ejpb.2021.03.010_b0660) 2016; 11 Chantarasrivong (10.1016/j.ejpb.2021.03.010_b1355) 2017; 14 Gros (10.1016/j.ejpb.2021.03.010_b1485) 2016; 22 Viaud (10.1016/j.ejpb.2021.03.010_b1570) 2009; 4 Ghaznavi (10.1016/j.ejpb.2021.03.010_b0855) 2018; 46 Burley (10.1016/j.ejpb.2021.03.010_b0950) 2018; 142 Zhao (10.1016/j.ejpb.2021.03.010_b0680) 2015; 68 Tang (10.1016/j.ejpb.2021.03.010_b0555) 2019; 7 Wang (10.1016/j.ejpb.2021.03.010_b1000) 2016; 16 van den Berg (10.1016/j.ejpb.2021.03.010_b0225) 2015; 23 Zheng (10.1016/j.ejpb.2021.03.010_b0550) 2013; 172 Chen (10.1016/j.ejpb.2021.03.010_b0805) 2001; 61 Heo (10.1016/j.ejpb.2021.03.010_b0410) 2014; 35 Conde (10.1016/j.ejpb.2021.03.010_b1120) 2015; 25 Park (10.1016/j.ejpb.2021.03.010_b1400) 2015; 44 Ngiow (10.1016/j.ejpb.2021.03.010_b1055) 2015; 27 Shen (10.1016/j.ejpb.2021.03.010_b1125) 2018; 12 Funovics (10.1016/j.ejpb.2021.03.010_b1450) 2005; 7 Seth (10.1016/j.ejpb.2021.03.010_b0750) 2014; 35 Weber (10.1016/j.ejpb.2021.03.010_b1440) 2016; 13 Ahmed (10.1016/j.ejpb.2021.03.010_b0080) 2003; 16 Yang (10.1016/j.ejpb.2021.03.010_b0580) 2017; 8 Draper (10.1016/j.ejpb.2021.03.010_b1525) 2013; 8 Link (10.1016/j.ejpb.2021.03.010_b0865) 1999; 103 Kachikwu (10.1016/j.ejpb.2021.03.010_b1050) 2011; 81 Lee (10.1016/j.ejpb.2021.03.010_b0845) 2012; 51 Sutton (10.1016/j.ejpb.2021.03.010_b1375) 2008; 18 Hori (10.1016/j.ejpb.2021.03.010_b1235) 2008; 29 Voura (10.1016/j.ejpb.2021.03.010_b1395) 2004; 10 Basto (10.1016/j.ejpb.2021.03.010_b0470) 2015; 64 Choi (10.1016/j.ejpb.2021.03.010_b0645) 2008; 29 Sehouli (10.1016/j.ejpb.2021.03.010_b1165) 2012; 23 Yu (10.1016/j.ejpb.2021.03.010_b1285) 2015; 112 Kim (10.1016/j.ejpb.2021.03.010_b1435) 2010; 1 Yang (10.1016/j.ejpb.2021.03.010_b0325) 2014; 10 Tan (10.1016/j.ejpb.2021.03.010_b0020) 2020; 124 Chester (10.1016/j.ejpb.2021.03.010_b0270) 2018; 131 Wu (10.1016/j.ejpb.2021.03.010_b1305) 2015; 25 Lauss (10.1016/j.ejpb.2021.03.010_b0350) 2017; 8 Schuster (10.1016/j.ejpb.2021.03.010_b0195) 2017; 377 Kim (10.1016/j.ejpb.2021.03.010_b1195) 2015; 33 Fang (10.1016/j.ejpb.2021.03.010_b1455) 2011; 63 Teo (10.1016/j.ejpb.2021.03.010_b0605) 2015; 4 Demento (10.1016/j.ejpb.2021.03.010_b0495) 2012; 33 Roy (10.1016/j.ejpb.2021.03.010_b0755) 2013; 445 Yu (10.1016/j.ejpb.2021.03.010_b0980) 2017; 11 Lim (10.1016/j.ejpb.2021.03.010_b0175) 2017; 168 Xu (10.1016/j.ejpb.2021.03.010_b1015) 2017; 11 Wang (10.1016/j.ejpb.2021.03.010_b1365) 2020; 5 Smith (10.1016/j.ejpb.2021.03.010_b1380) 2008; 8 Peer (10.1016/j.ejpb.2021.03.010_b0730) 2007; 2 Kong (10.1016/j.ejpb.2021.03.010_b0785) 2017; 7 Kim (10.1016/j.ejpb.2021.03.010_b1425) 2018; 12 Restifo (10.1016/j.ejpb.2021.03.010_b0690) 2012; 12 Reddy (10.1016/j.ejpb.2021.03.010_b1460) 2007; 25 Tam (10.1016/j.ejpb.2021.03.010_b0500) 2016; 113 Oh (10.1016/j.ejpb.2021.03.010_b1260) 2003; 21 Yin (10.1016/j.ejpb.2021.03.010_b0780) 2018; 15 Champiat (10.1016/j.ejpb.2021.03.010_b0395) 2016; 27 Peranzoni (10.1016/j.ejpb.2021.03.010_b0625) 2018; 115 Mottram (10.1016/j.ejpb.2021.03.010_b1470) 2007; 4 Liu (10.1016/j.ejpb.2021.03.010_b1150) 2018; 26 Kranz (10.1016/j.ejpb.2021.03.010_b0520) 2016; 534 Gollnick (10.1016/j.ejpb.2021.03.010_b0965) 2002; 62 Sheu (10.1016/j.ejpb.2021.03.010_b1310) 2013; 48 Deng (10.1016/j.ejpb.2021.03.010_b1040) 2014; 41 Zhou (10.1016/j.ejpb.2021.03.010_b0810) 2015; 359 Cho (10.1016/j.ejpb.2021.03.010_b0465) 2011; 6 Zheng (10.1016/j.ejpb.2021.03.010_b0670) 2017; 11 Korbelik (10.1016/j.ejpb.2021.03.010_b0985) 2015; 5 Deng (10.1016/j.ejpb.2021.03.010_b1070) 2014; 124 Du (10.1016/j.ejpb.2021.03.010_b0130) 2018; 28 Wang (10.1016/j.ejpb.2021.03.010_b1405) 2012; 33 Sahin (10.1016/j.ejpb.2021.03.010_b1490) 2017; 547 Fodor (10.1016/j.ejpb.2021.03.010_b1170) 2006; 147 Raynal (10.1016/j.ejpb.2021.03.010_b1295) 2004; 39 Tannock (10.1016/j.ejpb.2021.03.010_b0005) 1998; 351 Xie (10.1016/j.ejpb.2021.03.010_b1080) 2019; 31 Yuan (10.1016/j.ejpb.2021.03.010_b0870) 2012; 134 Pollard (10.1016/j.ejpb.2021.03.010_b0515) 2013; 19 Rosenbaum (10.1016/j.ejpb.2021.03.010_b0530) 2017; 377 Nakatsuji (10.1016/j.ejpb.2021.03.010_b0840) 2017; 7 Maleki Vareki (10.1016/j.ejpb.2021.03.010_b0165) 2017; 116 Stephan (10.1016/j.ejpb.2021.03.010_b0545) 2010; 16 Iero (10.1016/j.ejpb.2021.03.010_b1535) 2008; 15 SoRelle (10.1016/j.ejpb.2021.03.010_b1410) 2017 Luo (10.1016/j.ejpb.2021.03.010_b1100) 2015; 38 Koshy (10.1016/j.ejpb.2021.03.010_b1240) 2014; 35 Migliorini (10.1016/j.ejpb.2021.03.010_b0230) 2018; 24 Sharma (10.1016/j.ejpb.2021.03.010_b068 |
| References_xml | – volume: 18 start-page: 1073 year: 2018 end-page: 1083 ident: b0260 article-title: Understanding how combinatorial targeting of TLRs and TNFR family costimulatory members promote enhanced T cell responses publication-title: Expert. Opin. Biol. Th. contributor: fullname: Vella – volume: 157 start-page: 9 year: 2009 end-page: 19 ident: b0255 article-title: Cancer immunotherapy: co-stimulatory agonists and co-inhibitory antagonists publication-title: Clin. Exp. Immunol. contributor: fullname: Allison – volume: 9 start-page: 719 year: 2007 end-page: 727 ident: b1340 article-title: Localization to atherosclerotic plaque and biodistribution of biochemically derivatized superparamagnetic iron oxide nanoparticles (SPIONs) contrast particles for magnetic resonance imaging (MRI) publication-title: Biomed. Microdevices contributor: fullname: Lee – volume: 8 start-page: e61825 year: 2013 ident: b1525 article-title: A randomized, observer-blinded immunogenicity trial of Cervarix(®) and Gardasil(®) Human Papillomavirus vaccines in 12–15 year old girls publication-title: PLoS One contributor: fullname: Beddows – volume: 120 start-page: 4691 year: 2016 end-page: 4716 ident: b0825 article-title: Recent Progress in Cancer Thermal Therapy Using Gold Nanoparticles publication-title: J. Phys. Chem. C contributor: fullname: Murphy – volume: 51 start-page: 8800 year: 2012 end-page: 8805 ident: b0845 article-title: Imageable antigen-presenting gold nanoparticle vaccines for effective cancer immunotherapy in vivo publication-title: Angew. Chem. (Int. ed. in English) contributor: fullname: Jon – volume: 8 start-page: 860 year: 2018 end-page: 873 ident: b0930 article-title: An Endogenous Vaccine Based on Fluorophores and Multivalent Immunoadjuvants Regulates Tumor Micro-Environment for Synergistic Photothermal and Immunotherapy publication-title: Theranostics contributor: fullname: Gong – volume: 142 start-page: 2363 year: 2018 end-page: 2374 ident: b0950 article-title: Near-infrared photoimmunotherapy targeting EGFR-Shedding new light on glioblastoma treatment publication-title: Int. J. Cancer contributor: fullname: Kramer-Marek – volume: 8 start-page: 1324 year: 2017 ident: b1480 article-title: Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors publication-title: Nat. Commun. contributor: fullname: Meyerson – volume: 13 start-page: 195 year: 2017 end-page: 207 ident: b0160 article-title: Cancer immunotherapy - immune checkpoint blockade and associated endocrinopathies, Nature reviews publication-title: Endocrinology contributor: fullname: Girotra – volume: 117 start-page: 1175 year: 2007 end-page: 1183 ident: b0380 article-title: A cytokine-mediated link between innate immunity, inflammation, and cancer publication-title: J. Clin. Invest. contributor: fullname: Karin – volume: 8 start-page: 352ra110 year: 2016 ident: b0620 article-title: Spatially selective depletion of tumor-associated regulatory T cells with near-infrared photoimmunotherapy publication-title: Sci. Transl. Med. contributor: fullname: Kobayashi – volume: 8 start-page: 3636 year: 2014 end-page: 3645 ident: b0675 article-title: Nanoparticle-delivered transforming growth factor-β siRNA enhances vaccination against advanced melanoma by modifying tumor microenvironment publication-title: ACS Nano contributor: fullname: Huang – volume: 531 year: 2021 ident: b0070 article-title: Interleukin-10 (IL-10) participates in host defense against bacterial pathogens and promotes IgM antibody production in Nile tilapia (Oreochromis niloticus) publication-title: Aquaculture contributor: fullname: Ye – volume: 154 start-page: 249 year: 2011 end-page: 257 ident: b1230 article-title: The efficacy of intracranial PLG-based vaccines is dependent on direct implantation into brain tissue publication-title: J. Controll. Release : Off. J. Controll. Release Soc. contributor: fullname: Emerich – volume: 119 start-page: 2231 year: 2009 end-page: 2244 ident: b1475 article-title: Polyethylenimine-based siRNA nanocomplexes reprogram tumor-associated dendritic cells via TLR5 to elicit therapeutic antitumor immunity publication-title: J. Clin. Invest. contributor: fullname: Conejo-Garcia – volume: 12 start-page: 813 year: 2017 end-page: 820 ident: b0535 article-title: In situ programming of leukaemia-specific T cells using synthetic DNA nanocarriers publication-title: Nat. Nanotechnol. contributor: fullname: Stephan – volume: 507 start-page: 519 year: 2014 end-page: 522 ident: b1505 article-title: Structure-based programming of lymph-node targeting in molecular vaccines publication-title: Nature contributor: fullname: Irvine – volume: 2019 start-page: 4508794 year: 2019 ident: b0390 article-title: Current Challenges in Cancer Immunotherapy: Multimodal Approaches to Improve Efficacy and Patient Response Rates publication-title: J. Oncol. contributor: fullname: Szewczuk – volume: 68 start-page: 54 year: 2015 end-page: 66 ident: b0680 article-title: Nanoparticle delivery of CDDO-Me remodels the tumor microenvironment and enhances vaccine therapy for melanoma publication-title: Biomaterials contributor: fullname: Huang – volume: 23 start-page: 1541 year: 2015 end-page: 1550 ident: b0225 article-title: Case Report of a Fatal Serious Adverse Event Upon Administration of T Cells Transduced With a MART-1-specific T-cell Receptor publication-title: Mol. Therapy : J. Am. Soc. Gene Therapy contributor: fullname: Haanen – volume: 18 start-page: 175 year: 2019 end-page: 196 ident: b0570 article-title: Delivery technologies for cancer immunotherapy publication-title: Nat. Rev. Drug Discovery contributor: fullname: Mitchell – volume: 40 start-page: 88 year: 2015 end-page: 97 ident: b0485 article-title: CD40-targeted dendritic cell delivery of PLGA-nanoparticle vaccines induce potent anti-tumor responses publication-title: Biomaterials contributor: fullname: Ossendorp – volume: 7 start-page: 13193 year: 2016 ident: b0905 article-title: Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy publication-title: Nat. Commun. contributor: fullname: Liu – volume: 27 start-page: 559 year: 2016 end-page: 574 ident: b0395 article-title: Management of immune checkpoint blockade dysimmune toxicities: a collaborative position paper publication-title: Ann. Oncol. contributor: fullname: Marabelle – volume: 107 start-page: 331 year: 2015 end-page: 339 ident: b1350 article-title: Selectins: initiators of leucocyte adhesion and signalling at the vascular wall publication-title: Cardiovasc. Res. contributor: fullname: McEver – start-page: 220954 year: 2017 ident: b1410 article-title: Wide-field dynamic monitoring of immune cell trafficking in murine models of glioblastoma publication-title: bioRxiv contributor: fullname: de la Zerda – volume: 25 start-page: 2000 year: 2007 end-page: 2005 ident: b0015 article-title: Outcome of patients experiencing progression or relapse after primary treatment with two cycles of chemotherapy and radiotherapy for early-stage favorable Hodgkin's lymphoma publication-title: J. Clin. Oncol. contributor: fullname: Josting – volume: 41 start-page: 843 year: 2014 end-page: 852 ident: b1040 article-title: STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors publication-title: Immunity contributor: fullname: Weichselbaum – volume: 21 start-page: 3771 year: 2015 end-page: 3782 ident: b1110 article-title: TLR9-Targeted STAT3 Silencing Abrogates Immunosuppressive Activity of Myeloid-Derived Suppressor Cells from Prostate Cancer Patients publication-title: Clin. Cancer Res. contributor: fullname: Kortylewski – volume: 39 start-page: 56 year: 2004 end-page: 63 ident: b1295 article-title: Macrophage endocytosis of superparamagnetic iron oxide nanoparticles: mechanisms and comparison of ferumoxides and ferumoxtran-10 publication-title: Invest. Radiol. contributor: fullname: Corot – volume: 9 start-page: 1319 year: 2012 end-page: 1330 ident: b0335 article-title: Developing mRNA-vaccine technologies publication-title: RNA Biol. contributor: fullname: Kallen – volume: 17 start-page: 261 year: 2018 end-page: 279 ident: b0320 article-title: mRNA vaccines - a new era in vaccinology publication-title: Nat. Rev. Drug Discovery contributor: fullname: Weissman – volume: 19 start-page: 705 year: 2013 end-page: 713 ident: b0515 article-title: Challenges and advances towards the rational design of mRNA vaccines publication-title: Trends Mol. Med. contributor: fullname: Grooten – volume: 5 start-page: 628 year: 2020 end-page: 653 ident: b1365 article-title: Nano-immunoimaging publication-title: Nanoscale Horiz. contributor: fullname: Smith – volume: 5 start-page: 22 year: 2017 ident: b0145 article-title: Safety, tumor trafficking and immunogenicity of chimeric antigen receptor (CAR)-T cells specific for TAG-72 in colorectal cancer publication-title: J. ImmunoTher. Cancer contributor: fullname: Sherwin – volume: 17 start-page: 184 year: 2015 end-page: 193 ident: b0770 article-title: Biodegradable microparticles loaded with doxorubicin and CpG ODN for in situ immunization against cancer publication-title: AAPS J. contributor: fullname: Weiner – volume: 29 start-page: 3671 year: 2008 end-page: 3682 ident: b1235 article-title: Injectable dendritic cell-carrying alginate gels for immunization and immunotherapy publication-title: Biomaterials contributor: fullname: Irvine – volume: 152 start-page: 168 year: 2011 end-page: 176 ident: b0585 article-title: Functional aliphatic polyesters for biomedical and pharmaceutical applications publication-title: J. Controll. Release : Off. J. Controll. Release Soc. contributor: fullname: Hennink – volume: 31 start-page: e1802244 year: 2019 ident: b1080 article-title: Emerging Strategies of Nanomaterial-Mediated Tumor Radiosensitization publication-title: Adv. Mater. (Deerfield Beach Fla.) contributor: fullname: Zhao – volume: 21 start-page: 2837 year: 2003 end-page: 2843 ident: b1260 article-title: Enhanced adjuvanticity of interleukin-2 plasmid DNA administered in polyethylenimine complexes publication-title: Vaccine contributor: fullname: Kim – volume: 1 start-page: 278 year: 2010 end-page: 284 ident: b1435 article-title: Deeply penetrating in vivo photoacoustic imaging using a clinical ultrasound array system publication-title: Biomed. Opt. Express contributor: fullname: Wang – volume: 114 start-page: 613 year: 2005 end-page: 622 ident: b1540 article-title: Exosomes: a new delivery system for tumor antigens in cancer immunotherapy publication-title: Int. J. Cancer contributor: fullname: Kim – volume: 63 start-page: 136 year: 2011 end-page: 151 ident: b1455 article-title: The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect publication-title: Adv. Drug Deliv. Rev. contributor: fullname: Maeda – volume: 74 start-page: 1670 year: 2014 end-page: 1681 ident: b1225 article-title: Identification of immune factors regulating antitumor immunity using polymeric vaccines with multiple adjuvants publication-title: Cancer Res. contributor: fullname: Mooney – volume: 35 start-page: 709 year: 2017 end-page: 717 ident: b0155 article-title: Pneumonitis in Patients Treated With Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy publication-title: J. Clin. Oncol. contributor: fullname: Hellmann – volume: 50 start-page: 1 year: 2018 end-page: 11 ident: b0120 article-title: Immune checkpoint inhibitors: recent progress and potential biomarkers publication-title: Exp. Mol. Med. contributor: fullname: Elkord – volume: 11 start-page: 285 year: 2016 ident: b1445 article-title: Human CIK Cells Loaded with Au Nanorods as a Theranostic Platform for Targeted Photoacoustic Imaging and Enhanced Immunotherapy and Photothermal Therapy publication-title: Nanoscale Res. Lett. contributor: fullname: Cui – volume: 38 start-page: 577 year: 2017 end-page: 593 ident: b0305 article-title: Integrating Next-Generation Dendritic Cell Vaccines into the Current Cancer Immunotherapy Landscape publication-title: Trends Immunol. contributor: fullname: Agostinis – volume: 18 start-page: 444 year: 2017 end-page: 459.e441 ident: b0140 article-title: Immune Checkpoint Inhibitors for Patients With Advanced Non-Small-Cell Lung Cancer: A Systematic Review publication-title: Clinical Lung Cancer contributor: fullname: Ung – volume: 32 start-page: 478 year: 1957 end-page: 484 ident: b0880 article-title: A tricarbocyanine dye for continuous recording of dilution curves in whole blood independent of variations in blood oxygen saturation publication-title: Proc. Staff Meetings. Mayo Clinic contributor: fullname: Wood – volume: 11 start-page: e0156626 year: 2016 ident: b1300 article-title: In Vivo Non-Invasive Tracking of Macrophage Recruitment to Experimental Stroke publication-title: PLoS One contributor: fullname: Hoehn – volume: 30 year: 2018 ident: b0890 article-title: Antigen-Directed Fabrication of a Multifunctional Nanovaccine with Ultrahigh Antigen Loading Efficiency for Tumor Photothermal-Immunotherapy publication-title: Adv. Mater. (Deerfield Beach Fla.) contributor: fullname: Yan – volume: 28 start-page: 200 year: 2011 end-page: 214 ident: b1090 article-title: Cancer immunotherapy and nanomedicine publication-title: Pharm. Res. contributor: fullname: Huang – volume: 147 start-page: 121 year: 2006 end-page: 125 ident: b1170 article-title: Interactions between radiation and hormonal therapy in breast cancer: simultaneous or sequential treatment publication-title: Orv. Hetil. contributor: fullname: Fodor – volume: 4 start-page: 734 year: 2012 end-page: 745 ident: b1020 article-title: Blocking IDO activity to enhance anti-tumor immunity publication-title: Front. Biosci. (Elite Edition) contributor: fullname: Munn – volume: 11 start-page: 4905 year: 2005 end-page: 4911 ident: b1155 article-title: Timing is everything: preclinical evidence supporting simultaneous rather than sequential chemohormonal therapy for prostate cancer publication-title: Clin. Cancer Res. contributor: fullname: Gleave – volume: 24 start-page: 535 year: 2018 end-page: 540 ident: b0230 article-title: CAR T-Cell Therapies in Glioblastoma: A First Look publication-title: Clin. Cancer Res. contributor: fullname: June – volume: 3 start-page: 3702 year: 2018 end-page: 3707 ident: b1060 article-title: Radiation Therapy Combined with Cowpea Mosaic Virus Nanoparticle in Situ Vaccination Initiates Immune-Mediated Tumor Regression publication-title: ACS Omega contributor: fullname: Steinmetz – volume: 11 start-page: 295 year: 2016 end-page: 303 ident: b0660 article-title: In situ vaccination with cowpea mosaic virus nanoparticles suppresses metastatic cancer publication-title: Nat. Nanotechnol. contributor: fullname: Fiering – volume: 14 start-page: 2181 year: 2014 end-page: 2188 ident: b1515 article-title: Cancer cell membrane-coated nanoparticles for anticancer vaccination and drug delivery publication-title: Nano Lett. contributor: fullname: Zhang – volume: 13 start-page: 125 year: 2014 end-page: 138 ident: b0650 article-title: Imaging macrophages with nanoparticles publication-title: Nat. Mater. contributor: fullname: Pittet – volume: 10 start-page: 993 year: 2004 end-page: 998 ident: b1395 article-title: Tracking metastatic tumor cell extravasation with quantum dot nanocrystals and fluorescence emission-scanning microscopy publication-title: Nat. Med. contributor: fullname: Simon – volume: 9 start-page: 581 year: 2009 end-page: 593 ident: b1530 article-title: Membrane vesicles as conveyors of immune responses publication-title: Nat. Rev. Immunol. contributor: fullname: Segura – volume: 24 start-page: 1499 year: 2018 end-page: 1503 ident: b0540 article-title: Induction of resistance to chimeric antigen receptor T cell therapy by transduction of a single leukemic B cell publication-title: Nat. Med. contributor: fullname: Melenhorst – volume: 16 start-page: 400 year: 2017 end-page: 423 ident: b0640 article-title: Targeting iron metabolism in drug discovery and delivery publication-title: Nat. Rev. Drug Discovery contributor: fullname: Rivella – volume: 3 start-page: 356 year: 2015 end-page: 367 ident: b0210 article-title: Identification of chimeric antigen receptors that mediate constitutive or inducible proliferation of T cells publication-title: Cancer Immunol. Res. contributor: fullname: June – volume: 7 start-page: 904 year: 2005 end-page: 911 ident: b1450 article-title: Nanoparticles for the optical imaging of tumor E-selectin publication-title: Neoplasia (New York, N.Y.) contributor: fullname: Josephson – volume: 2 start-page: 751 year: 2007 end-page: 760 ident: b0730 article-title: Nanocarriers as an emerging platform for cancer therapy publication-title: Nat. Nanotechnol. contributor: fullname: Langer – volume: 33 start-page: 97 year: 2015 end-page: 101 ident: b1215 article-title: Biopolymer implants enhance the efficacy of adoptive T-cell therapy publication-title: Nat. Biotechnol. contributor: fullname: Stephan – volume: 9 start-page: 6918 year: 2015 end-page: 6933 ident: b1510 article-title: Erythrocyte Membrane-Enveloped Polymeric Nanoparticles as Nanovaccine for Induction of Antitumor Immunity against Melanoma publication-title: ACS Nano contributor: fullname: Zhang – volume: 379 start-page: 2040 year: 2018 end-page: 2051 ident: b0425 article-title: Pembrolizumab plus Chemotherapy for Squamous Non-Small-Cell Lung Cancer publication-title: New Engl. J. Med. contributor: fullname: Kowalski – volume: 7 start-page: 651 year: 2011 end-page: 658 ident: b0360 article-title: Dual Roles of Immune Cells and Their Factors in Cancer Development and Progression publication-title: Int. J. Biol. Sci. contributor: fullname: Chen – volume: 131 start-page: 1079 year: 2005 end-page: 1085 ident: b1130 article-title: Combination nonviral murine interleukin 2 and interleukin 12 gene therapy and radiotherapy for head and neck squamous cell carcinoma publication-title: Arch. Otolaryngol.–Head Neck Surg. contributor: fullname: Liu – volume: 119 start-page: 725 year: 1991 end-page: 732 ident: b0010 article-title: Interval between Symptom Onset and Diagnosis of Pediatric Solid Tumors publication-title: J. Pediatr.-Us contributor: fullname: Vietti – volume: 138 start-page: 16686 year: 2016 end-page: 16695 ident: b1010 article-title: Photodynamic Therapy Mediated by Nontoxic Core-Shell Nanoparticles Synergizes with Immune Checkpoint Blockade To Elicit Antitumor Immunity and Antimetastatic Effect on Breast Cancer publication-title: J. Am. Chem. Soc. contributor: fullname: Lin – volume: 377 start-page: 2531 year: 2017 end-page: 2544 ident: b0200 article-title: Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma publication-title: New Engl. J. Med. contributor: fullname: Go – volume: 12 start-page: 1978 year: 2018 end-page: 1989 ident: b1025 article-title: Enhanced Immunotherapy Based on Photodynamic Therapy for Both Primary and Lung Metastasis Tumor Eradication publication-title: ACS Nano contributor: fullname: Zhang – volume: 3 start-page: 768 year: 2019 end-page: 782 ident: b0405 article-title: Engineering patient-specific cancer immunotherapies publication-title: Nat. Biomed. Eng. contributor: fullname: Moon – volume: 11 start-page: 2481 year: 2016 end-page: 2490 ident: b1360 article-title: Magnetic resonance imaging of ultrasmall superparamagnetic iron oxide-labeled exosomes from stem cells: a new method to obtain labeled exosomes publication-title: Int. J. Nanomed. contributor: fullname: Mariotti – volume: 9 year: 2017 ident: b0790 article-title: Gold nanoparticle-mediated photothermal therapy: applications and opportunities for multimodal cancer treatment publication-title: Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. contributor: fullname: Day – volume: 114 start-page: 79 year: 2017 end-page: 101 ident: b0085 article-title: Delivering safer immunotherapies for cancer publication-title: Adv. Drug Deliv. Rev. contributor: fullname: Irvine – volume: 2014 year: 2014 ident: b0365 article-title: Chronic Inflammation and Cytokines in the Tumor Microenvironment publication-title: J. Immunol. Res. contributor: fullname: Hermoso – volume: 14 start-page: 169 year: 2008 end-page: 177 ident: b0990 article-title: Phase I immunotherapeutic trial with long peptides spanning the E6 and E7 sequences of high-risk human papillomavirus 16 in end-stage cervical cancer patients shows low toxicity and robust immunogenicity publication-title: Clin. Cancer Res. contributor: fullname: Melief – volume: 4 start-page: 435 year: 2005 end-page: 446 ident: b1390 article-title: Quantum dot bioconjugates for imaging, labelling and sensing publication-title: Nat. Mater. contributor: fullname: Mattoussi – volume: 16 start-page: 489 year: 2017 end-page: 496 ident: b1520 article-title: Designer vaccine nanodiscs for personalized cancer immunotherapy publication-title: Nat. Mater. contributor: fullname: Moon – volume: 35 start-page: 590 year: 2014 end-page: 600 ident: b0410 article-title: Programmed nanoparticles for combined immunomodulation, antigen presentation and tracking of immunotherapeutic cells publication-title: Biomaterials contributor: fullname: Lim – volume: 9 start-page: 347 year: 2017 end-page: 360 ident: b0075 article-title: Recent progress in GM-CSF-based cancer immunotherapy publication-title: Immunotherapy contributor: fullname: Liu – volume: 9 start-page: 6401 year: 2015 end-page: 6411 ident: b0475 article-title: Antigen-Loaded Upconversion Nanoparticles for Dendritic Cell Stimulation, Tracking, and Vaccination in Dendritic Cell-Based Immunotherapy publication-title: ACS nano contributor: fullname: Liu – volume: 10 start-page: 1273 year: 2014 end-page: 1285 ident: b0800 article-title: Local hyperthermia treatment of tumors induces CD8(+) T cell-mediated resistance against distal and secondary tumors publication-title: Nanomed. Nanotechnol. Biol. Med. contributor: fullname: Fiering – volume: 33 start-page: 1974 year: 2015 end-page: 1982 ident: b0100 article-title: Immune Checkpoint Blockade in Cancer Therapy publication-title: J. Clin. Oncol. contributor: fullname: Wolchok – volume: 35 start-page: 6646 year: 2014 end-page: 6656 ident: b0860 article-title: Engineered, self-assembled near-infrared photothermal agents for combined tumor immunotherapy and chemo-photothermal therapy publication-title: Biomaterials contributor: fullname: Qu – volume: 15 start-page: 4161 year: 2018 end-page: 4172 ident: b0780 article-title: Co-delivery of Doxorubicin and Interferon-γ by Thermosensitive Nanoparticles for Cancer Immunochemotherapy publication-title: Mol. Pharm. contributor: fullname: Zhang – volume: 14 start-page: 1528 year: 2017 end-page: 1537 ident: b1355 article-title: Synthesis and Functional Characterization of Novel Sialyl LewisX Mimic-Decorated Liposomes for E-selectin-Mediated Targeting to Inflamed Endothelial Cells publication-title: Mol. Pharm. contributor: fullname: Hashida – volume: 27 start-page: 2008 year: 2010 end-page: 2017 ident: b0590 article-title: Hydrophilic polyester microspheres: effect of molecular weight and copolymer composition on release of BSA publication-title: Pharm. Res. contributor: fullname: Hennink – volume: 61 start-page: 459 year: 2001 end-page: 461 ident: b0805 article-title: Antitumor immunity induced by laser immunotherapy and its adoptive transfer publication-title: Cancer Res. contributor: fullname: Nordquist – volume: 8 start-page: 115748 year: 2017 end-page: 115753 ident: b0580 article-title: Platelet-inspired medicine for tumor therapy publication-title: Oncotarget contributor: fullname: Zhou – volume: 172 start-page: 2126 year: 1950 end-page: 2136 ident: b1560 article-title: Exosomes as potent cell-free peptide-based vaccine. I. Dendritic cell-derived exosomes transfer functional MHC class I/peptide complexes to dendritic cells publication-title: J. Immunol. (Baltimore, Md.) contributor: fullname: Zitvogel – volume: 16 start-page: 56 year: 2016 end-page: 66 ident: b1200 article-title: Biomaterials and emerging anticancer therapeutics: engineering the microenvironment publication-title: Nat. Rev. Cancer contributor: fullname: Mooney – volume: 166 start-page: 7309 year: 1950 end-page: 7318 ident: b1565 article-title: Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles publication-title: J. Immunol. (Baltimore Md.) contributor: fullname: Amigorena – volume: 27 start-page: 437 year: 2015 end-page: 438 ident: b1055 article-title: Radiotherapy complements immune checkpoint blockade publication-title: Cancer Cell contributor: fullname: Smyth – volume: 18 year: 2019 ident: b0245 article-title: The emerging world of TCR-T cell trials against cancer: A systematic review publication-title: Technol. Cancer Res. Treat. contributor: fullname: Wang – volume: 38 start-page: 50 year: 2015 end-page: 60 ident: b1100 article-title: Nanovaccine loaded with poly I: C and STAT3 siRNA robustly elicits anti-tumor immune responses through modulating tumor-associated dendritic cells in vivo publication-title: Biomaterials contributor: fullname: Ma – volume: 61 start-page: 1387 year: 2012 end-page: 1394 ident: b0955 article-title: Photodynamic therapy-generated cancer vaccine elicits acute phase and hormonal response in treated mice publication-title: Cancer Immunol., Immunotherapy : CII contributor: fullname: Merchant – volume: 31 start-page: 220 year: 2010 end-page: 227 ident: b0665 article-title: TGF-beta and immune cells: an important regulatory axis in the tumor microenvironment and progression publication-title: Trends Immunol. contributor: fullname: Moses – volume: 9 start-page: 798 year: 2009 end-page: 809 ident: b0375 article-title: STATs in cancer inflammation and immunity: a leading role for STAT3 publication-title: Nat. Rev. Cancer contributor: fullname: Jove – volume: 3 start-page: 3856 year: 2011 end-page: 3893 ident: b0045 article-title: Cytokines in cancer immunotherapy publication-title: Cancers contributor: fullname: Margolin – volume: 4 start-page: 132ra153 year: 2012 ident: b0185 article-title: Decade-long safety and function of retroviral-modified chimeric antigen receptor T cells publication-title: Sci. Translat. Med. contributor: fullname: June – volume: 15 start-page: 663 year: 2016 end-page: 665 ident: b0300 article-title: The cancer vaccine resurgence publication-title: Nat. Rev. Drug Discovery contributor: fullname: Mullard – volume: 10 start-page: 3153 year: 2014 end-page: 3164 ident: b0325 article-title: DNA vaccine for cancer immunotherapy publication-title: Human Vaccines Immunotherapeut. contributor: fullname: Hung – volume: 23 start-page: 1929 year: 2017 end-page: 1936 ident: b0290 article-title: Results from an Integrated Safety Analysis of Urelumab, an Agonist Anti-CD137 Monoclonal Antibody publication-title: Clin. Cancer Res. contributor: fullname: Levy – volume: 8 start-page: 16673 year: 2018 ident: b1465 article-title: Enhanced EPR directed and Imaging guided Photothermal Therapy using Vitamin E Modified Toco-Photoxil publication-title: Sci. Rep. contributor: fullname: De – volume: 30 start-page: 531 year: 2014 end-page: 539 ident: b0920 article-title: Local tumour hyperthermia as immunotherapy for metastatic cancer, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia publication-title: Group contributor: fullname: Fiering – volume: 359 start-page: 169 year: 2015 end-page: 177 ident: b0810 article-title: InCVAX–a novel strategy for treatment of late-stage, metastatic cancers through photoimmunotherapy induced tumor-specific immunity publication-title: Cancer Lett. contributor: fullname: Chen – volume: 7 start-page: 595 year: 2019 ident: b0040 article-title: Immunotherapy and targeted therapy-the new roadmap in cancer treatment publication-title: Ann. Transl. Med. contributor: fullname: Phan – volume: 11 start-page: 986 year: 2016 end-page: 994 ident: b0635 article-title: Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues publication-title: Nat. Nanotechnol. contributor: fullname: Daldrup-Link – volume: 17 start-page: 2270 year: 2011 end-page: 2280 ident: b1180 article-title: Local activation of CD8 T cells and systemic tumor eradication without toxicity via slow release and local delivery of agonistic CD40 antibody publication-title: Clin. Cancer Res. contributor: fullname: Melief – volume: 377 start-page: 2545 year: 2017 end-page: 2554 ident: b0195 article-title: Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas publication-title: New Engl. J. Med. contributor: fullname: June – volume: 114 start-page: 175 year: 2017 end-page: 183 ident: b0915 article-title: Combinatorial immunotherapy and nanoparticle mediated hyperthermia publication-title: Adv. Drug Deliv. Rev. contributor: fullname: Tunnell – volume: 12 start-page: 9830 year: 2018 end-page: 9841 ident: b1125 article-title: Local Blockade of Interleukin 10 and C-X-C Motif Chemokine Ligand 12 with Nano-Delivery Promotes Antitumor Response in Murine Cancers publication-title: ACS Nano contributor: fullname: Huang – volume: 33 start-page: 5584 year: 2012 end-page: 5592 ident: b1315 article-title: The manipulation of natural killer cells to target tumor sites using magnetic nanoparticles publication-title: Biomaterials contributor: fullname: Cheng – volume: 8 start-page: 1738 year: 2017 ident: b0350 article-title: Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma publication-title: Nat. Commun. contributor: fullname: Jönsson – volume: 112 start-page: 8260 year: 2015 end-page: 8265 ident: b1285 article-title: Microneedle-array patches loaded with hypoxia-sensitive vesicles provide fast glucose-responsive insulin delivery publication-title: Proc. Nat. Acad. Sci. USA contributor: fullname: Gu – volume: 5 start-page: 15 year: 2015 ident: b0985 article-title: Calreticulin as cancer treatment adjuvant: combination with photodynamic therapy and photodynamic therapy-generated vaccines publication-title: Front. Oncol. contributor: fullname: Čiplys – volume: 75 start-page: 237 year: 2016 end-page: 249 ident: b1275 article-title: Chitosan thermogels for local expansion and delivery of tumor-specific T lymphocytes towards enhanced cancer immunotherapies publication-title: Biomaterials contributor: fullname: Lapointe – volume: 4 start-page: e4942 year: 2009 ident: b1570 article-title: Dendritic cell-derived exosomes promote natural killer cell activation and proliferation: a role for NKG2D ligands and IL-15Ralpha publication-title: PLoS One contributor: fullname: Chaput – volume: 168 start-page: 707 year: 2017 end-page: 723 ident: b0685 article-title: Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy publication-title: Cell contributor: fullname: Ribas – volume: 28 start-page: 1383 year: 2013 end-page: 1392 ident: b0945 article-title: Generation of an effective anti-lung cancer vaccine by DTPP-mediated photodynamic therapy and mechanistic studies publication-title: Lasers Med. Sci. contributor: fullname: Yang – volume: 33 start-page: 64 year: 2015 end-page: 72 ident: b1195 article-title: Injectable, spontaneously assembling, inorganic scaffolds modulate immune cells in vivo and increase vaccine efficacy publication-title: Nat. Biotechnol. contributor: fullname: Mooney – volume: 44 start-page: 1302 year: 2015 end-page: 1317 ident: b1400 article-title: Upconverting nanoparticles: a versatile platform for wide-field two-photon microscopy and multi-modal in vivo imaging publication-title: Chem. Soc. Rev. contributor: fullname: Hyeon – volume: 122 start-page: 1707 year: 2010 end-page: 1715 ident: b1330 article-title: High-resolution magnetic resonance imaging enhanced with superparamagnetic nanoparticles measures macrophage burden in atherosclerosis publication-title: Circulation contributor: fullname: Aikawa – volume: 21 start-page: 227 year: 2014 end-page: 235 ident: b0055 article-title: Inhibition of tumor angiogenesis by interferon-γ by suppression of tumor-associated macrophage differentiation publication-title: Oncol. Res. contributor: fullname: Ge – volume: 23 start-page: 4621 year: 2013 end-page: 4628 ident: b1220 article-title: Inflammatory cytokines presented from polymer matrices differentially generate and activate DCs in situ publication-title: Adv. Funct. Mater. contributor: fullname: Mooney – volume: 210 start-page: 1695 year: 2013 end-page: 1710 ident: b0135 article-title: Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma publication-title: J. Exp. Med. contributor: fullname: Quezada – volume: 377 start-page: 1313 year: 2017 end-page: 1315 ident: b0530 article-title: Tragedy, Perseverance, and Chance - The Story of CAR-T Therapy publication-title: New Engl. J. Med. contributor: fullname: Rosenbaum – volume: 252 start-page: 401 year: 2009 end-page: 409 ident: b1325 article-title: Rapid-clearance iron nanoparticles for inflammation imaging of atherosclerotic plaque: initial experience in animal model publication-title: Radiology contributor: fullname: Canet-Soulas – volume: 172 start-page: 426 year: 2013 end-page: 435 ident: b0550 article-title: In vivo targeting of adoptively transferred T-cells with antibody- and cytokine-conjugated liposomes publication-title: J. Controll. Release : Off. J. Controll. Release Soc. contributor: fullname: Irvine – volume: 547 start-page: 222 year: 2017 end-page: 226 ident: b1490 article-title: Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer publication-title: Nature contributor: fullname: Türeci – volume: 8 start-page: 5670 year: 2014 end-page: 5681 ident: b0815 article-title: Combinatorial photothermal and immuno cancer therapy using chitosan-coated hollow copper sulfide nanoparticles publication-title: ACS Nano contributor: fullname: Lu – volume: 9 start-page: 1074 year: 2018 ident: b0830 article-title: Chemo-photothermal therapy combination elicits anti-tumor immunity against advanced metastatic cancer publication-title: Nat. Commun. contributor: fullname: Moon – volume: 11 start-page: 895 year: 2012 end-page: 905 ident: b0615 article-title: Combination delivery of TGF-β inhibitor and IL-2 by nanoscale liposomal polymeric gels enhances tumour immunotherapy publication-title: Nat. Mater. contributor: fullname: Fahmy – volume: 1 year: 2010 ident: b1370 article-title: Potential toxicity of superparamagnetic iron oxide nanoparticles (SPION) publication-title: Nano Rev. contributor: fullname: Doak – volume: 25 start-page: 1159 year: 2007 end-page: 1164 ident: b1460 article-title: Exploiting lymphatic transport and complement activation in nanoparticle vaccines publication-title: Nat. Biotechnol. contributor: fullname: Hubbell – volume: 33 start-page: 649 year: 2018 end-page: 663.e644 ident: b0125 article-title: Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies publication-title: Cancer Cell contributor: fullname: Quezada – volume: 8 start-page: 27 year: 2014 end-page: 38 ident: b0460 article-title: Therapeutic vaccines and cancer: focus on DPX-0907 publication-title: Biologics : Targets & Therapy contributor: fullname: Mansour – volume: 132 start-page: 967 year: 2013 end-page: 977 ident: b1095 article-title: Silencing IDO in dendritic cells: a novel approach to enhance cancer immunotherapy in a murine breast cancer model publication-title: Int. J. Cancer contributor: fullname: Min – volume: 35 start-page: 7805 year: 2019 end-page: 7815 ident: b0850 article-title: Comprehensive Evaluation of Degradable and Cost-Effective Plasmonic Nanoshells for Localized Photothermolysis of Cancer Cells publication-title: Langmuir : ACS J. Surfaces Colloids contributor: fullname: Srivastava – volume: 9 start-page: 1614 year: 2007 end-page: 1622 ident: b1555 article-title: A vaccine based on exosomes secreted by a dendritic cell line confers protection against T. gondii infection in syngeneic and allogeneic mice publication-title: Microbes Infect. contributor: fullname: Dimier-Poisson – volume: 45 start-page: e124 year: 2017 end-page: e131 ident: b0215 article-title: Cytokine Release Syndrome After Chimeric Antigen Receptor T Cell Therapy for Acute Lymphoblastic Leukemia publication-title: Crit. Care Med. contributor: fullname: Teachey – volume: 12 start-page: 700 year: 2016 end-page: 709 ident: b1135 article-title: Folate-Modified Chitosan Nanoparticles Coated Interferon-Inducible Protein-10 Gene Enhance Cytotoxic T Lymphocytes' Responses to Hepatocellular Carcinoma publication-title: J. Biomed. Nanotechnol. contributor: fullname: Lu – volume: 8 start-page: 1747 year: 2017 ident: b0560 article-title: T cell-targeting nanoparticles focus delivery of immunotherapy to improve antitumor immunity publication-title: Nat. Commun. contributor: fullname: Goldberg – volume: 9 start-page: 1532 year: 2018 ident: b0895 article-title: A cancer vaccine-mediated postoperative immunotherapy for recurrent and metastatic tumors publication-title: Nat. Commun. contributor: fullname: Li – volume: 14 start-page: 428 year: 2012 end-page: 439 ident: b1140 article-title: Highly potent mRNA based cancer vaccines represent an attractive platform for combination therapies supporting an improved therapeutic effect publication-title: J. Gene Med. contributor: fullname: Kallen – volume: 22 start-page: 1459 year: 2016 end-page: 1468 ident: b0435 article-title: Combination of Photodynamic Therapy and Specific Immunotherapy Efficiently Eradicates Established Tumors publication-title: Clin. Cancer Res. contributor: fullname: Ossendorp – volume: 12 start-page: 692 year: 2017 ident: b0970 article-title: Neutrophil-mediated anticancer drug delivery for suppression of postoperative malignant glioma recurrence publication-title: Nat. Nanotechnol. contributor: fullname: Sun – volume: 16 start-page: 566 year: 2016 end-page: 581 ident: b0180 article-title: Engineered T cells: the promise and challenges of cancer immunotherapy publication-title: Nat. Rev. Cancer contributor: fullname: Levine – volume: 26 start-page: 3662 year: 2008 end-page: 3672 ident: b1550 article-title: Enhancement of immunostimulatory properties of exosomal vaccines by incorporation of fusion-competent G protein of vesicular stomatitis virus publication-title: Vaccine contributor: fullname: Kuate – volume: 3 start-page: 9 year: 2005 ident: b1575 article-title: A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer publication-title: J. Transl. Med. contributor: fullname: Lyerly – volume: 11 start-page: 728 year: 2005 end-page: 734 ident: b1065 article-title: Immune-mediated inhibition of metastases after treatment with local radiation and CTLA-4 blockade in a mouse model of breast cancer publication-title: Clin. Cancer Res. contributor: fullname: Formenti – volume: 27 start-page: 1 year: 2014 end-page: 7 ident: b0900 article-title: Regulatory T cells in cancer immunotherapy publication-title: Curr. Opin. Immunol. contributor: fullname: Sakaguchi – volume: 46 start-page: 1594 year: 2018 end-page: 1604 ident: b0855 article-title: Folic acid conjugated PEG coated gold-iron oxide core-shell nanocomplex as a potential agent for targeted photothermal therapy of cancer publication-title: Artif. Cells Nanomed. Biotechnol. contributor: fullname: Montazerabadi – volume: 16 start-page: 1035 year: 2010 end-page: 1041 ident: b0545 article-title: Therapeutic cell engineering with surface-conjugated synthetic nanoparticles publication-title: Nat. Med. contributor: fullname: Irvine – volume: 30 start-page: v913 year: 2019 end-page: v914 ident: b0420 article-title: LBA4_PR - Nivolumab (NIVO) + low-dose ipilimumab (IPI) vs platinum-doublet chemotherapy (chemo) as first-line (1L) treatment (tx) for advanced non-small cell lung cancer (NSCLC): CheckMate 227 part 1 final analysis publication-title: Ann. Oncol. contributor: fullname: Hellmann – volume: 10 start-page: e0128910 year: 2015 ident: b1115 article-title: Systemic siRNA Nanoparticle-Based Drugs Combined with Radiofrequency Ablation for Cancer Therapy publication-title: PLoS One contributor: fullname: Goldberg – volume: 2 start-page: 306 year: 2018 end-page: 319 ident: b1345 article-title: Ferumoxytol-based Dual-modality Imaging Probe for Detection of Stem Cell Transplant Rejection publication-title: Nanotheranostics contributor: fullname: Daldrup-Link – volume: 137 start-page: 7600 year: 2015 end-page: 7603 ident: b1030 article-title: A Chlorin-Based Nanoscale Metal-Organic Framework for Photodynamic Therapy of Colon Cancers publication-title: J. Am. Chem. Soc. contributor: fullname: Lin – volume: 16 start-page: 5503 year: 2016 end-page: 5513 ident: b1000 article-title: Acid-Activatable Versatile Micelleplexes for PD-L1 Blockade-Enhanced Cancer Photodynamic Immunotherapy publication-title: Nano Lett. contributor: fullname: Li – volume: 34 start-page: 2969 year: 2016 end-page: 2979 ident: b0725 article-title: Nivolumab in Combination With Platinum-Based Doublet Chemotherapy for First-Line Treatment of Advanced Non-Small-Cell Lung Cancer publication-title: J. Clin. Oncol. contributor: fullname: Antonia – volume: 16 start-page: 2334 year: 2016 end-page: 2340 ident: b1280 article-title: Enhanced Cancer Immunotherapy by Microneedle Patch-Assisted Delivery of Anti-PD1 Antibody publication-title: Nano Lett. contributor: fullname: Gu – volume: 28 start-page: 4324 year: 2010 end-page: 4332 ident: b1075 article-title: In situ vaccination with a TLR9 agonist induces systemic lymphoma regression: a phase I/II study publication-title: J. Clin. Oncol. contributor: fullname: Levy – volume: 23 start-page: 5349 year: 2017 end-page: 5357 ident: b0285 article-title: Phase Ib Study of Utomilumab (PF-05082566), a 4–1BB/CD137 Agonist, in Combination with Pembrolizumab (MK-3475) in Patients with Advanced Solid Tumors publication-title: Clin. Cancer Res. contributor: fullname: Chow – volume: 30 start-page: 617 year: 1993 end-page: 625 ident: b1290 article-title: Intracellular labeling of T-cells with superparamagnetic contrast agents publication-title: Magn. Reson. Med. contributor: fullname: Ho – volume: 5 start-page: 197ra103 year: 2013 ident: b0240 article-title: Identification of a Titin-derived HLA-A1-presented peptide as a cross-reactive target for engineered MAGE A3-directed T cells publication-title: Sci. Transl. Med. contributor: fullname: Jakobsen – volume: 4 start-page: 399 year: 2009 end-page: 413 ident: b1420 article-title: Molecular imaging and therapy of cancer with radiolabeled nanoparticles publication-title: Nano Today contributor: fullname: Cai – volume: 240 start-page: 227 year: 2016 end-page: 234 ident: b0340 article-title: Materials for non-viral intracellular delivery of messenger RNA therapeutics publication-title: J. Controlled Release : Off. J. Controlled Release Soc. contributor: fullname: Anderson – volume: 9 start-page: 162 year: 2009 end-page: 174 ident: b0370 article-title: Myeloid-derived suppressor cells as regulators of the immune system publication-title: Nat. Rev. Immunol. contributor: fullname: Nagaraj – volume: 7 start-page: 8606 year: 2017 ident: b0820 article-title: Synergistic Immuno Photothermal Nanotherapy (SYMPHONY) for the Treatment of Unresectable and Metastatic Cancers publication-title: Sci. Rep. contributor: fullname: Vo-Dinh – volume: 25 start-page: 4183 year: 2015 end-page: 4194 ident: b1120 article-title: Dual targeted immunotherapy via in vivo delivery of biohybrid RNAi-peptide nanoparticles to tumour-associated macrophages and cancer cells publication-title: Adv. Funct. Mater. contributor: fullname: Tian – volume: 18 start-page: 2021 year: 2008 end-page: 2032 ident: b1375 article-title: Cell tracking with optical imaging publication-title: Eur. Radiol. contributor: fullname: Daldrup-Link – volume: 10 start-page: 5981 year: 2015 end-page: 5992 ident: b0760 article-title: Sequential delivery of an anticancer drug and combined immunomodulatory nanoparticles for efficient chemoimmunotherapy publication-title: Int. J. Nanomed. contributor: fullname: Lim – volume: 263 start-page: 79 year: 2010 end-page: 87 ident: b0740 article-title: Paclitaxel enhances early dendritic cell maturation and function through TLR4 signaling in mice publication-title: Cell. Immunol. contributor: fullname: Armstrong – volume: 2 start-page: 675 year: 2002 end-page: 687 ident: b0050 article-title: Viruses and interferon: a fight for supremacy publication-title: Nat. Rev. Immunol. contributor: fullname: Gale – volume: 19 start-page: 465 year: 2013 end-page: 472 ident: b0505 article-title: Persistent antigen at vaccination sites induces tumor-specific CD8+ T cell sequestration, dysfunction and deletion publication-title: Nat. Med. contributor: fullname: Overwijk – volume: 17 start-page: 7387 year: 2017 end-page: 7393 ident: b0765 article-title: Immunogenic Cell Death Amplified by Co-localized Adjuvant Delivery for Cancer Immunotherapy publication-title: Nano Lett. contributor: fullname: Moon – volume: 207 year: 2020 ident: b0490 article-title: Cancer immunotherapy with immunoadjuvants, nanoparticles, and checkpoint inhibitors: Recent progress and challenges in treatment and tracking response to immunotherapy publication-title: Pharmacol. Therapeut. contributor: fullname: Ranjan – volume: 32 start-page: 180 year: 2011 end-page: 186 ident: b0065 article-title: Cytokines and the inception of CD8 T cell responses publication-title: Trends Immunol. contributor: fullname: Zajac – volume: 10 start-page: 664 year: 2011 end-page: 669 ident: b0975 article-title: Cancer vaccines generated by photodynamic therapy publication-title: Photochem. Photobiol. Sci. : Off. J. Eur. Photochemistry Assoc. Eur. Soc. Photobiol. contributor: fullname: Korbelik – volume: 48 start-page: 351 year: 2019 end-page: 381 ident: b0525 article-title: Nanomedicine and macroscale materials in immuno-oncology publication-title: Chem. Soc. Rev. contributor: fullname: Shi – volume: 547 start-page: 217 year: 2017 end-page: 221 ident: b1495 article-title: An immunogenic personal neoantigen vaccine for patients with melanoma publication-title: Nature contributor: fullname: Wu – volume: 351 year: 1998 ident: b0005 article-title: Conventional cancer therapy: promise broken or promise delayed? publication-title: Lancet contributor: fullname: Tannock – volume: 9 start-page: 6 year: 2018 ident: b0295 article-title: Nanoparticle anchoring targets immune agonists to tumors enabling anti-cancer immunity without systemic toxicity publication-title: Nat. Commun. contributor: fullname: Irvine – volume: 534 start-page: 396 year: 2016 end-page: 401 ident: b0520 article-title: Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy publication-title: Nature contributor: fullname: Sahin – volume: 23 start-page: 741 year: 2005 end-page: 750 ident: b1175 article-title: Autoimmunity in a phase I trial of a fully human anti-cytotoxic T-lymphocyte antigen-4 monoclonal antibody with multiple melanoma peptides and Montanide ISA 51 for patients with resected stages III and IV melanoma publication-title: J. Clin. Oncol. contributor: fullname: Weber – volume: 131 start-page: 49 year: 2018 end-page: 57 ident: b0270 article-title: Immunotherapy targeting 4–1BB: mechanistic rationale, clinical results, and future strategies publication-title: Blood contributor: fullname: Melero – volume: 4 start-page: eaao1736 year: 2018 ident: b0705 article-title: Elimination of established tumors with nanodisc-based combination chemoimmunotherapy publication-title: Sci. Adv. contributor: fullname: Moon – volume: 117 start-page: 901 year: 2017 end-page: 986 ident: b1385 article-title: Nanomaterials for In Vivo Imaging publication-title: Chem. Rev. contributor: fullname: Gambhir – volume: 63 start-page: 6838 year: 2003 end-page: 6846 ident: b1320 article-title: In vivo high resolution three-dimensional imaging of antigen-specific cytotoxic T-lymphocyte trafficking to tumors publication-title: Cancer Res. contributor: fullname: Weissleder – volume: 213 start-page: 1133 year: 2016 end-page: 1139 ident: b0095 article-title: Combined IL-21-primed polyclonal CTL plus CTLA4 blockade controls refractory metastatic melanoma in a patient publication-title: J. Exp. Med. contributor: fullname: Yee – volume: 139 start-page: 693 year: 2009 end-page: 706 ident: b0385 article-title: An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation publication-title: Cell contributor: fullname: Struhl – volume: 64 start-page: 36 year: 2015 end-page: 45 ident: b0470 article-title: Immune response profile elicited by the model antigen ovalbumin expressed in fusion with the bacterial OprI lipoprotein publication-title: Mol. Immunol. contributor: fullname: Leitão – volume: 342 start-page: 1432 year: 2013 end-page: 1433 ident: b0565 article-title: Breakthrough of the year 2013. Cancer immunotherapy publication-title: Science (New York N.Y.) contributor: fullname: Couzin-Frankel – volume: 7 start-page: 303ra139 year: 2015 ident: b0190 article-title: Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia publication-title: Sci. Translat. Med. contributor: fullname: June – volume: 35 start-page: 7992 year: 2014 end-page: 8001 ident: b0750 article-title: Poly (γ-glutamic acid) based combination of water-insoluble paclitaxel and TLR7 agonist for chemo-immunotherapy publication-title: Biomaterials contributor: fullname: Lim – volume: 10 year: 2018 ident: b1265 article-title: In situ formed reactive oxygen species-responsive scaffold with gemcitabine and checkpoint inhibitor for combination therapy publication-title: Sci. Transl. Med. contributor: fullname: Gu – volume: 378 start-page: 158 year: 2018 end-page: 168 ident: b0150 article-title: Immune-Related Adverse Events Associated with Immune Checkpoint Blockade publication-title: New Engl. J. Med. contributor: fullname: Hellmann – volume: 6 start-page: 7556 year: 2015 ident: b1245 article-title: Injectable cryogel-based whole-cell cancer vaccines publication-title: Nat. Commun. contributor: fullname: Mooney – volume: 28 start-page: xii11 year: 2017 end-page: xii17 ident: b0345 article-title: Preclinical and clinical development of neoantigen vaccines publication-title: Ann. Oncol. contributor: fullname: Gillanders – volume: 8 year: 2020 ident: b0315 article-title: Therapeutic Vaccines and Cancer Immunotherapy publication-title: Vaccines (Basel) contributor: fullname: Daemen – volume: 348 start-page: 69 year: 2015 end-page: 74 ident: b0400 article-title: Neoantigens in cancer immunotherapy publication-title: Science (New York, N.Y.) contributor: fullname: Schreiber – volume: 15 start-page: 335 year: 2015 end-page: 349 ident: b0925 article-title: Fever and the thermal regulation of immunity: the immune system feels the heat publication-title: Nat. Rev. Immunol. contributor: fullname: Fisher – volume: 11 start-page: 4463 year: 2017 end-page: 4474 ident: b1015 article-title: Near-Infrared-Triggered Photodynamic Therapy with Multitasking Upconversion Nanoparticles in Combination with Checkpoint Blockade for Immunotherapy of Colorectal Cancer publication-title: ACS Nano contributor: fullname: Liu – volume: 8 start-page: e69073 year: 2013 ident: b0795 article-title: Elimination of metastatic melanoma using gold nanoshell-enabled photothermal therapy and adoptive T cell transfer publication-title: PLoS One contributor: fullname: Foster – volume: 6 start-page: 675 year: 2011 end-page: 682 ident: b0465 article-title: A multifunctional core-shell nanoparticle for dendritic cell-based cancer immunotherapy publication-title: Nat. Nanotechnol. contributor: fullname: Seong – volume: 97 start-page: 1381 year: 2007 end-page: 1387 ident: b0960 article-title: Photodynamic therapy-generated vaccines: relevance of tumour cell death expression publication-title: Br. J. Cancer contributor: fullname: Sun – volume: 14 start-page: 1760 year: 2017 end-page: 1770 ident: b1205 article-title: A Light Responsive Nanoparticle-Based Delivery System Using Pheophorbide A Graft Polyethylenimine for Dendritic Cell-Based Cancer Immunotherapy publication-title: Mol. Pharm. contributor: fullname: Li – volume: 445 start-page: 171 year: 2013 end-page: 180 ident: b0755 article-title: Nanoparticle mediated co-delivery of paclitaxel and a TLR-4 agonist results in tumor regression and enhanced immune response in the tumor microenvironment of a mouse model publication-title: Int. J. Pharm. contributor: fullname: Bhaskar – volume: 115 start-page: 57 year: 2017 end-page: 81 ident: b1160 article-title: Nanoformulation-based sequential combination cancer therapy publication-title: Adv. Drug Deliv. Rev. contributor: fullname: Oh – volume: 106 start-page: 157 year: 2016 end-page: 171 ident: b1500 article-title: Bioengineered protein-based nanocage for drug delivery publication-title: Adv. Drug Deliv. Rev. contributor: fullname: Kim – volume: 61 start-page: 33 year: 2015 end-page: 40 ident: b0595 article-title: Polymeric microparticles for sustained and local delivery of antiCD40 and antiCTLA-4 in immunotherapy of cancer publication-title: Biomaterials contributor: fullname: Hennink – volume: 5 start-page: 231 year: 2013 end-page: 238 ident: b1430 article-title: Imaging of genetically engineered T cells by PET using gold nanoparticles complexed to Copper-64 publication-title: Integrat. Biol. : Quant. Biosci. From Nano Macro contributor: fullname: Cooper – volume: 9 year: 2017 ident: b0630 article-title: In vivo imaging reveals a tumor-associated macrophage-mediated resistance pathway in anti-PD-1 therapy publication-title: Sci. Transl. Med. contributor: fullname: Pittet – volume: 378 start-page: 2078 year: 2018 end-page: 2092 ident: b0430 article-title: Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer publication-title: New Engl. J. Med. contributor: fullname: Garassino – volume: 82 start-page: 1322 year: 2007 end-page: 1331 ident: b0910 article-title: Enhancement of natural killer (NK) cell cytotoxicity by fever-range thermal stress is dependent on NKG2D function and is associated with plasma membrane NKG2D clustering and increased expression of MICA on target cells publication-title: J. Leukoc. Biol. contributor: fullname: Repasky – volume: 23 start-page: 2259 year: 2012 end-page: 2264 ident: b1165 article-title: A randomized phase III adjuvant study in high-risk cervical cancer: simultaneous radiochemotherapy with cisplatin (S-RC) versus systemic paclitaxel and carboplatin followed by percutaneous radiation (PC-R): a NOGGO-AGO Intergroup Study publication-title: Ann. Oncol. contributor: fullname: Kuemmel – volume: 160 start-page: 117 year: 2012 end-page: 134 ident: b0415 article-title: Doxil®–the first FDA-approved nano-drug: lessons learned publication-title: J. Controlled Release : Off. J. Control. Release Soc. contributor: fullname: Barenholz – volume: 379 start-page: 2108 year: 2018 end-page: 2121 ident: b0710 article-title: Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer publication-title: New Eng. J. Med. contributor: fullname: Emens – volume: 8 start-page: 2599 year: 2008 end-page: 2606 ident: b1380 article-title: Real-time intravital imaging of RGD-quantum dot binding to luminal endothelium in mouse tumor neovasculature publication-title: Nano Lett. contributor: fullname: Gambhir – volume: 13 start-page: 639 year: 2016 end-page: 650 ident: b1440 article-title: Contrast agents for molecular photoacoustic imaging publication-title: Nat. Methods contributor: fullname: Bohndiek – volume: 22 start-page: 433 year: 2016 end-page: 438 ident: b1485 article-title: Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients publication-title: Nat. Med. contributor: fullname: Rosenberg – volume: 12 start-page: 252 year: 2012 end-page: 264 ident: b0105 article-title: The blockade of immune checkpoints in cancer immunotherapy publication-title: Nat. Rev. Cancer contributor: fullname: Pardoll – volume: 3 start-page: 609 year: 2003 end-page: 620 ident: b0275 article-title: Co-stimulatory members of the TNFR family: keys to effective T-cell immunity? publication-title: Nat. Rev. Immunol. contributor: fullname: Croft – volume: 192 start-page: 209 year: 2014 end-page: 218 ident: b0480 article-title: Targeting nanoparticles to CD40, DEC-205 or CD11c molecules on dendritic cells for efficient CD8(+) T cell response: a comparative study publication-title: J. Controll. Release : Off. J. Controll. Release Soc. contributor: fullname: Ossendorp – volume: 43 start-page: 1407 year: 2013 end-page: 1412 ident: b1415 article-title: The future of immunoimaging–deeper, bigger, more precise, and definitively more colorful publication-title: Eur. J. Immunol. contributor: fullname: Germain – volume: 31 start-page: 51 year: 2013 end-page: 72 ident: b0700 article-title: Immunogenic cell death in cancer therapy publication-title: Annu. Rev. Immunol. contributor: fullname: Zitvogel – volume: 16 start-page: 121 year: 2016 end-page: 126 ident: b0170 article-title: Acquired resistance to immunotherapy and future challenges publication-title: Nat. Rev. Cancer contributor: fullname: Snyder – volume: 9 year: 2017 ident: b0575 article-title: Matrix-binding checkpoint immunotherapies enhance antitumor efficacy and reduce adverse events publication-title: Sci. Transl. Med. contributor: fullname: Hubbell – volume: 14 start-page: 223 year: 2017 end-page: 234 ident: b0940 article-title: Anti-tumor immunity of BAM-SiPc-mediated vascular photodynamic therapy in a BALB/c mouse model publication-title: Cell. Mol. Immunol. contributor: fullname: Fong – volume: 39 start-page: 1 year: 2016 end-page: 6 ident: b0115 article-title: Immune suppressive mechanisms in the tumor microenvironment publication-title: Curr. Opin. Immunol. contributor: fullname: Bronte – volume: 134 start-page: 11358 year: 2012 end-page: 11361 ident: b0870 article-title: TAT peptide-functionalized gold nanostars: enhanced intracellular delivery and efficient NIR photothermal therapy using ultralow irradiance publication-title: J. Am. Chem. Soc. contributor: fullname: Vo-Dinh – volume: 11 start-page: 3089 year: 2017 end-page: 3100 ident: b0670 article-title: Enhancing Adoptive Cell Therapy of Cancer through Targeted Delivery of Small-Molecule Immunomodulators to Internalizing or Noninternalizing Receptors publication-title: ACS Nano contributor: fullname: Irvine – volume: 103 start-page: 3073 year: 1999 end-page: 3077 ident: b0865 article-title: Simulation of the Optical Absorption Spectra of Gold Nanorods as a Function of Their Aspect Ratio and the Effect of the Medium Dielectric Constant publication-title: J. Phys. Chem. B contributor: fullname: El-Sayed – volume: 17 start-page: 6366 year: 2017 end-page: 6375 ident: b0775 article-title: Tumor Microenvironment Responsive Nanogel for the Combinatorial Antitumor Effect of Chemotherapy and Immunotherapy publication-title: Nano Lett. contributor: fullname: Zhang – volume: 28 start-page: 8912 year: 2016 end-page: 8920 ident: b0600 article-title: Inflammation-Triggered Cancer Immunotherapy by Programmed Delivery of CpG and Anti-PD1 Antibody publication-title: Adv. Mater. (Deerfield Beach Fla.) contributor: fullname: Gu – volume: 4 start-page: 1180 year: 2015 end-page: 1189 ident: b0605 article-title: Ovarian cancer immunotherapy using PD-L1 siRNA targeted delivery from folic acid-functionalized polyethylenimine: strategies to enhance T cell killing publication-title: Adv. Healthcare Mater. contributor: fullname: Ghaem-Maghami – volume: 29 start-page: 235 year: 2011 end-page: 271 ident: b0025 article-title: Natural innate and adaptive immunity to cancer publication-title: Annu. Rev. Immunol. contributor: fullname: Smyth – volume: 7 start-page: 12499 year: 2016 ident: b0995 article-title: Core-shell nanoscale coordination polymers combine chemotherapy and photodynamic therapy to potentiate checkpoint blockade cancer immunotherapy publication-title: Nat. Commun. contributor: fullname: Lin – volume: 155 start-page: 435 year: 2011 end-page: 441 ident: b0735 article-title: Targeted chemoimmunotherapy using drug-loaded aptamer-dendrimer bioconjugates publication-title: J. Controll. Release : Off. J. Controll. Release Soc. contributor: fullname: Jon – volume: 2015 start-page: 794528 year: 2015 ident: b0330 article-title: RNA-Based Vaccines in Cancer Immunotherapy publication-title: J. Immunol. Res. contributor: fullname: Holl – volume: 5 start-page: e11995 year: 2010 ident: b1185 article-title: Immunization with cocktail of HIV-derived peptides in montanide ISA-51 is immunogenic, but causes sterile abscesses and unacceptable reactogenicity publication-title: PLoS One contributor: fullname: Haynes – volume: 32 start-page: 1119 year: 2012 end-page: 1136 ident: b0355 article-title: Multiple Associations Between a Broad Spectrum of Autoimmune Diseases publication-title: Chronic Inflammatory Dis. Cancer, Anticancer Res contributor: fullname: Slansky – volume: 7 start-page: 1643 year: 2010 end-page: 1654 ident: b1105 article-title: STAT3 silencing in dendritic cells by siRNA polyplexes encapsulated in PLGA nanoparticles for the modulation of anticancer immune response publication-title: Mol. Pharm. contributor: fullname: Lavasanifar – volume: 33 start-page: 3235 year: 2012 end-page: 3242 ident: b0935 article-title: Antitumor immunologically modified carbon nanotubes for photothermal therapy publication-title: Biomaterials contributor: fullname: Xing – volume: 33 start-page: 4957 year: 2012 end-page: 4964 ident: b0495 article-title: Role of sustained antigen release from nanoparticle vaccines in shaping the T cell memory phenotype publication-title: Biomaterials contributor: fullname: Fahmy – volume: 81 start-page: 1128 year: 2011 end-page: 1135 ident: b1050 article-title: Radiation enhances regulatory T cell representation publication-title: Int. J. Radiat. Oncol. Biol. Phys. contributor: fullname: Schaue – volume: 33 start-page: 4872 year: 2012 end-page: 4881 ident: b1405 article-title: Towards whole-body imaging at the single cell level using ultra-sensitive stem cell labeling with oligo-arginine modified upconversion nanoparticles publication-title: Biomaterials contributor: fullname: Liu – volume: 12 start-page: 269 year: 2012 end-page: 281 ident: b0690 article-title: Adoptive immunotherapy for cancer: harnessing the T cell response publication-title: Nat. Rev. Immunol. contributor: fullname: Rosenberg – volume: 42 start-page: 299 year: 2019 end-page: 306 ident: b0035 article-title: Immune checkpoint inhibitors win the 2018 Nobel Prize publication-title: Biomed. J. contributor: fullname: Chang – volume: 48 start-page: 492 year: 2013 end-page: 499 ident: b1310 article-title: MRI-monitored transcatheter intra-arterial delivery of SPIO-labeled natural killer cells to hepatocellular carcinoma: preclinical studies in a rodent model publication-title: Invest. Radiol. contributor: fullname: Larson – volume: 122 start-page: 863 year: 2013 end-page: 871 ident: b0250 article-title: Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma publication-title: Blood contributor: fullname: June – volume: 21 start-page: 1919 year: 2013 end-page: 1929 ident: b0610 article-title: Intravenous delivery of siRNA targeting CD47 effectively inhibits melanoma tumor growth and lung metastasis publication-title: Mol. Therapy : J. Am. Soc. Gene Therapy contributor: fullname: Huang – volume: 4 start-page: 92 year: 2017 end-page: 101 ident: b0220 article-title: Global Manufacturing of CAR T Cell Therapy, Molecular therapy publication-title: Methods Clin. Develop. contributor: fullname: Keir – volume: 9 year: 2017 ident: b0235 article-title: A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma publication-title: Sci. Transl. Med. contributor: fullname: Maus – volume: 25 start-page: 3581 year: 2015 end-page: 3591 ident: b1305 article-title: Negatively Charged Magnetite Nanoparticle Clusters as Efficient MRI Probes for Dendritic Cell Labeling and In Vivo Tracking publication-title: Adv. Funct. Mater. contributor: fullname: Ai – volume: 7 start-page: 4694 year: 2017 ident: b0840 article-title: Surface chemistry for cytosolic gene delivery and photothermal transgene expression by gold nanorods publication-title: Sci. Rep. contributor: fullname: Kengaku – volume: 11 start-page: 10147 year: 2017 end-page: 10158 ident: b0980 article-title: Inhibiting Metastasis and Preventing Tumor Relapse by Triggering Host Immunity with Tumor-Targeted Photodynamic Therapy Using Photosensitizer-Loaded Functional Nanographenes publication-title: ACS Nano contributor: fullname: Liu – volume: 13 start-page: 349 year: 2013 end-page: 361 ident: b1270 article-title: Beyond oxidative stress: an immunologist's guide to reactive oxygen species publication-title: Nat. Rev. Immunol. contributor: fullname: Cunningham-Bussel – volume: 12 start-page: 12015 year: 2018 end-page: 12029 ident: b1425 article-title: Quantitative Imaging of Tumor-Associated Macrophages and Their Response to Therapy Using (64)Cu-Labeled Macrin publication-title: ACS Nano contributor: fullname: Miller – volume: 26 start-page: 45 year: 2018 end-page: 55 ident: b1150 article-title: Combination Immunotherapy of MUC1 mRNA Nano-vaccine and CTLA-4 Blockade Effectively Inhibits Growth of Triple Negative Breast Cancer publication-title: Mol. Therapy : J. Am. Soc. Gene Therapy contributor: fullname: Huang – volume: 17 start-page: 528 year: 2018 end-page: 534 ident: b1250 article-title: A facile approach to enhance antigen response for personalized cancer vaccination publication-title: Nat. Mater. contributor: fullname: Mooney – volume: 4 start-page: 73 year: 2007 end-page: 84 ident: b1470 article-title: Type 1 and 2 immunity following vaccination is influenced by nanoparticle size: formulation of a model vaccine for respiratory syncytial virus publication-title: Mol. Pharm. contributor: fullname: Plebanski – volume: 9 start-page: 2187 year: 2014 end-page: 2202 ident: b0455 article-title: Nanoengineered strategies to optimize dendritic cells for gastrointestinal tumor immunotherapy: from biology to translational medicine publication-title: Nanomed. (London, England) contributor: fullname: Mishra – volume: 13 start-page: 507 year: 2011 end-page: 530 ident: b1085 article-title: In vivo delivery of RNAi with lipid-based nanoparticles publication-title: Annu. Rev. Biomed. Eng. contributor: fullname: Liu – volume: 7 start-page: 3276 year: 2017 end-page: 3292 ident: b0785 article-title: Biodegradable Hollow Mesoporous Silica Nanoparticles for Regulating Tumor Microenvironment and Enhancing Antitumor Efficiency publication-title: Theranostics contributor: fullname: Zhang – volume: 18 start-page: 212 year: 2018 end-page: 219 ident: b1210 article-title: Synthetic immune niches for cancer immunotherapy publication-title: Nat. Rev. Immunol. contributor: fullname: Figdor – volume: 125 start-page: 1016 year: 2009 end-page: 1026 ident: b1545 article-title: Essential role of Notch signaling in apoptosis of human pancreatic tumoral cells mediated by exosomal nanoparticles publication-title: Int. J. Cancer contributor: fullname: Verine – volume: 8 start-page: 304 year: 2017 ident: b0060 article-title: Type I Interferons and Natural Killer Cell Regulation in Cancer publication-title: Front. Immunol. contributor: fullname: Stoiber – volume: 31 start-page: 1426 year: 2014 end-page: 1437 ident: b1335 article-title: CD44 targeting magnetic glyconanoparticles for atherosclerotic plaque imaging publication-title: Pharm. Res. contributor: fullname: Huang – volume: 124 start-page: 687 year: 2014 end-page: 695 ident: b1070 article-title: Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice publication-title: J Clin Invest contributor: fullname: Fu – volume: 9 start-page: 757 year: 2004 end-page: 764 ident: b0510 article-title: Transfection of RNA encoding tumor antigens following maturation of dendritic cells leads to prolonged presentation of antigen and the generation of high-affinity tumor-reactive cytotoxic T lymphocytes publication-title: Mol. Therapy : J. Am. Soc. Gene Therapy contributor: fullname: Yee – volume: 8 start-page: 151 year: 2009 end-page: 158 ident: b1190 article-title: Infection-mimicking materials to program dendritic cells in situ publication-title: Nat. Mater. contributor: fullname: Mooney – volume: 2 start-page: 578 year: 2018 end-page: 588 ident: b0655 article-title: TLR7/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy publication-title: Nat. Biomed. Eng. contributor: fullname: Weissleder – volume: 161 start-page: 205 year: 2015 end-page: 214 ident: b0030 article-title: Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential publication-title: Cell contributor: fullname: Allison – volume: 35 start-page: 2477 year: 2014 end-page: 2487 ident: b1240 article-title: Injectable, porous, and cell-responsive gelatin cryogels publication-title: Biomaterials contributor: fullname: Mooney – volume: 3 start-page: 3273 year: 2009 end-page: 3286 ident: b1255 article-title: Polyethyleneimine coating enhances the cellular uptake of mesoporous silica nanoparticles and allows safe delivery of siRNA and DNA constructs publication-title: ACS Nano contributor: fullname: Nel – volume: 4 start-page: 29729 year: 2014 end-page: 29734 ident: b0875 article-title: Prussian blue nanoparticles for laser-induced photothermal therapy of tumors publication-title: RSC Adv. contributor: fullname: Fernandes – volume: 146 start-page: 136 year: 2017 end-page: 145 ident: b0835 article-title: DNA nanotechnology-based composite-type gold nanoparticle-immunostimulatory DNA hydrogel for tumor photothermal immunotherapy publication-title: Biomaterials contributor: fullname: Nishikawa – volume: 62 start-page: 1604 year: 2002 end-page: 1608 ident: b0965 article-title: Generation of effective antitumor vaccines using photodynamic therapy publication-title: Cancer Res. contributor: fullname: Henderson – volume: 8 start-page: 561 year: 2017 ident: b0110 article-title: PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome publication-title: Front. Pharmacol. contributor: fullname: Iyer – volume: 61 start-page: 3689 year: 2001 end-page: 3697 ident: b0745 article-title: Cyclophosphamide, doxorubicin, and paclitaxel enhance the antitumor immune response of granulocyte/macrophage-colony stimulating factor-secreting whole-cell vaccines in HER-2/neu tolerized mice publication-title: Cancer Res. contributor: fullname: Jaffee – volume: 58 start-page: 862 year: 2004 end-page: 870 ident: b1045 article-title: Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated publication-title: Int. J. Radiat. Oncol. Biol. Phys. contributor: fullname: Formenti – volume: 168 start-page: 724 year: 2017 end-page: 740 ident: b0175 article-title: The Principles of Engineering Immune Cells to Treat Cancer publication-title: Cell contributor: fullname: June – volume: 131 start-page: 39 year: 2018 end-page: 48 ident: b0265 article-title: The immunobiology of CD27 and OX40 and their potential as targets for cancer immunotherapy publication-title: Blood contributor: fullname: Al-Shamkhani – volume: 186 start-page: 249 year: 2016 end-page: 265 ident: b0090 article-title: Soluble and membrane-bound interleukin (IL)-15 Rα/IL-15 complexes mediate proliferation of high-avidity central memory CD8(+) T cells for adoptive immunotherapy of cancer and infections publication-title: Clin. Exp. Immunol. contributor: fullname: O'Reilly – volume: 115 start-page: E4041 year: 2018 end-page: e4050 ident: b0625 article-title: Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti-PD-1 treatment publication-title: Proc. Nat. Acad. Sci. USA contributor: fullname: Donnadieu – volume: 113 start-page: E6639 year: 2016 end-page: e6648 ident: b0500 article-title: Sustained antigen availability during germinal center initiation enhances antibody responses to vaccination publication-title: Proc. Nat. Acad. Sci. USA contributor: fullname: Irvine – volume: 9 start-page: 180 year: 2014 ident: b1145 article-title: mRNA-based vaccines synergize with radiation therapy to eradicate established tumors publication-title: Radiat. Oncol. (London, England) contributor: fullname: Huber – volume: 16 start-page: 69 year: 2003 end-page: 81 ident: b0080 article-title: Interferon in the treatment of hairy-cell leukemia publication-title: Best Pract. Res. Clin. Haematol. contributor: fullname: Rai – volume: 378 start-page: 439 year: 2018 end-page: 448 ident: b0205 article-title: Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia publication-title: New Engl. J. Med. contributor: fullname: Grupp – volume: 189 start-page: 558 year: 1950 end-page: 566 ident: b1035 article-title: Radiotherapy promotes tumor-specific effector CD8+ T cells via dendritic cell activation publication-title: J. Immunol. (Baltimore Md.) contributor: fullname: van den Broek – volume: 09 start-page: 1630001 year: 2015 ident: b0885 article-title: Photonics immunotherapy — A novel strategy for cancer treatment publication-title: Journal of Innovative Optical Health Sciences contributor: fullname: Chen – volume: 363 start-page: 411 year: 2010 end-page: 422 ident: b0310 article-title: Sipuleucel-T immunotherapy for castration-resistant prostate cancer publication-title: New Engl. J. Med. contributor: fullname: Schellhammer – volume: 124 year: 2020 ident: b0020 article-title: Cancer immunotherapy: Pros, cons and beyond publication-title: Biomed. Pharmacother. contributor: fullname: Zhu – volume: 116 start-page: 116 year: 2017 end-page: 124 ident: b0165 article-title: Biomarkers of response to PD-1/PD-L1 inhibition publication-title: Critical Rev. Oncol./Hematol. contributor: fullname: Duran – volume: 29 start-page: 964 year: 2008 end-page: 970 ident: b0645 article-title: Iron intake, oxidative stress-related genes (MnSOD and MPO) and prostate cancer risk in CARET cohort publication-title: Carcinogenesis contributor: fullname: Ambrosone – volume: 393 start-page: 1819 year: 2019 end-page: 1830 ident: b0450 article-title: Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial publication-title: Lancet contributor: fullname: Lopes – volume: 28 start-page: 1707249 year: 2018 ident: b1005 article-title: Size/Charge Changeable Acidity-Responsive Micelleplex for Photodynamic-Improved PD-L1 Immunotherapy with Enhanced Tumor Penetration publication-title: Adv. Funct. Mater. contributor: fullname: Cai – volume: 28 start-page: 416 year: 2018 end-page: 432 ident: b0130 article-title: A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy publication-title: Cell Res. contributor: fullname: Liu – volume: 17 start-page: 97 year: 2017 end-page: 111 ident: b0695 article-title: Immunogenic cell death in cancer and infectious disease publication-title: Nat. Rev. Immunol. contributor: fullname: Kroemer – volume: 15 start-page: 80 year: 2008 end-page: 88 ident: b1535 article-title: Tumour-released exosomes and their implications in cancer immunity publication-title: Cell Death Differ. contributor: fullname: Rivoltini – volume: 26 start-page: 8154 year: 2014 end-page: 8162 ident: b0440 article-title: Immunological responses triggered by photothermal therapy with carbon nanotubes in combination with anti-CTLA-4 therapy to inhibit cancer metastasis publication-title: Adv. Mater. (Deerfield Beach Fla.) contributor: fullname: Liu – volume: 7 start-page: 715 year: 2019 end-page: 732 ident: b0555 article-title: Harnessing the layer-by-layer assembly technique to design biomaterials vaccines for immune modulation in translational applications publication-title: Biomater. Sci. contributor: fullname: Zhang – volume: 10 year: 2018 ident: 10.1016/j.ejpb.2021.03.010_b1265 article-title: In situ formed reactive oxygen species-responsive scaffold with gemcitabine and checkpoint inhibitor for combination therapy publication-title: Sci. Transl. Med. doi: 10.1126/scitranslmed.aan3682 contributor: fullname: Wang – volume: 18 year: 2019 ident: 10.1016/j.ejpb.2021.03.010_b0245 article-title: The emerging world of TCR-T cell trials against cancer: A systematic review publication-title: Technol. Cancer Res. Treat. doi: 10.1177/1533033819831068 contributor: fullname: Zhang – volume: 8 year: 2020 ident: 10.1016/j.ejpb.2021.03.010_b0315 article-title: Therapeutic Vaccines and Cancer Immunotherapy publication-title: Vaccines (Basel) contributor: fullname: Bhatt – volume: 33 start-page: 64 year: 2015 ident: 10.1016/j.ejpb.2021.03.010_b1195 article-title: Injectable, spontaneously assembling, inorganic scaffolds modulate immune cells in vivo and increase vaccine efficacy publication-title: Nat. Biotechnol. doi: 10.1038/nbt.3071 contributor: fullname: Kim – volume: 14 start-page: 1760 year: 2017 ident: 10.1016/j.ejpb.2021.03.010_b1205 article-title: A Light Responsive Nanoparticle-Based Delivery System Using Pheophorbide A Graft Polyethylenimine for Dendritic Cell-Based Cancer Immunotherapy publication-title: Mol. Pharm. doi: 10.1021/acs.molpharmaceut.7b00015 contributor: fullname: Zhang – volume: 189 start-page: 558 issue: 2012 year: 1950 ident: 10.1016/j.ejpb.2021.03.010_b1035 article-title: Radiotherapy promotes tumor-specific effector CD8+ T cells via dendritic cell activation publication-title: J. Immunol. (Baltimore Md.) contributor: fullname: Gupta – volume: 14 start-page: 2181 year: 2014 ident: 10.1016/j.ejpb.2021.03.010_b1515 article-title: Cancer cell membrane-coated nanoparticles for anticancer vaccination and drug delivery publication-title: Nano Lett. doi: 10.1021/nl500618u contributor: fullname: Fang – volume: 16 start-page: 489 year: 2017 ident: 10.1016/j.ejpb.2021.03.010_b1520 article-title: Designer vaccine nanodiscs for personalized cancer immunotherapy publication-title: Nat. Mater. doi: 10.1038/nmat4822 contributor: fullname: Kuai – volume: 18 start-page: 212 year: 2018 ident: 10.1016/j.ejpb.2021.03.010_b1210 article-title: Synthetic immune niches for cancer immunotherapy publication-title: Nat. Rev. Immunol. doi: 10.1038/nri.2017.89 contributor: fullname: Weiden – volume: 17 start-page: 6366 year: 2017 ident: 10.1016/j.ejpb.2021.03.010_b0775 article-title: Tumor Microenvironment Responsive Nanogel for the Combinatorial Antitumor Effect of Chemotherapy and Immunotherapy publication-title: Nano Lett. doi: 10.1021/acs.nanolett.7b03186 contributor: fullname: Song – volume: 12 start-page: 692 year: 2017 ident: 10.1016/j.ejpb.2021.03.010_b0970 article-title: Neutrophil-mediated anticancer drug delivery for suppression of postoperative malignant glioma recurrence publication-title: Nat. Nanotechnol. doi: 10.1038/nnano.2017.54 contributor: fullname: Xue – volume: 25 start-page: 1159 year: 2007 ident: 10.1016/j.ejpb.2021.03.010_b1460 article-title: Exploiting lymphatic transport and complement activation in nanoparticle vaccines publication-title: Nat. Biotechnol. doi: 10.1038/nbt1332 contributor: fullname: Reddy – volume: 8 start-page: 1747 year: 2017 ident: 10.1016/j.ejpb.2021.03.010_b0560 article-title: T cell-targeting nanoparticles focus delivery of immunotherapy to improve antitumor immunity publication-title: Nat. Commun. doi: 10.1038/s41467-017-01830-8 contributor: fullname: Schmid – volume: 4 start-page: 435 year: 2005 ident: 10.1016/j.ejpb.2021.03.010_b1390 article-title: Quantum dot bioconjugates for imaging, labelling and sensing publication-title: Nat. Mater. doi: 10.1038/nmat1390 contributor: fullname: Medintz – volume: 8 start-page: e61825 year: 2013 ident: 10.1016/j.ejpb.2021.03.010_b1525 article-title: A randomized, observer-blinded immunogenicity trial of Cervarix(®) and Gardasil(®) Human Papillomavirus vaccines in 12–15 year old girls publication-title: PLoS One doi: 10.1371/journal.pone.0061825 contributor: fullname: Draper – volume: 7 start-page: 1643 year: 2010 ident: 10.1016/j.ejpb.2021.03.010_b1105 article-title: STAT3 silencing in dendritic cells by siRNA polyplexes encapsulated in PLGA nanoparticles for the modulation of anticancer immune response publication-title: Mol. Pharm. doi: 10.1021/mp100067u contributor: fullname: Alshamsan – volume: 7 start-page: 4694 year: 2017 ident: 10.1016/j.ejpb.2021.03.010_b0840 article-title: Surface chemistry for cytosolic gene delivery and photothermal transgene expression by gold nanorods publication-title: Sci. Rep. doi: 10.1038/s41598-017-04912-1 contributor: fullname: Nakatsuji – volume: 7 start-page: 651 year: 2011 ident: 10.1016/j.ejpb.2021.03.010_b0360 article-title: Dual Roles of Immune Cells and Their Factors in Cancer Development and Progression publication-title: Int. J. Biol. Sci. doi: 10.7150/ijbs.7.651 contributor: fullname: Zamarron – volume: 11 start-page: 986 year: 2016 ident: 10.1016/j.ejpb.2021.03.010_b0635 article-title: Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues publication-title: Nat. Nanotechnol. doi: 10.1038/nnano.2016.168 contributor: fullname: Zanganeh – volume: 6 start-page: 7556 year: 2015 ident: 10.1016/j.ejpb.2021.03.010_b1245 article-title: Injectable cryogel-based whole-cell cancer vaccines publication-title: Nat. Commun. doi: 10.1038/ncomms8556 contributor: fullname: Bencherif – volume: 9 year: 2017 ident: 10.1016/j.ejpb.2021.03.010_b0630 article-title: In vivo imaging reveals a tumor-associated macrophage-mediated resistance pathway in anti-PD-1 therapy publication-title: Sci. Transl. Med. doi: 10.1126/scitranslmed.aal3604 contributor: fullname: Arlauckas – volume: 8 start-page: 561 year: 2017 ident: 10.1016/j.ejpb.2021.03.010_b0110 article-title: PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome publication-title: Front. Pharmacol. doi: 10.3389/fphar.2017.00561 contributor: fullname: Alsaab – volume: 9 start-page: 6 year: 2018 ident: 10.1016/j.ejpb.2021.03.010_b0295 article-title: Nanoparticle anchoring targets immune agonists to tumors enabling anti-cancer immunity without systemic toxicity publication-title: Nat. Commun. doi: 10.1038/s41467-017-02251-3 contributor: fullname: Zhang – volume: 8 start-page: 1738 year: 2017 ident: 10.1016/j.ejpb.2021.03.010_b0350 article-title: Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma publication-title: Nat. Commun. doi: 10.1038/s41467-017-01460-0 contributor: fullname: Lauss – volume: 112 start-page: 8260 year: 2015 ident: 10.1016/j.ejpb.2021.03.010_b1285 article-title: Microneedle-array patches loaded with hypoxia-sensitive vesicles provide fast glucose-responsive insulin delivery publication-title: Proc. Nat. Acad. Sci. USA doi: 10.1073/pnas.1505405112 contributor: fullname: Yu – volume: 161 start-page: 205 year: 2015 ident: 10.1016/j.ejpb.2021.03.010_b0030 article-title: Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential publication-title: Cell doi: 10.1016/j.cell.2015.03.030 contributor: fullname: Sharma – volume: 82 start-page: 1322 year: 2007 ident: 10.1016/j.ejpb.2021.03.010_b0910 article-title: Enhancement of natural killer (NK) cell cytotoxicity by fever-range thermal stress is dependent on NKG2D function and is associated with plasma membrane NKG2D clustering and increased expression of MICA on target cells publication-title: J. Leukoc. Biol. doi: 10.1189/jlb.1106699 contributor: fullname: Ostberg – volume: 21 start-page: 227 year: 2014 ident: 10.1016/j.ejpb.2021.03.010_b0055 article-title: Inhibition of tumor angiogenesis by interferon-γ by suppression of tumor-associated macrophage differentiation publication-title: Oncol. Res. doi: 10.3727/096504014X13890370410285 contributor: fullname: Sun – volume: 6 start-page: 675 year: 2011 ident: 10.1016/j.ejpb.2021.03.010_b0465 article-title: A multifunctional core-shell nanoparticle for dendritic cell-based cancer immunotherapy publication-title: Nat. Nanotechnol. doi: 10.1038/nnano.2011.149 contributor: fullname: Cho – volume: 378 start-page: 158 year: 2018 ident: 10.1016/j.ejpb.2021.03.010_b0150 article-title: Immune-Related Adverse Events Associated with Immune Checkpoint Blockade publication-title: New Engl. J. Med. doi: 10.1056/NEJMra1703481 contributor: fullname: Postow – volume: 27 start-page: 559 year: 2016 ident: 10.1016/j.ejpb.2021.03.010_b0395 article-title: Management of immune checkpoint blockade dysimmune toxicities: a collaborative position paper publication-title: Ann. Oncol. doi: 10.1093/annonc/mdv623 contributor: fullname: Champiat – volume: 14 start-page: 223 year: 2017 ident: 10.1016/j.ejpb.2021.03.010_b0940 article-title: Anti-tumor immunity of BAM-SiPc-mediated vascular photodynamic therapy in a BALB/c mouse model publication-title: Cell. Mol. Immunol. doi: 10.1038/cmi.2015.84 contributor: fullname: Yeung – volume: 8 start-page: 1324 year: 2017 ident: 10.1016/j.ejpb.2021.03.010_b1480 article-title: Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors publication-title: Nat. Commun. doi: 10.1038/s41467-017-00965-y contributor: fullname: Adalsteinsson – volume: 34 start-page: 2969 year: 2016 ident: 10.1016/j.ejpb.2021.03.010_b0725 article-title: Nivolumab in Combination With Platinum-Based Doublet Chemotherapy for First-Line Treatment of Advanced Non-Small-Cell Lung Cancer publication-title: J. Clin. Oncol. doi: 10.1200/JCO.2016.66.9861 contributor: fullname: Rizvi – volume: 5 start-page: 22 year: 2017 ident: 10.1016/j.ejpb.2021.03.010_b0145 article-title: Safety, tumor trafficking and immunogenicity of chimeric antigen receptor (CAR)-T cells specific for TAG-72 in colorectal cancer publication-title: J. ImmunoTher. Cancer doi: 10.1186/s40425-017-0222-9 contributor: fullname: Hege – volume: 43 start-page: 1407 year: 2013 ident: 10.1016/j.ejpb.2021.03.010_b1415 article-title: The future of immunoimaging–deeper, bigger, more precise, and definitively more colorful publication-title: Eur. J. Immunol. doi: 10.1002/eji.201243119 contributor: fullname: Tang – volume: 131 start-page: 39 year: 2018 ident: 10.1016/j.ejpb.2021.03.010_b0265 article-title: The immunobiology of CD27 and OX40 and their potential as targets for cancer immunotherapy publication-title: Blood doi: 10.1182/blood-2017-07-741025 contributor: fullname: Buchan – volume: 4 start-page: eaao1736 year: 2018 ident: 10.1016/j.ejpb.2021.03.010_b0705 article-title: Elimination of established tumors with nanodisc-based combination chemoimmunotherapy publication-title: Sci. Adv. doi: 10.1126/sciadv.aao1736 contributor: fullname: Kuai – volume: 48 start-page: 492 year: 2013 ident: 10.1016/j.ejpb.2021.03.010_b1310 article-title: MRI-monitored transcatheter intra-arterial delivery of SPIO-labeled natural killer cells to hepatocellular carcinoma: preclinical studies in a rodent model publication-title: Invest. Radiol. doi: 10.1097/RLI.0b013e31827994e5 contributor: fullname: Sheu – volume: 359 start-page: 169 year: 2015 ident: 10.1016/j.ejpb.2021.03.010_b0810 article-title: InCVAX–a novel strategy for treatment of late-stage, metastatic cancers through photoimmunotherapy induced tumor-specific immunity publication-title: Cancer Lett. doi: 10.1016/j.canlet.2015.01.029 contributor: fullname: Zhou – volume: 33 start-page: 5584 year: 2012 ident: 10.1016/j.ejpb.2021.03.010_b1315 article-title: The manipulation of natural killer cells to target tumor sites using magnetic nanoparticles publication-title: Biomaterials doi: 10.1016/j.biomaterials.2012.04.041 contributor: fullname: Jang – volume: 131 start-page: 49 year: 2018 ident: 10.1016/j.ejpb.2021.03.010_b0270 article-title: Immunotherapy targeting 4–1BB: mechanistic rationale, clinical results, and future strategies publication-title: Blood doi: 10.1182/blood-2017-06-741041 contributor: fullname: Chester – volume: 139 start-page: 693 year: 2009 ident: 10.1016/j.ejpb.2021.03.010_b0385 article-title: An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation publication-title: Cell doi: 10.1016/j.cell.2009.10.014 contributor: fullname: Iliopoulos – volume: 17 start-page: 97 year: 2017 ident: 10.1016/j.ejpb.2021.03.010_b0695 article-title: Immunogenic cell death in cancer and infectious disease publication-title: Nat. Rev. Immunol. doi: 10.1038/nri.2016.107 contributor: fullname: Galluzzi – volume: 10 start-page: 664 year: 2011 ident: 10.1016/j.ejpb.2021.03.010_b0975 article-title: Cancer vaccines generated by photodynamic therapy publication-title: Photochem. Photobiol. Sci. : Off. J. Eur. Photochemistry Assoc. Eur. Soc. Photobiol. doi: 10.1039/c0pp00343c contributor: fullname: Korbelik – volume: 11 start-page: e0156626 year: 2016 ident: 10.1016/j.ejpb.2021.03.010_b1300 article-title: In Vivo Non-Invasive Tracking of Macrophage Recruitment to Experimental Stroke publication-title: PLoS One doi: 10.1371/journal.pone.0156626 contributor: fullname: Selt – volume: 13 start-page: 195 year: 2017 ident: 10.1016/j.ejpb.2021.03.010_b0160 article-title: Cancer immunotherapy - immune checkpoint blockade and associated endocrinopathies, Nature reviews publication-title: Endocrinology contributor: fullname: Byun – volume: 348 start-page: 69 year: 2015 ident: 10.1016/j.ejpb.2021.03.010_b0400 article-title: Neoantigens in cancer immunotherapy publication-title: Science (New York, N.Y.) doi: 10.1126/science.aaa4971 contributor: fullname: Schumacher – volume: 155 start-page: 435 year: 2011 ident: 10.1016/j.ejpb.2021.03.010_b0735 article-title: Targeted chemoimmunotherapy using drug-loaded aptamer-dendrimer bioconjugates publication-title: J. Controll. Release : Off. J. Controll. Release Soc. doi: 10.1016/j.jconrel.2011.05.025 contributor: fullname: Lee – volume: 40 start-page: 88 year: 2015 ident: 10.1016/j.ejpb.2021.03.010_b0485 article-title: CD40-targeted dendritic cell delivery of PLGA-nanoparticle vaccines induce potent anti-tumor responses publication-title: Biomaterials doi: 10.1016/j.biomaterials.2014.10.053 contributor: fullname: Rosalia – volume: 116 start-page: 116 year: 2017 ident: 10.1016/j.ejpb.2021.03.010_b0165 article-title: Biomarkers of response to PD-1/PD-L1 inhibition publication-title: Critical Rev. Oncol./Hematol. doi: 10.1016/j.critrevonc.2017.06.001 contributor: fullname: Maleki Vareki – volume: 12 start-page: 813 year: 2017 ident: 10.1016/j.ejpb.2021.03.010_b0535 article-title: In situ programming of leukaemia-specific T cells using synthetic DNA nanocarriers publication-title: Nat. Nanotechnol. doi: 10.1038/nnano.2017.57 contributor: fullname: Smith – volume: 7 start-page: 13193 year: 2016 ident: 10.1016/j.ejpb.2021.03.010_b0905 article-title: Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy publication-title: Nat. Commun. doi: 10.1038/ncomms13193 contributor: fullname: Chen – volume: 10 start-page: 1273 year: 2014 ident: 10.1016/j.ejpb.2021.03.010_b0800 article-title: Local hyperthermia treatment of tumors induces CD8(+) T cell-mediated resistance against distal and secondary tumors publication-title: Nanomed. Nanotechnol. Biol. Med. doi: 10.1016/j.nano.2014.01.011 contributor: fullname: Toraya-Brown – volume: 157 start-page: 9 year: 2009 ident: 10.1016/j.ejpb.2021.03.010_b0255 article-title: Cancer immunotherapy: co-stimulatory agonists and co-inhibitory antagonists publication-title: Clin. Exp. Immunol. doi: 10.1111/j.1365-2249.2009.03912.x contributor: fullname: Peggs – volume: 28 start-page: 200 year: 2011 ident: 10.1016/j.ejpb.2021.03.010_b1090 article-title: Cancer immunotherapy and nanomedicine publication-title: Pharm. Res. doi: 10.1007/s11095-010-0258-8 contributor: fullname: Sheng – volume: 2014 year: 2014 ident: 10.1016/j.ejpb.2021.03.010_b0365 article-title: Chronic Inflammation and Cytokines in the Tumor Microenvironment publication-title: J. Immunol. Res. doi: 10.1155/2014/149185 contributor: fullname: Landskron – volume: 50 start-page: 1 year: 2018 ident: 10.1016/j.ejpb.2021.03.010_b0120 article-title: Immune checkpoint inhibitors: recent progress and potential biomarkers publication-title: Exp. Mol. Med. doi: 10.1038/s12276-018-0191-1 contributor: fullname: Darvin – volume: 23 start-page: 1541 year: 2015 ident: 10.1016/j.ejpb.2021.03.010_b0225 article-title: Case Report of a Fatal Serious Adverse Event Upon Administration of T Cells Transduced With a MART-1-specific T-cell Receptor publication-title: Mol. Therapy : J. Am. Soc. Gene Therapy doi: 10.1038/mt.2015.60 contributor: fullname: van den Berg – volume: 117 start-page: 1175 year: 2007 ident: 10.1016/j.ejpb.2021.03.010_b0380 article-title: A cytokine-mediated link between innate immunity, inflammation, and cancer publication-title: J. Clin. Invest. doi: 10.1172/JCI31537 contributor: fullname: Lin – volume: 17 start-page: 528 year: 2018 ident: 10.1016/j.ejpb.2021.03.010_b1250 article-title: A facile approach to enhance antigen response for personalized cancer vaccination publication-title: Nat. Mater. doi: 10.1038/s41563-018-0028-2 contributor: fullname: Li – volume: 61 start-page: 459 year: 2001 ident: 10.1016/j.ejpb.2021.03.010_b0805 article-title: Antitumor immunity induced by laser immunotherapy and its adoptive transfer publication-title: Cancer Res. contributor: fullname: Chen – volume: 28 start-page: 1383 year: 2013 ident: 10.1016/j.ejpb.2021.03.010_b0945 article-title: Generation of an effective anti-lung cancer vaccine by DTPP-mediated photodynamic therapy and mechanistic studies publication-title: Lasers Med. Sci. doi: 10.1007/s10103-013-1270-0 contributor: fullname: Zheng – volume: 378 start-page: 439 year: 2018 ident: 10.1016/j.ejpb.2021.03.010_b0205 article-title: Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia publication-title: New Engl. J. Med. doi: 10.1056/NEJMoa1709866 contributor: fullname: Maude – volume: 119 start-page: 2231 year: 2009 ident: 10.1016/j.ejpb.2021.03.010_b1475 article-title: Polyethylenimine-based siRNA nanocomplexes reprogram tumor-associated dendritic cells via TLR5 to elicit therapeutic antitumor immunity publication-title: J. Clin. Invest. contributor: fullname: Cubillos-Ruiz – volume: 3 start-page: 609 year: 2003 ident: 10.1016/j.ejpb.2021.03.010_b0275 article-title: Co-stimulatory members of the TNFR family: keys to effective T-cell immunity? publication-title: Nat. Rev. Immunol. doi: 10.1038/nri1148 contributor: fullname: Croft – volume: 120 start-page: 4691 year: 2016 ident: 10.1016/j.ejpb.2021.03.010_b0825 article-title: Recent Progress in Cancer Thermal Therapy Using Gold Nanoparticles publication-title: J. Phys. Chem. C doi: 10.1021/acs.jpcc.5b11232 contributor: fullname: Abadeer – volume: 23 start-page: 5349 year: 2017 ident: 10.1016/j.ejpb.2021.03.010_b0285 article-title: Phase Ib Study of Utomilumab (PF-05082566), a 4–1BB/CD137 Agonist, in Combination with Pembrolizumab (MK-3475) in Patients with Advanced Solid Tumors publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-17-1243 contributor: fullname: Tolcher – volume: 35 start-page: 6646 year: 2014 ident: 10.1016/j.ejpb.2021.03.010_b0860 article-title: Engineered, self-assembled near-infrared photothermal agents for combined tumor immunotherapy and chemo-photothermal therapy publication-title: Biomaterials doi: 10.1016/j.biomaterials.2014.04.073 contributor: fullname: Tao – volume: 142 start-page: 2363 year: 2018 ident: 10.1016/j.ejpb.2021.03.010_b0950 article-title: Near-infrared photoimmunotherapy targeting EGFR-Shedding new light on glioblastoma treatment publication-title: Int. J. Cancer doi: 10.1002/ijc.31246 contributor: fullname: Burley – volume: 64 start-page: 36 year: 2015 ident: 10.1016/j.ejpb.2021.03.010_b0470 article-title: Immune response profile elicited by the model antigen ovalbumin expressed in fusion with the bacterial OprI lipoprotein publication-title: Mol. Immunol. doi: 10.1016/j.molimm.2014.10.020 contributor: fullname: Basto – volume: 15 start-page: 80 year: 2008 ident: 10.1016/j.ejpb.2021.03.010_b1535 article-title: Tumour-released exosomes and their implications in cancer immunity publication-title: Cell Death Differ. doi: 10.1038/sj.cdd.4402237 contributor: fullname: Iero – volume: 61 start-page: 33 year: 2015 ident: 10.1016/j.ejpb.2021.03.010_b0595 article-title: Polymeric microparticles for sustained and local delivery of antiCD40 and antiCTLA-4 in immunotherapy of cancer publication-title: Biomaterials doi: 10.1016/j.biomaterials.2015.04.043 contributor: fullname: Rahimian – volume: 23 start-page: 4621 year: 2013 ident: 10.1016/j.ejpb.2021.03.010_b1220 article-title: Inflammatory cytokines presented from polymer matrices differentially generate and activate DCs in situ publication-title: Adv. Funct. Mater. doi: 10.1002/adfm.201203859 contributor: fullname: Ali – volume: 28 start-page: 1707249 year: 2018 ident: 10.1016/j.ejpb.2021.03.010_b1005 article-title: Size/Charge Changeable Acidity-Responsive Micelleplex for Photodynamic-Improved PD-L1 Immunotherapy with Enhanced Tumor Penetration publication-title: Adv. Funct. Mater. doi: 10.1002/adfm.201707249 contributor: fullname: Dai – volume: 35 start-page: 709 year: 2017 ident: 10.1016/j.ejpb.2021.03.010_b0155 article-title: Pneumonitis in Patients Treated With Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy publication-title: J. Clin. Oncol. doi: 10.1200/JCO.2016.68.2005 contributor: fullname: Naidoo – volume: 2019 start-page: 4508794 year: 2019 ident: 10.1016/j.ejpb.2021.03.010_b0390 article-title: Current Challenges in Cancer Immunotherapy: Multimodal Approaches to Improve Efficacy and Patient Response Rates publication-title: J. Oncol. doi: 10.1155/2019/4508794 contributor: fullname: Sambi – volume: 25 start-page: 3581 year: 2015 ident: 10.1016/j.ejpb.2021.03.010_b1305 article-title: Negatively Charged Magnetite Nanoparticle Clusters as Efficient MRI Probes for Dendritic Cell Labeling and In Vivo Tracking publication-title: Adv. Funct. Mater. doi: 10.1002/adfm.201501031 contributor: fullname: Wu – volume: 29 start-page: 3671 year: 2008 ident: 10.1016/j.ejpb.2021.03.010_b1235 article-title: Injectable dendritic cell-carrying alginate gels for immunization and immunotherapy publication-title: Biomaterials doi: 10.1016/j.biomaterials.2008.05.033 contributor: fullname: Hori – volume: 30 start-page: 617 year: 1993 ident: 10.1016/j.ejpb.2021.03.010_b1290 article-title: Intracellular labeling of T-cells with superparamagnetic contrast agents publication-title: Magn. Reson. Med. doi: 10.1002/mrm.1910300513 contributor: fullname: Yeh – volume: 5 start-page: 197ra103 year: 2013 ident: 10.1016/j.ejpb.2021.03.010_b0240 article-title: Identification of a Titin-derived HLA-A1-presented peptide as a cross-reactive target for engineered MAGE A3-directed T cells publication-title: Sci. Transl. Med. doi: 10.1126/scitranslmed.3006034 contributor: fullname: Cameron – volume: 377 start-page: 1313 year: 2017 ident: 10.1016/j.ejpb.2021.03.010_b0530 article-title: Tragedy, Perseverance, and Chance - The Story of CAR-T Therapy publication-title: New Engl. J. Med. doi: 10.1056/NEJMp1711886 contributor: fullname: Rosenbaum – volume: 39 start-page: 56 year: 2004 ident: 10.1016/j.ejpb.2021.03.010_b1295 article-title: Macrophage endocytosis of superparamagnetic iron oxide nanoparticles: mechanisms and comparison of ferumoxides and ferumoxtran-10 publication-title: Invest. Radiol. doi: 10.1097/01.rli.0000101027.57021.28 contributor: fullname: Raynal – volume: 12 start-page: 12015 year: 2018 ident: 10.1016/j.ejpb.2021.03.010_b1425 article-title: Quantitative Imaging of Tumor-Associated Macrophages and Their Response to Therapy Using (64)Cu-Labeled Macrin publication-title: ACS Nano doi: 10.1021/acsnano.8b04338 contributor: fullname: Kim – volume: 113 start-page: E6639 year: 2016 ident: 10.1016/j.ejpb.2021.03.010_b0500 article-title: Sustained antigen availability during germinal center initiation enhances antibody responses to vaccination publication-title: Proc. Nat. Acad. Sci. USA doi: 10.1073/pnas.1606050113 contributor: fullname: Tam – volume: 146 start-page: 136 year: 2017 ident: 10.1016/j.ejpb.2021.03.010_b0835 article-title: DNA nanotechnology-based composite-type gold nanoparticle-immunostimulatory DNA hydrogel for tumor photothermal immunotherapy publication-title: Biomaterials doi: 10.1016/j.biomaterials.2017.09.014 contributor: fullname: Yata – volume: 27 start-page: 437 year: 2015 ident: 10.1016/j.ejpb.2021.03.010_b1055 article-title: Radiotherapy complements immune checkpoint blockade publication-title: Cancer Cell doi: 10.1016/j.ccell.2015.03.015 contributor: fullname: Ngiow – start-page: 220954 year: 2017 ident: 10.1016/j.ejpb.2021.03.010_b1410 article-title: Wide-field dynamic monitoring of immune cell trafficking in murine models of glioblastoma publication-title: bioRxiv contributor: fullname: SoRelle – volume: 210 start-page: 1695 year: 2013 ident: 10.1016/j.ejpb.2021.03.010_b0135 article-title: Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma publication-title: J. Exp. Med. doi: 10.1084/jem.20130579 contributor: fullname: Simpson – volume: 9 start-page: 581 year: 2009 ident: 10.1016/j.ejpb.2021.03.010_b1530 article-title: Membrane vesicles as conveyors of immune responses publication-title: Nat. Rev. Immunol. doi: 10.1038/nri2567 contributor: fullname: Théry – volume: 12 start-page: 700 year: 2016 ident: 10.1016/j.ejpb.2021.03.010_b1135 article-title: Folate-Modified Chitosan Nanoparticles Coated Interferon-Inducible Protein-10 Gene Enhance Cytotoxic T Lymphocytes' Responses to Hepatocellular Carcinoma publication-title: J. Biomed. Nanotechnol. doi: 10.1166/jbn.2016.2216 contributor: fullname: Duan – volume: 68 start-page: 54 year: 2015 ident: 10.1016/j.ejpb.2021.03.010_b0680 article-title: Nanoparticle delivery of CDDO-Me remodels the tumor microenvironment and enhances vaccine therapy for melanoma publication-title: Biomaterials doi: 10.1016/j.biomaterials.2015.07.053 contributor: fullname: Zhao – volume: 15 start-page: 663 year: 2016 ident: 10.1016/j.ejpb.2021.03.010_b0300 article-title: The cancer vaccine resurgence publication-title: Nat. Rev. Drug Discovery doi: 10.1038/nrd.2016.201 contributor: fullname: Mullard – volume: 7 start-page: 12499 year: 2016 ident: 10.1016/j.ejpb.2021.03.010_b0995 article-title: Core-shell nanoscale coordination polymers combine chemotherapy and photodynamic therapy to potentiate checkpoint blockade cancer immunotherapy publication-title: Nat. Commun. doi: 10.1038/ncomms12499 contributor: fullname: He – volume: 75 start-page: 237 year: 2016 ident: 10.1016/j.ejpb.2021.03.010_b1275 article-title: Chitosan thermogels for local expansion and delivery of tumor-specific T lymphocytes towards enhanced cancer immunotherapies publication-title: Biomaterials doi: 10.1016/j.biomaterials.2015.10.021 contributor: fullname: Monette – volume: 12 start-page: 252 year: 2012 ident: 10.1016/j.ejpb.2021.03.010_b0105 article-title: The blockade of immune checkpoints in cancer immunotherapy publication-title: Nat. Rev. Cancer doi: 10.1038/nrc3239 contributor: fullname: Pardoll – volume: 9 year: 2017 ident: 10.1016/j.ejpb.2021.03.010_b0790 article-title: Gold nanoparticle-mediated photothermal therapy: applications and opportunities for multimodal cancer treatment publication-title: Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. doi: 10.1002/wnan.1449 contributor: fullname: Riley – volume: 23 start-page: 741 year: 2005 ident: 10.1016/j.ejpb.2021.03.010_b1175 article-title: Autoimmunity in a phase I trial of a fully human anti-cytotoxic T-lymphocyte antigen-4 monoclonal antibody with multiple melanoma peptides and Montanide ISA 51 for patients with resected stages III and IV melanoma publication-title: J. Clin. Oncol. doi: 10.1200/JCO.2005.01.128 contributor: fullname: Sanderson – volume: 122 start-page: 863 year: 2013 ident: 10.1016/j.ejpb.2021.03.010_b0250 article-title: Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma publication-title: Blood doi: 10.1182/blood-2013-03-490565 contributor: fullname: Linette – volume: 35 start-page: 590 year: 2014 ident: 10.1016/j.ejpb.2021.03.010_b0410 article-title: Programmed nanoparticles for combined immunomodulation, antigen presentation and tracking of immunotherapeutic cells publication-title: Biomaterials doi: 10.1016/j.biomaterials.2013.10.009 contributor: fullname: Heo – volume: 393 start-page: 1819 year: 2019 ident: 10.1016/j.ejpb.2021.03.010_b0450 article-title: Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial publication-title: Lancet doi: 10.1016/S0140-6736(18)32409-7 contributor: fullname: Mok – volume: 16 start-page: 566 year: 2016 ident: 10.1016/j.ejpb.2021.03.010_b0180 article-title: Engineered T cells: the promise and challenges of cancer immunotherapy publication-title: Nat. Rev. Cancer doi: 10.1038/nrc.2016.97 contributor: fullname: Fesnak – volume: 137 start-page: 7600 year: 2015 ident: 10.1016/j.ejpb.2021.03.010_b1030 article-title: A Chlorin-Based Nanoscale Metal-Organic Framework for Photodynamic Therapy of Colon Cancers publication-title: J. Am. Chem. Soc. doi: 10.1021/jacs.5b04069 contributor: fullname: Lu – volume: 166 start-page: 7309 issue: 2001 year: 1950 ident: 10.1016/j.ejpb.2021.03.010_b1565 article-title: Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles publication-title: J. Immunol. (Baltimore Md.) contributor: fullname: Théry – volume: 8 start-page: e69073 year: 2013 ident: 10.1016/j.ejpb.2021.03.010_b0795 article-title: Elimination of metastatic melanoma using gold nanoshell-enabled photothermal therapy and adoptive T cell transfer publication-title: PLoS One doi: 10.1371/journal.pone.0069073 contributor: fullname: Bear – volume: 377 start-page: 2531 year: 2017 ident: 10.1016/j.ejpb.2021.03.010_b0200 article-title: Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma publication-title: New Engl. J. Med. doi: 10.1056/NEJMoa1707447 contributor: fullname: Neelapu – volume: 13 start-page: 349 year: 2013 ident: 10.1016/j.ejpb.2021.03.010_b1270 article-title: Beyond oxidative stress: an immunologist's guide to reactive oxygen species publication-title: Nat. Rev. Immunol. doi: 10.1038/nri3423 contributor: fullname: Nathan – volume: 10 start-page: 5981 year: 2015 ident: 10.1016/j.ejpb.2021.03.010_b0760 article-title: Sequential delivery of an anticancer drug and combined immunomodulatory nanoparticles for efficient chemoimmunotherapy publication-title: Int. J. Nanomed. contributor: fullname: Heo – volume: 39 start-page: 1 year: 2016 ident: 10.1016/j.ejpb.2021.03.010_b0115 article-title: Immune suppressive mechanisms in the tumor microenvironment publication-title: Curr. Opin. Immunol. doi: 10.1016/j.coi.2015.10.009 contributor: fullname: Munn – volume: 38 start-page: 50 year: 2015 ident: 10.1016/j.ejpb.2021.03.010_b1100 article-title: Nanovaccine loaded with poly I: C and STAT3 siRNA robustly elicits anti-tumor immune responses through modulating tumor-associated dendritic cells in vivo publication-title: Biomaterials doi: 10.1016/j.biomaterials.2014.10.050 contributor: fullname: Luo – volume: 21 start-page: 2837 year: 2003 ident: 10.1016/j.ejpb.2021.03.010_b1260 article-title: Enhanced adjuvanticity of interleukin-2 plasmid DNA administered in polyethylenimine complexes publication-title: Vaccine doi: 10.1016/S0264-410X(03)00178-6 contributor: fullname: Oh – volume: 17 start-page: 2270 year: 2011 ident: 10.1016/j.ejpb.2021.03.010_b1180 article-title: Local activation of CD8 T cells and systemic tumor eradication without toxicity via slow release and local delivery of agonistic CD40 antibody publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-10-2888 contributor: fullname: Fransen – volume: 9 start-page: 757 year: 2004 ident: 10.1016/j.ejpb.2021.03.010_b0510 article-title: Transfection of RNA encoding tumor antigens following maturation of dendritic cells leads to prolonged presentation of antigen and the generation of high-affinity tumor-reactive cytotoxic T lymphocytes publication-title: Mol. Therapy : J. Am. Soc. Gene Therapy doi: 10.1016/j.ymthe.2004.02.011 contributor: fullname: Liao – volume: 351 issue: Suppl 2 year: 1998 ident: 10.1016/j.ejpb.2021.03.010_b0005 article-title: Conventional cancer therapy: promise broken or promise delayed? publication-title: Lancet contributor: fullname: Tannock – volume: 74 start-page: 1670 year: 2014 ident: 10.1016/j.ejpb.2021.03.010_b1225 article-title: Identification of immune factors regulating antitumor immunity using polymeric vaccines with multiple adjuvants publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-13-0777 contributor: fullname: Ali – volume: 9 start-page: 6918 year: 2015 ident: 10.1016/j.ejpb.2021.03.010_b1510 article-title: Erythrocyte Membrane-Enveloped Polymeric Nanoparticles as Nanovaccine for Induction of Antitumor Immunity against Melanoma publication-title: ACS Nano doi: 10.1021/acsnano.5b01042 contributor: fullname: Guo – volume: 25 start-page: 2000 year: 2007 ident: 10.1016/j.ejpb.2021.03.010_b0015 article-title: Outcome of patients experiencing progression or relapse after primary treatment with two cycles of chemotherapy and radiotherapy for early-stage favorable Hodgkin's lymphoma publication-title: J. Clin. Oncol. doi: 10.1200/JCO.2006.10.1386 contributor: fullname: Sieniawski – volume: 3 start-page: 3856 year: 2011 ident: 10.1016/j.ejpb.2021.03.010_b0045 article-title: Cytokines in cancer immunotherapy publication-title: Cancers doi: 10.3390/cancers3043856 contributor: fullname: Lee – volume: 30 start-page: v913 year: 2019 ident: 10.1016/j.ejpb.2021.03.010_b0420 article-title: LBA4_PR - Nivolumab (NIVO) + low-dose ipilimumab (IPI) vs platinum-doublet chemotherapy (chemo) as first-line (1L) treatment (tx) for advanced non-small cell lung cancer (NSCLC): CheckMate 227 part 1 final analysis publication-title: Ann. Oncol. doi: 10.1093/annonc/mdz394.075 contributor: fullname: Peters – volume: 61 start-page: 1387 year: 2012 ident: 10.1016/j.ejpb.2021.03.010_b0955 article-title: Photodynamic therapy-generated cancer vaccine elicits acute phase and hormonal response in treated mice publication-title: Cancer Immunol., Immunotherapy : CII doi: 10.1007/s00262-012-1206-8 contributor: fullname: Korbelik – volume: 4 start-page: 399 year: 2009 ident: 10.1016/j.ejpb.2021.03.010_b1420 article-title: Molecular imaging and therapy of cancer with radiolabeled nanoparticles publication-title: Nano Today doi: 10.1016/j.nantod.2009.07.001 contributor: fullname: Hong – volume: 41 start-page: 843 year: 2014 ident: 10.1016/j.ejpb.2021.03.010_b1040 article-title: STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors publication-title: Immunity doi: 10.1016/j.immuni.2014.10.019 contributor: fullname: Deng – volume: 2 start-page: 675 year: 2002 ident: 10.1016/j.ejpb.2021.03.010_b0050 article-title: Viruses and interferon: a fight for supremacy publication-title: Nat. Rev. Immunol. doi: 10.1038/nri888 contributor: fullname: Katze – volume: 27 start-page: 2008 year: 2010 ident: 10.1016/j.ejpb.2021.03.010_b0590 article-title: Hydrophilic polyester microspheres: effect of molecular weight and copolymer composition on release of BSA publication-title: Pharm. Res. doi: 10.1007/s11095-010-0205-8 contributor: fullname: Ghassemi – volume: 134 start-page: 11358 year: 2012 ident: 10.1016/j.ejpb.2021.03.010_b0870 article-title: TAT peptide-functionalized gold nanostars: enhanced intracellular delivery and efficient NIR photothermal therapy using ultralow irradiance publication-title: J. Am. Chem. Soc. doi: 10.1021/ja304180y contributor: fullname: Yuan – volume: 3 start-page: 3702 year: 2018 ident: 10.1016/j.ejpb.2021.03.010_b1060 article-title: Radiation Therapy Combined with Cowpea Mosaic Virus Nanoparticle in Situ Vaccination Initiates Immune-Mediated Tumor Regression publication-title: ACS Omega doi: 10.1021/acsomega.8b00227 contributor: fullname: Patel – volume: 22 start-page: 433 year: 2016 ident: 10.1016/j.ejpb.2021.03.010_b1485 article-title: Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients publication-title: Nat. Med. doi: 10.1038/nm.4051 contributor: fullname: Gros – volume: 9 start-page: 162 year: 2009 ident: 10.1016/j.ejpb.2021.03.010_b0370 article-title: Myeloid-derived suppressor cells as regulators of the immune system publication-title: Nat. Rev. Immunol. doi: 10.1038/nri2506 contributor: fullname: Gabrilovich – volume: 35 start-page: 7992 year: 2014 ident: 10.1016/j.ejpb.2021.03.010_b0750 article-title: Poly (γ-glutamic acid) based combination of water-insoluble paclitaxel and TLR7 agonist for chemo-immunotherapy publication-title: Biomaterials doi: 10.1016/j.biomaterials.2014.05.076 contributor: fullname: Seth – volume: 9 start-page: 1532 year: 2018 ident: 10.1016/j.ejpb.2021.03.010_b0895 article-title: A cancer vaccine-mediated postoperative immunotherapy for recurrent and metastatic tumors publication-title: Nat. Commun. doi: 10.1038/s41467-018-03915-4 contributor: fullname: Wang – volume: 378 start-page: 2078 year: 2018 ident: 10.1016/j.ejpb.2021.03.010_b0430 article-title: Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer publication-title: New Engl. J. Med. doi: 10.1056/NEJMoa1801005 contributor: fullname: Gandhi – volume: 22 start-page: 1459 year: 2016 ident: 10.1016/j.ejpb.2021.03.010_b0435 article-title: Combination of Photodynamic Therapy and Specific Immunotherapy Efficiently Eradicates Established Tumors publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-15-0515 contributor: fullname: Kleinovink – volume: 58 start-page: 862 year: 2004 ident: 10.1016/j.ejpb.2021.03.010_b1045 article-title: Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated publication-title: Int. J. Radiat. Oncol. Biol. Phys. doi: 10.1016/j.ijrobp.2003.09.012 contributor: fullname: Demaria – volume: 33 start-page: 3235 year: 2012 ident: 10.1016/j.ejpb.2021.03.010_b0935 article-title: Antitumor immunologically modified carbon nanotubes for photothermal therapy publication-title: Biomaterials doi: 10.1016/j.biomaterials.2011.12.029 contributor: fullname: Zhou – volume: 114 start-page: 79 year: 2017 ident: 10.1016/j.ejpb.2021.03.010_b0085 article-title: Delivering safer immunotherapies for cancer publication-title: Adv. Drug Deliv. Rev. doi: 10.1016/j.addr.2017.05.011 contributor: fullname: Milling – volume: 33 start-page: 649 year: 2018 ident: 10.1016/j.ejpb.2021.03.010_b0125 article-title: Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies publication-title: Cancer Cell doi: 10.1016/j.ccell.2018.02.010 contributor: fullname: Arce Vargas – volume: 15 start-page: 335 year: 2015 ident: 10.1016/j.ejpb.2021.03.010_b0925 article-title: Fever and the thermal regulation of immunity: the immune system feels the heat publication-title: Nat. Rev. Immunol. doi: 10.1038/nri3843 contributor: fullname: Evans – volume: 62 start-page: 1604 year: 2002 ident: 10.1016/j.ejpb.2021.03.010_b0965 article-title: Generation of effective antitumor vaccines using photodynamic therapy publication-title: Cancer Res. contributor: fullname: Gollnick – volume: 23 start-page: 1929 year: 2017 ident: 10.1016/j.ejpb.2021.03.010_b0290 article-title: Results from an Integrated Safety Analysis of Urelumab, an Agonist Anti-CD137 Monoclonal Antibody publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-16-1272 contributor: fullname: Segal – volume: 31 start-page: 220 year: 2010 ident: 10.1016/j.ejpb.2021.03.010_b0665 article-title: TGF-beta and immune cells: an important regulatory axis in the tumor microenvironment and progression publication-title: Trends Immunol. doi: 10.1016/j.it.2010.04.002 contributor: fullname: Yang – volume: 547 start-page: 222 year: 2017 ident: 10.1016/j.ejpb.2021.03.010_b1490 article-title: Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer publication-title: Nature doi: 10.1038/nature23003 contributor: fullname: Sahin – volume: 17 start-page: 261 year: 2018 ident: 10.1016/j.ejpb.2021.03.010_b0320 article-title: mRNA vaccines - a new era in vaccinology publication-title: Nat. Rev. Drug Discovery doi: 10.1038/nrd.2017.243 contributor: fullname: Pardi – volume: 51 start-page: 8800 year: 2012 ident: 10.1016/j.ejpb.2021.03.010_b0845 article-title: Imageable antigen-presenting gold nanoparticle vaccines for effective cancer immunotherapy in vivo publication-title: Angew. Chem. (Int. ed. in English) doi: 10.1002/anie.201203193 contributor: fullname: Lee – volume: 30 start-page: 531 year: 2014 ident: 10.1016/j.ejpb.2021.03.010_b0920 article-title: Local tumour hyperthermia as immunotherapy for metastatic cancer, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia publication-title: Group contributor: fullname: Toraya-Brown – volume: 13 start-page: 125 year: 2014 ident: 10.1016/j.ejpb.2021.03.010_b0650 article-title: Imaging macrophages with nanoparticles publication-title: Nat. Mater. doi: 10.1038/nmat3780 contributor: fullname: Weissleder – volume: 507 start-page: 519 year: 2014 ident: 10.1016/j.ejpb.2021.03.010_b1505 article-title: Structure-based programming of lymph-node targeting in molecular vaccines publication-title: Nature doi: 10.1038/nature12978 contributor: fullname: Liu – volume: 11 start-page: 2481 year: 2016 ident: 10.1016/j.ejpb.2021.03.010_b1360 article-title: Magnetic resonance imaging of ultrasmall superparamagnetic iron oxide-labeled exosomes from stem cells: a new method to obtain labeled exosomes publication-title: Int. J. Nanomed. contributor: fullname: Busato – volume: 30 year: 2018 ident: 10.1016/j.ejpb.2021.03.010_b0890 article-title: Antigen-Directed Fabrication of a Multifunctional Nanovaccine with Ultrahigh Antigen Loading Efficiency for Tumor Photothermal-Immunotherapy publication-title: Adv. Mater. (Deerfield Beach Fla.) doi: 10.1002/adma.201704408 contributor: fullname: Pan – volume: 3 start-page: 3273 year: 2009 ident: 10.1016/j.ejpb.2021.03.010_b1255 article-title: Polyethyleneimine coating enhances the cellular uptake of mesoporous silica nanoparticles and allows safe delivery of siRNA and DNA constructs publication-title: ACS Nano doi: 10.1021/nn900918w contributor: fullname: Xia – volume: 4 start-page: e4942 year: 2009 ident: 10.1016/j.ejpb.2021.03.010_b1570 article-title: Dendritic cell-derived exosomes promote natural killer cell activation and proliferation: a role for NKG2D ligands and IL-15Ralpha publication-title: PLoS One doi: 10.1371/journal.pone.0004942 contributor: fullname: Viaud – volume: 31 start-page: e1802244 year: 2019 ident: 10.1016/j.ejpb.2021.03.010_b1080 article-title: Emerging Strategies of Nanomaterial-Mediated Tumor Radiosensitization publication-title: Adv. Mater. (Deerfield Beach Fla.) doi: 10.1002/adma.201802244 contributor: fullname: Xie – volume: 26 start-page: 45 year: 2018 ident: 10.1016/j.ejpb.2021.03.010_b1150 article-title: Combination Immunotherapy of MUC1 mRNA Nano-vaccine and CTLA-4 Blockade Effectively Inhibits Growth of Triple Negative Breast Cancer publication-title: Mol. Therapy : J. Am. Soc. Gene Therapy doi: 10.1016/j.ymthe.2017.10.020 contributor: fullname: Liu – volume: 8 start-page: 2599 year: 2008 ident: 10.1016/j.ejpb.2021.03.010_b1380 article-title: Real-time intravital imaging of RGD-quantum dot binding to luminal endothelium in mouse tumor neovasculature publication-title: Nano Lett. doi: 10.1021/nl080141f contributor: fullname: Smith – volume: 16 start-page: 121 year: 2016 ident: 10.1016/j.ejpb.2021.03.010_b0170 article-title: Acquired resistance to immunotherapy and future challenges publication-title: Nat. Rev. Cancer doi: 10.1038/nrc.2016.2 contributor: fullname: Restifo – volume: 122 start-page: 1707 year: 2010 ident: 10.1016/j.ejpb.2021.03.010_b1330 article-title: High-resolution magnetic resonance imaging enhanced with superparamagnetic nanoparticles measures macrophage burden in atherosclerosis publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.109.891804 contributor: fullname: Morishige – volume: 4 start-page: 132ra153 year: 2012 ident: 10.1016/j.ejpb.2021.03.010_b0185 article-title: Decade-long safety and function of retroviral-modified chimeric antigen receptor T cells publication-title: Sci. Translat. Med. doi: 10.1126/scitranslmed.3003761 contributor: fullname: Scholler – volume: 15 start-page: 4161 year: 2018 ident: 10.1016/j.ejpb.2021.03.010_b0780 article-title: Co-delivery of Doxorubicin and Interferon-γ by Thermosensitive Nanoparticles for Cancer Immunochemotherapy publication-title: Mol. Pharm. doi: 10.1021/acs.molpharmaceut.8b00564 contributor: fullname: Yin – volume: 8 start-page: 5670 year: 2014 ident: 10.1016/j.ejpb.2021.03.010_b0815 article-title: Combinatorial photothermal and immuno cancer therapy using chitosan-coated hollow copper sulfide nanoparticles publication-title: ACS Nano doi: 10.1021/nn5002112 contributor: fullname: Guo – volume: 28 start-page: 8912 year: 2016 ident: 10.1016/j.ejpb.2021.03.010_b0600 article-title: Inflammation-Triggered Cancer Immunotherapy by Programmed Delivery of CpG and Anti-PD1 Antibody publication-title: Adv. Mater. (Deerfield Beach Fla.) doi: 10.1002/adma.201506312 contributor: fullname: Wang – volume: 27 start-page: 1 year: 2014 ident: 10.1016/j.ejpb.2021.03.010_b0900 article-title: Regulatory T cells in cancer immunotherapy publication-title: Curr. Opin. Immunol. doi: 10.1016/j.coi.2013.12.005 contributor: fullname: Nishikawa – volume: 147 start-page: 121 year: 2006 ident: 10.1016/j.ejpb.2021.03.010_b1170 article-title: Interactions between radiation and hormonal therapy in breast cancer: simultaneous or sequential treatment publication-title: Orv. Hetil. contributor: fullname: Fodor – volume: 7 start-page: 3276 year: 2017 ident: 10.1016/j.ejpb.2021.03.010_b0785 article-title: Biodegradable Hollow Mesoporous Silica Nanoparticles for Regulating Tumor Microenvironment and Enhancing Antitumor Efficiency publication-title: Theranostics doi: 10.7150/thno.19987 contributor: fullname: Kong – volume: 263 start-page: 79 year: 2010 ident: 10.1016/j.ejpb.2021.03.010_b0740 article-title: Paclitaxel enhances early dendritic cell maturation and function through TLR4 signaling in mice publication-title: Cell. Immunol. doi: 10.1016/j.cellimm.2010.03.001 contributor: fullname: Pfannenstiel – volume: 445 start-page: 171 year: 2013 ident: 10.1016/j.ejpb.2021.03.010_b0755 article-title: Nanoparticle mediated co-delivery of paclitaxel and a TLR-4 agonist results in tumor regression and enhanced immune response in the tumor microenvironment of a mouse model publication-title: Int. J. Pharm. doi: 10.1016/j.ijpharm.2013.01.045 contributor: fullname: Roy – volume: 103 start-page: 3073 year: 1999 ident: 10.1016/j.ejpb.2021.03.010_b0865 article-title: Simulation of the Optical Absorption Spectra of Gold Nanorods as a Function of Their Aspect Ratio and the Effect of the Medium Dielectric Constant publication-title: J. Phys. Chem. B doi: 10.1021/jp990183f contributor: fullname: Link – volume: 531 year: 2021 ident: 10.1016/j.ejpb.2021.03.010_b0070 article-title: Interleukin-10 (IL-10) participates in host defense against bacterial pathogens and promotes IgM antibody production in Nile tilapia (Oreochromis niloticus) publication-title: Aquaculture doi: 10.1016/j.aquaculture.2020.735829 contributor: fullname: Wu – volume: 160 start-page: 117 year: 2012 ident: 10.1016/j.ejpb.2021.03.010_b0415 article-title: Doxil®–the first FDA-approved nano-drug: lessons learned publication-title: J. Controlled Release : Off. J. Control. Release Soc. doi: 10.1016/j.jconrel.2012.03.020 contributor: fullname: Barenholz – volume: 12 start-page: 9830 year: 2018 ident: 10.1016/j.ejpb.2021.03.010_b1125 article-title: Local Blockade of Interleukin 10 and C-X-C Motif Chemokine Ligand 12 with Nano-Delivery Promotes Antitumor Response in Murine Cancers publication-title: ACS Nano doi: 10.1021/acsnano.8b00967 contributor: fullname: Shen – volume: 63 start-page: 6838 year: 2003 ident: 10.1016/j.ejpb.2021.03.010_b1320 article-title: In vivo high resolution three-dimensional imaging of antigen-specific cytotoxic T-lymphocyte trafficking to tumors publication-title: Cancer Res. contributor: fullname: Kircher – volume: 5 start-page: e11995 year: 2010 ident: 10.1016/j.ejpb.2021.03.010_b1185 article-title: Immunization with cocktail of HIV-derived peptides in montanide ISA-51 is immunogenic, but causes sterile abscesses and unacceptable reactogenicity publication-title: PLoS One doi: 10.1371/journal.pone.0011995 contributor: fullname: Graham – ident: 10.1016/j.ejpb.2021.03.010_b0720 – volume: 8 start-page: 115748 year: 2017 ident: 10.1016/j.ejpb.2021.03.010_b0580 article-title: Platelet-inspired medicine for tumor therapy publication-title: Oncotarget doi: 10.18632/oncotarget.22853 contributor: fullname: Yang – volume: 379 start-page: 2040 year: 2018 ident: 10.1016/j.ejpb.2021.03.010_b0425 article-title: Pembrolizumab plus Chemotherapy for Squamous Non-Small-Cell Lung Cancer publication-title: New Engl. J. Med. doi: 10.1056/NEJMoa1810865 contributor: fullname: Paz-Ares – volume: 11 start-page: 895 year: 2012 ident: 10.1016/j.ejpb.2021.03.010_b0615 article-title: Combination delivery of TGF-β inhibitor and IL-2 by nanoscale liposomal polymeric gels enhances tumour immunotherapy publication-title: Nat. Mater. doi: 10.1038/nmat3355 contributor: fullname: Park – volume: 23 start-page: 2259 year: 2012 ident: 10.1016/j.ejpb.2021.03.010_b1165 article-title: A randomized phase III adjuvant study in high-risk cervical cancer: simultaneous radiochemotherapy with cisplatin (S-RC) versus systemic paclitaxel and carboplatin followed by percutaneous radiation (PC-R): a NOGGO-AGO Intergroup Study publication-title: Ann. Oncol. doi: 10.1093/annonc/mdr628 contributor: fullname: Sehouli – volume: 192 start-page: 209 year: 2014 ident: 10.1016/j.ejpb.2021.03.010_b0480 article-title: Targeting nanoparticles to CD40, DEC-205 or CD11c molecules on dendritic cells for efficient CD8(+) T cell response: a comparative study publication-title: J. Controll. Release : Off. J. Controll. Release Soc. doi: 10.1016/j.jconrel.2014.07.040 contributor: fullname: Cruz – volume: 115 start-page: 57 year: 2017 ident: 10.1016/j.ejpb.2021.03.010_b1160 article-title: Nanoformulation-based sequential combination cancer therapy publication-title: Adv. Drug Deliv. Rev. doi: 10.1016/j.addr.2017.04.003 contributor: fullname: Shim – volume: 9 start-page: 1614 year: 2007 ident: 10.1016/j.ejpb.2021.03.010_b1555 article-title: A vaccine based on exosomes secreted by a dendritic cell line confers protection against T. gondii infection in syngeneic and allogeneic mice publication-title: Microbes Infect. doi: 10.1016/j.micinf.2007.07.002 contributor: fullname: Beauvillain – volume: 9 start-page: 719 year: 2007 ident: 10.1016/j.ejpb.2021.03.010_b1340 article-title: Localization to atherosclerotic plaque and biodistribution of biochemically derivatized superparamagnetic iron oxide nanoparticles (SPIONs) contrast particles for magnetic resonance imaging (MRI) publication-title: Biomed. Microdevices doi: 10.1007/s10544-007-9081-3 contributor: fullname: Smith – volume: 154 start-page: 249 year: 2011 ident: 10.1016/j.ejpb.2021.03.010_b1230 article-title: The efficacy of intracranial PLG-based vaccines is dependent on direct implantation into brain tissue publication-title: J. Controll. Release : Off. J. Controll. Release Soc. doi: 10.1016/j.jconrel.2011.06.021 contributor: fullname: Ali – volume: 172 start-page: 2126 issue: 2004 year: 1950 ident: 10.1016/j.ejpb.2021.03.010_b1560 article-title: Exosomes as potent cell-free peptide-based vaccine. I. Dendritic cell-derived exosomes transfer functional MHC class I/peptide complexes to dendritic cells publication-title: J. Immunol. (Baltimore, Md.) contributor: fullname: André – volume: 33 start-page: 1974 year: 2015 ident: 10.1016/j.ejpb.2021.03.010_b0100 article-title: Immune Checkpoint Blockade in Cancer Therapy publication-title: J. Clin. Oncol. doi: 10.1200/JCO.2014.59.4358 contributor: fullname: Postow – volume: 7 start-page: 715 year: 2019 ident: 10.1016/j.ejpb.2021.03.010_b0555 article-title: Harnessing the layer-by-layer assembly technique to design biomaterials vaccines for immune modulation in translational applications publication-title: Biomater. Sci. doi: 10.1039/C8BM01219A contributor: fullname: Tang – volume: 9 year: 2017 ident: 10.1016/j.ejpb.2021.03.010_b0575 article-title: Matrix-binding checkpoint immunotherapies enhance antitumor efficacy and reduce adverse events publication-title: Sci. Transl. Med. doi: 10.1126/scitranslmed.aan0401 contributor: fullname: Ishihara – volume: 5 start-page: 231 year: 2013 ident: 10.1016/j.ejpb.2021.03.010_b1430 article-title: Imaging of genetically engineered T cells by PET using gold nanoparticles complexed to Copper-64 publication-title: Integrat. Biol. : Quant. Biosci. From Nano Macro doi: 10.1039/c2ib20093g contributor: fullname: Bhatnagar – volume: 3 start-page: 356 year: 2015 ident: 10.1016/j.ejpb.2021.03.010_b0210 article-title: Identification of chimeric antigen receptors that mediate constitutive or inducible proliferation of T cells publication-title: Cancer Immunol. Res. doi: 10.1158/2326-6066.CIR-14-0186 contributor: fullname: Frigault – volume: 32 start-page: 180 year: 2011 ident: 10.1016/j.ejpb.2021.03.010_b0065 article-title: Cytokines and the inception of CD8 T cell responses publication-title: Trends Immunol. doi: 10.1016/j.it.2011.01.004 contributor: fullname: Cox – ident: 10.1016/j.ejpb.2021.03.010_b0280 – volume: 131 start-page: 1079 year: 2005 ident: 10.1016/j.ejpb.2021.03.010_b1130 article-title: Combination nonviral murine interleukin 2 and interleukin 12 gene therapy and radiotherapy for head and neck squamous cell carcinoma publication-title: Arch. Otolaryngol.–Head Neck Surg. doi: 10.1001/archotol.131.12.1079 contributor: fullname: Xian – volume: 2015 start-page: 794528 year: 2015 ident: 10.1016/j.ejpb.2021.03.010_b0330 article-title: RNA-Based Vaccines in Cancer Immunotherapy publication-title: J. Immunol. Res. doi: 10.1155/2015/794528 contributor: fullname: McNamara – volume: 11 start-page: 10147 year: 2017 ident: 10.1016/j.ejpb.2021.03.010_b0980 article-title: Inhibiting Metastasis and Preventing Tumor Relapse by Triggering Host Immunity with Tumor-Targeted Photodynamic Therapy Using Photosensitizer-Loaded Functional Nanographenes publication-title: ACS Nano doi: 10.1021/acsnano.7b04736 contributor: fullname: Yu – volume: 9 start-page: 1319 year: 2012 ident: 10.1016/j.ejpb.2021.03.010_b0335 article-title: Developing mRNA-vaccine technologies publication-title: RNA Biol. doi: 10.4161/rna.22269 contributor: fullname: Schlake – volume: 13 start-page: 639 year: 2016 ident: 10.1016/j.ejpb.2021.03.010_b1440 article-title: Contrast agents for molecular photoacoustic imaging publication-title: Nat. Methods doi: 10.1038/nmeth.3929 contributor: fullname: Weber – volume: 138 start-page: 16686 year: 2016 ident: 10.1016/j.ejpb.2021.03.010_b1010 article-title: Photodynamic Therapy Mediated by Nontoxic Core-Shell Nanoparticles Synergizes with Immune Checkpoint Blockade To Elicit Antitumor Immunity and Antimetastatic Effect on Breast Cancer publication-title: J. Am. Chem. Soc. doi: 10.1021/jacs.6b09538 contributor: fullname: Duan – volume: 29 start-page: 964 year: 2008 ident: 10.1016/j.ejpb.2021.03.010_b0645 article-title: Iron intake, oxidative stress-related genes (MnSOD and MPO) and prostate cancer risk in CARET cohort publication-title: Carcinogenesis doi: 10.1093/carcin/bgn056 contributor: fullname: Choi – volume: 14 start-page: 169 year: 2008 ident: 10.1016/j.ejpb.2021.03.010_b0990 article-title: Phase I immunotherapeutic trial with long peptides spanning the E6 and E7 sequences of high-risk human papillomavirus 16 in end-stage cervical cancer patients shows low toxicity and robust immunogenicity publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-07-1881 contributor: fullname: Kenter – volume: 168 start-page: 724 year: 2017 ident: 10.1016/j.ejpb.2021.03.010_b0175 article-title: The Principles of Engineering Immune Cells to Treat Cancer publication-title: Cell doi: 10.1016/j.cell.2017.01.016 contributor: fullname: Lim – volume: 16 start-page: 400 year: 2017 ident: 10.1016/j.ejpb.2021.03.010_b0640 article-title: Targeting iron metabolism in drug discovery and delivery publication-title: Nat. Rev. Drug Discovery doi: 10.1038/nrd.2016.248 contributor: fullname: Crielaard – volume: 24 start-page: 535 year: 2018 ident: 10.1016/j.ejpb.2021.03.010_b0230 article-title: CAR T-Cell Therapies in Glioblastoma: A First Look publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-17-2871 contributor: fullname: Migliorini – volume: 8 start-page: 3636 year: 2014 ident: 10.1016/j.ejpb.2021.03.010_b0675 article-title: Nanoparticle-delivered transforming growth factor-β siRNA enhances vaccination against advanced melanoma by modifying tumor microenvironment publication-title: ACS Nano doi: 10.1021/nn500216y contributor: fullname: Xu – volume: 2 start-page: 306 year: 2018 ident: 10.1016/j.ejpb.2021.03.010_b1345 article-title: Ferumoxytol-based Dual-modality Imaging Probe for Detection of Stem Cell Transplant Rejection publication-title: Nanotheranostics doi: 10.7150/ntno.26389 contributor: fullname: Li – volume: 24 start-page: 1499 year: 2018 ident: 10.1016/j.ejpb.2021.03.010_b0540 article-title: Induction of resistance to chimeric antigen receptor T cell therapy by transduction of a single leukemic B cell publication-title: Nat. Med. doi: 10.1038/s41591-018-0201-9 contributor: fullname: Ruella – volume: 240 start-page: 227 year: 2016 ident: 10.1016/j.ejpb.2021.03.010_b0340 article-title: Materials for non-viral intracellular delivery of messenger RNA therapeutics publication-title: J. Controlled Release : Off. J. Controlled Release Soc. doi: 10.1016/j.jconrel.2015.12.032 contributor: fullname: Kauffman – volume: 13 start-page: 507 year: 2011 ident: 10.1016/j.ejpb.2021.03.010_b1085 article-title: In vivo delivery of RNAi with lipid-based nanoparticles publication-title: Annu. Rev. Biomed. Eng. doi: 10.1146/annurev-bioeng-071910-124709 contributor: fullname: Huang – volume: 3 start-page: 768 year: 2019 ident: 10.1016/j.ejpb.2021.03.010_b0405 article-title: Engineering patient-specific cancer immunotherapies publication-title: Nat. Biomed. Eng. doi: 10.1038/s41551-019-0436-x contributor: fullname: Scheetz – volume: 25 start-page: 4183 year: 2015 ident: 10.1016/j.ejpb.2021.03.010_b1120 article-title: Dual targeted immunotherapy via in vivo delivery of biohybrid RNAi-peptide nanoparticles to tumour-associated macrophages and cancer cells publication-title: Adv. Funct. Mater. doi: 10.1002/adfm.201501283 contributor: fullname: Conde – volume: 8 start-page: 16673 year: 2018 ident: 10.1016/j.ejpb.2021.03.010_b1465 article-title: Enhanced EPR directed and Imaging guided Photothermal Therapy using Vitamin E Modified Toco-Photoxil publication-title: Sci. Rep. doi: 10.1038/s41598-018-34898-3 contributor: fullname: Chauhan – volume: 114 start-page: 175 year: 2017 ident: 10.1016/j.ejpb.2021.03.010_b0915 article-title: Combinatorial immunotherapy and nanoparticle mediated hyperthermia publication-title: Adv. Drug Deliv. Rev. doi: 10.1016/j.addr.2017.06.008 contributor: fullname: Moy – volume: 125 start-page: 1016 year: 2009 ident: 10.1016/j.ejpb.2021.03.010_b1545 article-title: Essential role of Notch signaling in apoptosis of human pancreatic tumoral cells mediated by exosomal nanoparticles publication-title: Int. J. Cancer doi: 10.1002/ijc.24375 contributor: fullname: Ristorcelli – volume: 33 start-page: 97 year: 2015 ident: 10.1016/j.ejpb.2021.03.010_b1215 article-title: Biopolymer implants enhance the efficacy of adoptive T-cell therapy publication-title: Nat. Biotechnol. doi: 10.1038/nbt.3104 contributor: fullname: Stephan – volume: 16 start-page: 69 year: 2003 ident: 10.1016/j.ejpb.2021.03.010_b0080 article-title: Interferon in the treatment of hairy-cell leukemia publication-title: Best Pract. Res. Clin. Haematol. doi: 10.1016/S1521-6926(02)00084-1 contributor: fullname: Ahmed – volume: 14 start-page: 428 year: 2012 ident: 10.1016/j.ejpb.2021.03.010_b1140 article-title: Highly potent mRNA based cancer vaccines represent an attractive platform for combination therapies supporting an improved therapeutic effect publication-title: J. Gene Med. doi: 10.1002/jgm.2605 contributor: fullname: Fotin-Mleczek – volume: 11 start-page: 3089 year: 2017 ident: 10.1016/j.ejpb.2021.03.010_b0670 article-title: Enhancing Adoptive Cell Therapy of Cancer through Targeted Delivery of Small-Molecule Immunomodulators to Internalizing or Noninternalizing Receptors publication-title: ACS Nano doi: 10.1021/acsnano.7b00078 contributor: fullname: Zheng – volume: 16 start-page: 2334 year: 2016 ident: 10.1016/j.ejpb.2021.03.010_b1280 article-title: Enhanced Cancer Immunotherapy by Microneedle Patch-Assisted Delivery of Anti-PD1 Antibody publication-title: Nano Lett. doi: 10.1021/acs.nanolett.5b05030 contributor: fullname: Wang – volume: 4 start-page: 73 year: 2007 ident: 10.1016/j.ejpb.2021.03.010_b1470 article-title: Type 1 and 2 immunity following vaccination is influenced by nanoparticle size: formulation of a model vaccine for respiratory syncytial virus publication-title: Mol. Pharm. doi: 10.1021/mp060096p contributor: fullname: Mottram – volume: 42 start-page: 299 year: 2019 ident: 10.1016/j.ejpb.2021.03.010_b0035 article-title: Immune checkpoint inhibitors win the 2018 Nobel Prize publication-title: Biomed. J. doi: 10.1016/j.bj.2019.09.002 contributor: fullname: Huang – volume: 9 year: 2017 ident: 10.1016/j.ejpb.2021.03.010_b0235 article-title: A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma publication-title: Sci. Transl. Med. contributor: fullname: O'Rourke – volume: 35 start-page: 2477 year: 2014 ident: 10.1016/j.ejpb.2021.03.010_b1240 article-title: Injectable, porous, and cell-responsive gelatin cryogels publication-title: Biomaterials doi: 10.1016/j.biomaterials.2013.11.044 contributor: fullname: Koshy – volume: 172 start-page: 426 year: 2013 ident: 10.1016/j.ejpb.2021.03.010_b0550 article-title: In vivo targeting of adoptively transferred T-cells with antibody- and cytokine-conjugated liposomes publication-title: J. Controll. Release : Off. J. Controll. Release Soc. doi: 10.1016/j.jconrel.2013.05.037 contributor: fullname: Zheng – volume: 18 start-page: 444 year: 2017 ident: 10.1016/j.ejpb.2021.03.010_b0140 article-title: Immune Checkpoint Inhibitors for Patients With Advanced Non-Small-Cell Lung Cancer: A Systematic Review publication-title: Clinical Lung Cancer doi: 10.1016/j.cllc.2017.02.001 contributor: fullname: Ellis – volume: 152 start-page: 168 year: 2011 ident: 10.1016/j.ejpb.2021.03.010_b0585 article-title: Functional aliphatic polyesters for biomedical and pharmaceutical applications publication-title: J. Controll. Release : Off. J. Controll. Release Soc. doi: 10.1016/j.jconrel.2010.12.016 contributor: fullname: Seyednejad – volume: 114 start-page: 613 year: 2005 ident: 10.1016/j.ejpb.2021.03.010_b1540 article-title: Exosomes: a new delivery system for tumor antigens in cancer immunotherapy publication-title: Int. J. Cancer doi: 10.1002/ijc.20757 contributor: fullname: Cho – volume: 168 start-page: 707 year: 2017 ident: 10.1016/j.ejpb.2021.03.010_b0685 article-title: Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy publication-title: Cell doi: 10.1016/j.cell.2017.01.017 contributor: fullname: Sharma – volume: 26 start-page: 8154 year: 2014 ident: 10.1016/j.ejpb.2021.03.010_b0440 article-title: Immunological responses triggered by photothermal therapy with carbon nanotubes in combination with anti-CTLA-4 therapy to inhibit cancer metastasis publication-title: Adv. Mater. (Deerfield Beach Fla.) doi: 10.1002/adma.201402996 contributor: fullname: Wang – volume: 46 start-page: 1594 year: 2018 ident: 10.1016/j.ejpb.2021.03.010_b0855 article-title: Folic acid conjugated PEG coated gold-iron oxide core-shell nanocomplex as a potential agent for targeted photothermal therapy of cancer publication-title: Artif. Cells Nanomed. Biotechnol. contributor: fullname: Ghaznavi – volume: 9 start-page: 347 year: 2017 ident: 10.1016/j.ejpb.2021.03.010_b0075 article-title: Recent progress in GM-CSF-based cancer immunotherapy publication-title: Immunotherapy doi: 10.2217/imt-2016-0141 contributor: fullname: Yan – volume: 10 start-page: e0128910 year: 2015 ident: 10.1016/j.ejpb.2021.03.010_b1115 article-title: Systemic siRNA Nanoparticle-Based Drugs Combined with Radiofrequency Ablation for Cancer Therapy publication-title: PLoS One doi: 10.1371/journal.pone.0128910 contributor: fullname: Ahmed – volume: 379 start-page: 2108 year: 2018 ident: 10.1016/j.ejpb.2021.03.010_b0710 article-title: Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer publication-title: New Eng. J. Med. doi: 10.1056/NEJMoa1809615 contributor: fullname: Schmid – volume: 4 start-page: 29729 year: 2014 ident: 10.1016/j.ejpb.2021.03.010_b0875 article-title: Prussian blue nanoparticles for laser-induced photothermal therapy of tumors publication-title: RSC Adv. doi: 10.1039/C4RA05209A contributor: fullname: Hoffman – volume: 61 start-page: 3689 year: 2001 ident: 10.1016/j.ejpb.2021.03.010_b0745 article-title: Cyclophosphamide, doxorubicin, and paclitaxel enhance the antitumor immune response of granulocyte/macrophage-colony stimulating factor-secreting whole-cell vaccines in HER-2/neu tolerized mice publication-title: Cancer Res. contributor: fullname: Machiels – volume: 29 start-page: 235 year: 2011 ident: 10.1016/j.ejpb.2021.03.010_b0025 article-title: Natural innate and adaptive immunity to cancer publication-title: Annu. Rev. Immunol. doi: 10.1146/annurev-immunol-031210-101324 contributor: fullname: Vesely – volume: 16 start-page: 5503 year: 2016 ident: 10.1016/j.ejpb.2021.03.010_b1000 article-title: Acid-Activatable Versatile Micelleplexes for PD-L1 Blockade-Enhanced Cancer Photodynamic Immunotherapy publication-title: Nano Lett. doi: 10.1021/acs.nanolett.6b01994 contributor: fullname: Wang – volume: 21 start-page: 3771 year: 2015 ident: 10.1016/j.ejpb.2021.03.010_b1110 article-title: TLR9-Targeted STAT3 Silencing Abrogates Immunosuppressive Activity of Myeloid-Derived Suppressor Cells from Prostate Cancer Patients publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-14-3145 contributor: fullname: Hossain – volume: 7 start-page: 904 year: 2005 ident: 10.1016/j.ejpb.2021.03.010_b1450 article-title: Nanoparticles for the optical imaging of tumor E-selectin publication-title: Neoplasia (New York, N.Y.) doi: 10.1593/neo.05352 contributor: fullname: Funovics – volume: 7 start-page: 8606 year: 2017 ident: 10.1016/j.ejpb.2021.03.010_b0820 article-title: Synergistic Immuno Photothermal Nanotherapy (SYMPHONY) for the Treatment of Unresectable and Metastatic Cancers publication-title: Sci. Rep. doi: 10.1038/s41598-017-09116-1 contributor: fullname: Liu – volume: 28 start-page: 416 year: 2018 ident: 10.1016/j.ejpb.2021.03.010_b0130 article-title: A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy publication-title: Cell Res. doi: 10.1038/s41422-018-0011-0 contributor: fullname: Du – volume: 3 start-page: 9 year: 2005 ident: 10.1016/j.ejpb.2021.03.010_b1575 article-title: A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer publication-title: J. Transl. Med. doi: 10.1186/1479-5876-3-9 contributor: fullname: Morse – volume: 186 start-page: 249 year: 2016 ident: 10.1016/j.ejpb.2021.03.010_b0090 article-title: Soluble and membrane-bound interleukin (IL)-15 Rα/IL-15 complexes mediate proliferation of high-avidity central memory CD8(+) T cells for adoptive immunotherapy of cancer and infections publication-title: Clin. Exp. Immunol. doi: 10.1111/cei.12816 contributor: fullname: Hasan – volume: 26 start-page: 3662 year: 2008 ident: 10.1016/j.ejpb.2021.03.010_b1550 article-title: Enhancement of immunostimulatory properties of exosomal vaccines by incorporation of fusion-competent G protein of vesicular stomatitis virus publication-title: Vaccine doi: 10.1016/j.vaccine.2008.04.069 contributor: fullname: Temchura – volume: 21 start-page: 1919 year: 2013 ident: 10.1016/j.ejpb.2021.03.010_b0610 article-title: Intravenous delivery of siRNA targeting CD47 effectively inhibits melanoma tumor growth and lung metastasis publication-title: Mol. Therapy : J. Am. Soc. Gene Therapy doi: 10.1038/mt.2013.135 contributor: fullname: Wang – volume: 11 start-page: 295 year: 2016 ident: 10.1016/j.ejpb.2021.03.010_b0660 article-title: In situ vaccination with cowpea mosaic virus nanoparticles suppresses metastatic cancer publication-title: Nat. Nanotechnol. doi: 10.1038/nnano.2015.292 contributor: fullname: Lizotte – volume: 132 start-page: 967 year: 2013 ident: 10.1016/j.ejpb.2021.03.010_b1095 article-title: Silencing IDO in dendritic cells: a novel approach to enhance cancer immunotherapy in a murine breast cancer model publication-title: Int. J. Cancer doi: 10.1002/ijc.27710 contributor: fullname: Zheng – volume: 8 start-page: 151 year: 2009 ident: 10.1016/j.ejpb.2021.03.010_b1190 article-title: Infection-mimicking materials to program dendritic cells in situ publication-title: Nat. Mater. doi: 10.1038/nmat2357 contributor: fullname: Ali – volume: 12 start-page: 1978 year: 2018 ident: 10.1016/j.ejpb.2021.03.010_b1025 article-title: Enhanced Immunotherapy Based on Photodynamic Therapy for Both Primary and Lung Metastasis Tumor Eradication publication-title: ACS Nano doi: 10.1021/acsnano.7b09112 contributor: fullname: Song – volume: 342 start-page: 1432 year: 2013 ident: 10.1016/j.ejpb.2021.03.010_b0565 article-title: Breakthrough of the year 2013. Cancer immunotherapy publication-title: Science (New York N.Y.) doi: 10.1126/science.342.6165.1432 contributor: fullname: Couzin-Frankel – volume: 8 start-page: 860 year: 2018 ident: 10.1016/j.ejpb.2021.03.010_b0930 article-title: An Endogenous Vaccine Based on Fluorophores and Multivalent Immunoadjuvants Regulates Tumor Micro-Environment for Synergistic Photothermal and Immunotherapy publication-title: Theranostics doi: 10.7150/thno.19826 contributor: fullname: Li – volume: 4 start-page: 1180 year: 2015 ident: 10.1016/j.ejpb.2021.03.010_b0605 article-title: Ovarian cancer immunotherapy using PD-L1 siRNA targeted delivery from folic acid-functionalized polyethylenimine: strategies to enhance T cell killing publication-title: Adv. Healthcare Mater. doi: 10.1002/adhm.201500089 contributor: fullname: Teo – ident: 10.1016/j.ejpb.2021.03.010_b0445 doi: 10.1016/S0140-6736(15)01281-7 – volume: 9 start-page: 2187 year: 2014 ident: 10.1016/j.ejpb.2021.03.010_b0455 article-title: Nanoengineered strategies to optimize dendritic cells for gastrointestinal tumor immunotherapy: from biology to translational medicine publication-title: Nanomed. (London, England) doi: 10.2217/nnm.14.115 contributor: fullname: Bhargava – volume: 11 start-page: 4905 year: 2005 ident: 10.1016/j.ejpb.2021.03.010_b1155 article-title: Timing is everything: preclinical evidence supporting simultaneous rather than sequential chemohormonal therapy for prostate cancer publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-04-2140 contributor: fullname: Eigl – volume: 17 start-page: 184 year: 2015 ident: 10.1016/j.ejpb.2021.03.010_b0770 article-title: Biodegradable microparticles loaded with doxorubicin and CpG ODN for in situ immunization against cancer publication-title: AAPS J. doi: 10.1208/s12248-014-9676-6 contributor: fullname: Makkouk – volume: 31 start-page: 51 year: 2013 ident: 10.1016/j.ejpb.2021.03.010_b0700 article-title: Immunogenic cell death in cancer therapy publication-title: Annu. Rev. Immunol. doi: 10.1146/annurev-immunol-032712-100008 contributor: fullname: Kroemer – volume: 28 start-page: 4324 year: 2010 ident: 10.1016/j.ejpb.2021.03.010_b1075 article-title: In situ vaccination with a TLR9 agonist induces systemic lymphoma regression: a phase I/II study publication-title: J. Clin. Oncol. doi: 10.1200/JCO.2010.28.9793 contributor: fullname: Brody – volume: 63 start-page: 136 year: 2011 ident: 10.1016/j.ejpb.2021.03.010_b1455 article-title: The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect publication-title: Adv. Drug Deliv. Rev. doi: 10.1016/j.addr.2010.04.009 contributor: fullname: Fang – volume: 18 start-page: 1073 year: 2018 ident: 10.1016/j.ejpb.2021.03.010_b0260 article-title: Understanding how combinatorial targeting of TLRs and TNFR family costimulatory members promote enhanced T cell responses publication-title: Expert. Opin. Biol. Th. doi: 10.1080/14712598.2018.1518422 contributor: fullname: Shinde – volume: 16 start-page: 1035 year: 2010 ident: 10.1016/j.ejpb.2021.03.010_b0545 article-title: Therapeutic cell engineering with surface-conjugated synthetic nanoparticles publication-title: Nat. Med. doi: 10.1038/nm.2198 contributor: fullname: Stephan – volume: 11 start-page: 728 year: 2005 ident: 10.1016/j.ejpb.2021.03.010_b1065 article-title: Immune-mediated inhibition of metastases after treatment with local radiation and CTLA-4 blockade in a mouse model of breast cancer publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.728.11.2 contributor: fullname: Demaria – volume: 2 start-page: 578 year: 2018 ident: 10.1016/j.ejpb.2021.03.010_b0655 article-title: TLR7/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy publication-title: Nat. Biomed. Eng. doi: 10.1038/s41551-018-0236-8 contributor: fullname: Rodell – volume: 4 start-page: 734 year: 2012 ident: 10.1016/j.ejpb.2021.03.010_b1020 article-title: Blocking IDO activity to enhance anti-tumor immunity publication-title: Front. Biosci. (Elite Edition) doi: 10.2741/e414 contributor: fullname: Munn – volume: 12 start-page: 269 year: 2012 ident: 10.1016/j.ejpb.2021.03.010_b0690 article-title: Adoptive immunotherapy for cancer: harnessing the T cell response publication-title: Nat. Rev. Immunol. doi: 10.1038/nri3191 contributor: fullname: Restifo – ident: 10.1016/j.ejpb.2021.03.010_b0715 – volume: 7 start-page: 595 year: 2019 ident: 10.1016/j.ejpb.2021.03.010_b0040 article-title: Immunotherapy and targeted therapy-the new roadmap in cancer treatment publication-title: Ann. Transl. Med. doi: 10.21037/atm.2019.05.58 contributor: fullname: Shahid – volume: 10 start-page: 3153 year: 2014 ident: 10.1016/j.ejpb.2021.03.010_b0325 article-title: DNA vaccine for cancer immunotherapy publication-title: Human Vaccines Immunotherapeut. doi: 10.4161/21645515.2014.980686 contributor: fullname: Yang – volume: 32 start-page: 1119 year: 2012 ident: 10.1016/j.ejpb.2021.03.010_b0355 article-title: Multiple Associations Between a Broad Spectrum of Autoimmune Diseases publication-title: Chronic Inflammatory Dis. Cancer, Anticancer Res contributor: fullname: Franks – volume: 4 start-page: 92 year: 2017 ident: 10.1016/j.ejpb.2021.03.010_b0220 article-title: Global Manufacturing of CAR T Cell Therapy, Molecular therapy publication-title: Methods Clin. Develop. doi: 10.1016/j.omtm.2016.12.006 contributor: fullname: Levine – volume: 45 start-page: e124 year: 2017 ident: 10.1016/j.ejpb.2021.03.010_b0215 article-title: Cytokine Release Syndrome After Chimeric Antigen Receptor T Cell Therapy for Acute Lymphoblastic Leukemia publication-title: Crit. Care Med. doi: 10.1097/CCM.0000000000002053 contributor: fullname: Fitzgerald – volume: 97 start-page: 1381 year: 2007 ident: 10.1016/j.ejpb.2021.03.010_b0960 article-title: Photodynamic therapy-generated vaccines: relevance of tumour cell death expression publication-title: Br. J. Cancer doi: 10.1038/sj.bjc.6604059 contributor: fullname: Korbelik – volume: 19 start-page: 465 year: 2013 ident: 10.1016/j.ejpb.2021.03.010_b0505 article-title: Persistent antigen at vaccination sites induces tumor-specific CD8+ T cell sequestration, dysfunction and deletion publication-title: Nat. Med. doi: 10.1038/nm.3105 contributor: fullname: Hailemichael – volume: 107 start-page: 331 year: 2015 ident: 10.1016/j.ejpb.2021.03.010_b1350 article-title: Selectins: initiators of leucocyte adhesion and signalling at the vascular wall publication-title: Cardiovasc. Res. doi: 10.1093/cvr/cvv154 contributor: fullname: McEver – volume: 8 start-page: 352ra110 year: 2016 ident: 10.1016/j.ejpb.2021.03.010_b0620 article-title: Spatially selective depletion of tumor-associated regulatory T cells with near-infrared photoimmunotherapy publication-title: Sci. Transl. Med. doi: 10.1126/scitranslmed.aaf6843 contributor: fullname: Sato – volume: 124 start-page: 687 year: 2014 ident: 10.1016/j.ejpb.2021.03.010_b1070 article-title: Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice publication-title: J Clin Invest doi: 10.1172/JCI67313 contributor: fullname: Deng – volume: 106 start-page: 157 year: 2016 ident: 10.1016/j.ejpb.2021.03.010_b1500 article-title: Bioengineered protein-based nanocage for drug delivery publication-title: Adv. Drug Deliv. Rev. doi: 10.1016/j.addr.2016.03.002 contributor: fullname: Lee – volume: 377 start-page: 2545 year: 2017 ident: 10.1016/j.ejpb.2021.03.010_b0195 article-title: Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas publication-title: New Engl. J. Med. doi: 10.1056/NEJMoa1708566 contributor: fullname: Schuster – volume: 18 start-page: 175 year: 2019 ident: 10.1016/j.ejpb.2021.03.010_b0570 article-title: Delivery technologies for cancer immunotherapy publication-title: Nat. Rev. Drug Discovery doi: 10.1038/s41573-018-0006-z contributor: fullname: Riley – volume: 2 start-page: 751 year: 2007 ident: 10.1016/j.ejpb.2021.03.010_b0730 article-title: Nanocarriers as an emerging platform for cancer therapy publication-title: Nat. Nanotechnol. doi: 10.1038/nnano.2007.387 contributor: fullname: Peer – volume: 14 start-page: 1528 year: 2017 ident: 10.1016/j.ejpb.2021.03.010_b1355 article-title: Synthesis and Functional Characterization of Novel Sialyl LewisX Mimic-Decorated Liposomes for E-selectin-Mediated Targeting to Inflamed Endothelial Cells publication-title: Mol. Pharm. doi: 10.1021/acs.molpharmaceut.6b00982 contributor: fullname: Chantarasrivong – volume: 35 start-page: 7805 year: 2019 ident: 10.1016/j.ejpb.2021.03.010_b0850 article-title: Comprehensive Evaluation of Degradable and Cost-Effective Plasmonic Nanoshells for Localized Photothermolysis of Cancer Cells publication-title: Langmuir : ACS J. Surfaces Colloids doi: 10.1021/acs.langmuir.8b03460 contributor: fullname: Chauhan – volume: 33 start-page: 4957 year: 2012 ident: 10.1016/j.ejpb.2021.03.010_b0495 article-title: Role of sustained antigen release from nanoparticle vaccines in shaping the T cell memory phenotype publication-title: Biomaterials doi: 10.1016/j.biomaterials.2012.03.041 contributor: fullname: Demento – volume: 48 start-page: 351 year: 2019 ident: 10.1016/j.ejpb.2021.03.010_b0525 article-title: Nanomedicine and macroscale materials in immuno-oncology publication-title: Chem. Soc. Rev. doi: 10.1039/C8CS00473K contributor: fullname: Sun – volume: 115 start-page: E4041 year: 2018 ident: 10.1016/j.ejpb.2021.03.010_b0625 article-title: Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti-PD-1 treatment publication-title: Proc. Nat. Acad. Sci. USA doi: 10.1073/pnas.1720948115 contributor: fullname: Peranzoni – volume: 252 start-page: 401 year: 2009 ident: 10.1016/j.ejpb.2021.03.010_b1325 article-title: Rapid-clearance iron nanoparticles for inflammation imaging of atherosclerotic plaque: initial experience in animal model publication-title: Radiology doi: 10.1148/radiol.2522081484 contributor: fullname: Sigovan – volume: 9 start-page: 1074 year: 2018 ident: 10.1016/j.ejpb.2021.03.010_b0830 article-title: Chemo-photothermal therapy combination elicits anti-tumor immunity against advanced metastatic cancer publication-title: Nat. Commun. doi: 10.1038/s41467-018-03473-9 contributor: fullname: Nam – volume: 09 start-page: 1630001 year: 2015 ident: 10.1016/j.ejpb.2021.03.010_b0885 article-title: Photonics immunotherapy — A novel strategy for cancer treatment publication-title: Journal of Innovative Optical Health Sciences doi: 10.1142/S1793545816300019 contributor: fullname: Zhou – volume: 534 start-page: 396 year: 2016 ident: 10.1016/j.ejpb.2021.03.010_b0520 article-title: Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy publication-title: Nature doi: 10.1038/nature18300 contributor: fullname: Kranz – volume: 124 year: 2020 ident: 10.1016/j.ejpb.2021.03.010_b0020 article-title: Cancer immunotherapy: Pros, cons and beyond publication-title: Biomed. Pharmacother. doi: 10.1016/j.biopha.2020.109821 contributor: fullname: Tan – volume: 5 start-page: 628 year: 2020 ident: 10.1016/j.ejpb.2021.03.010_b1365 article-title: Nano-immunoimaging publication-title: Nanoscale Horiz. doi: 10.1039/C9NH00514E contributor: fullname: Wang – volume: 11 start-page: 285 year: 2016 ident: 10.1016/j.ejpb.2021.03.010_b1445 article-title: Human CIK Cells Loaded with Au Nanorods as a Theranostic Platform for Targeted Photoacoustic Imaging and Enhanced Immunotherapy and Photothermal Therapy publication-title: Nanoscale Res. Lett. doi: 10.1186/s11671-016-1468-8 contributor: fullname: Yang – volume: 11 start-page: 4463 year: 2017 ident: 10.1016/j.ejpb.2021.03.010_b1015 article-title: Near-Infrared-Triggered Photodynamic Therapy with Multitasking Upconversion Nanoparticles in Combination with Checkpoint Blockade for Immunotherapy of Colorectal Cancer publication-title: ACS Nano doi: 10.1021/acsnano.7b00715 contributor: fullname: Xu – volume: 33 start-page: 4872 year: 2012 ident: 10.1016/j.ejpb.2021.03.010_b1405 article-title: Towards whole-body imaging at the single cell level using ultra-sensitive stem cell labeling with oligo-arginine modified upconversion nanoparticles publication-title: Biomaterials doi: 10.1016/j.biomaterials.2012.03.047 contributor: fullname: Wang – volume: 16 start-page: 56 year: 2016 ident: 10.1016/j.ejpb.2021.03.010_b1200 article-title: Biomaterials and emerging anticancer therapeutics: engineering the microenvironment publication-title: Nat. Rev. Cancer doi: 10.1038/nrc.2015.3 contributor: fullname: Gu – volume: 9 start-page: 798 year: 2009 ident: 10.1016/j.ejpb.2021.03.010_b0375 article-title: STATs in cancer inflammation and immunity: a leading role for STAT3 publication-title: Nat. Rev. Cancer doi: 10.1038/nrc2734 contributor: fullname: Yu – volume: 363 start-page: 411 year: 2010 ident: 10.1016/j.ejpb.2021.03.010_b0310 article-title: Sipuleucel-T immunotherapy for castration-resistant prostate cancer publication-title: New Engl. J. Med. doi: 10.1056/NEJMoa1001294 contributor: fullname: Kantoff – volume: 28 start-page: xii11 year: 2017 ident: 10.1016/j.ejpb.2021.03.010_b0345 article-title: Preclinical and clinical development of neoantigen vaccines publication-title: Ann. Oncol. doi: 10.1093/annonc/mdx681 contributor: fullname: Li – volume: 81 start-page: 1128 year: 2011 ident: 10.1016/j.ejpb.2021.03.010_b1050 article-title: Radiation enhances regulatory T cell representation publication-title: Int. J. Radiat. Oncol. Biol. Phys. doi: 10.1016/j.ijrobp.2010.09.034 contributor: fullname: Kachikwu – volume: 44 start-page: 1302 year: 2015 ident: 10.1016/j.ejpb.2021.03.010_b1400 article-title: Upconverting nanoparticles: a versatile platform for wide-field two-photon microscopy and multi-modal in vivo imaging publication-title: Chem. Soc. Rev. doi: 10.1039/C4CS00173G contributor: fullname: Park – volume: 10 start-page: 993 year: 2004 ident: 10.1016/j.ejpb.2021.03.010_b1395 article-title: Tracking metastatic tumor cell extravasation with quantum dot nanocrystals and fluorescence emission-scanning microscopy publication-title: Nat. Med. doi: 10.1038/nm1096 contributor: fullname: Voura – volume: 8 start-page: 27 year: 2014 ident: 10.1016/j.ejpb.2021.03.010_b0460 article-title: Therapeutic vaccines and cancer: focus on DPX-0907 publication-title: Biologics : Targets & Therapy contributor: fullname: Karkada – volume: 38 start-page: 577 year: 2017 ident: 10.1016/j.ejpb.2021.03.010_b0305 article-title: Integrating Next-Generation Dendritic Cell Vaccines into the Current Cancer Immunotherapy Landscape publication-title: Trends Immunol. doi: 10.1016/j.it.2017.05.006 contributor: fullname: Garg – volume: 31 start-page: 1426 year: 2014 ident: 10.1016/j.ejpb.2021.03.010_b1335 article-title: CD44 targeting magnetic glyconanoparticles for atherosclerotic plaque imaging publication-title: Pharm. Res. doi: 10.1007/s11095-013-1021-8 contributor: fullname: El-Dakdouki – volume: 32 start-page: 478 year: 1957 ident: 10.1016/j.ejpb.2021.03.010_b0880 article-title: A tricarbocyanine dye for continuous recording of dilution curves in whole blood independent of variations in blood oxygen saturation publication-title: Proc. Staff Meetings. Mayo Clinic contributor: fullname: Fox – volume: 7 start-page: 303ra139 year: 2015 ident: 10.1016/j.ejpb.2021.03.010_b0190 article-title: Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia publication-title: Sci. Translat. Med. doi: 10.1126/scitranslmed.aac5415 contributor: fullname: Porter – volume: 1 start-page: 278 year: 2010 ident: 10.1016/j.ejpb.2021.03.010_b1435 article-title: Deeply penetrating in vivo photoacoustic imaging using a clinical ultrasound array system publication-title: Biomed. Opt. Express doi: 10.1364/BOE.1.000278 contributor: fullname: Kim – volume: 1 year: 2010 ident: 10.1016/j.ejpb.2021.03.010_b1370 article-title: Potential toxicity of superparamagnetic iron oxide nanoparticles (SPION) publication-title: Nano Rev. doi: 10.3402/nano.v1i0.5358 contributor: fullname: Singh – volume: 9 start-page: 6401 year: 2015 ident: 10.1016/j.ejpb.2021.03.010_b0475 article-title: Antigen-Loaded Upconversion Nanoparticles for Dendritic Cell Stimulation, Tracking, and Vaccination in Dendritic Cell-Based Immunotherapy publication-title: ACS nano doi: 10.1021/acsnano.5b02014 contributor: fullname: Xiang – volume: 207 year: 2020 ident: 10.1016/j.ejpb.2021.03.010_b0490 article-title: Cancer immunotherapy with immunoadjuvants, nanoparticles, and checkpoint inhibitors: Recent progress and challenges in treatment and tracking response to immunotherapy publication-title: Pharmacol. Therapeut. doi: 10.1016/j.pharmthera.2019.107456 contributor: fullname: Gorbet – volume: 117 start-page: 901 year: 2017 ident: 10.1016/j.ejpb.2021.03.010_b1385 article-title: Nanomaterials for In Vivo Imaging publication-title: Chem. Rev. doi: 10.1021/acs.chemrev.6b00073 contributor: fullname: Smith – volume: 19 start-page: 705 year: 2013 ident: 10.1016/j.ejpb.2021.03.010_b0515 article-title: Challenges and advances towards the rational design of mRNA vaccines publication-title: Trends Mol. Med. doi: 10.1016/j.molmed.2013.09.002 contributor: fullname: Pollard – volume: 8 start-page: 304 year: 2017 ident: 10.1016/j.ejpb.2021.03.010_b0060 article-title: Type I Interferons and Natural Killer Cell Regulation in Cancer publication-title: Front. Immunol. doi: 10.3389/fimmu.2017.00304 contributor: fullname: Müller – volume: 17 start-page: 7387 year: 2017 ident: 10.1016/j.ejpb.2021.03.010_b0765 article-title: Immunogenic Cell Death Amplified by Co-localized Adjuvant Delivery for Cancer Immunotherapy publication-title: Nano Lett. doi: 10.1021/acs.nanolett.7b03218 contributor: fullname: Fan – volume: 18 start-page: 2021 year: 2008 ident: 10.1016/j.ejpb.2021.03.010_b1375 article-title: Cell tracking with optical imaging publication-title: Eur. Radiol. doi: 10.1007/s00330-008-0984-z contributor: fullname: Sutton – volume: 547 start-page: 217 year: 2017 ident: 10.1016/j.ejpb.2021.03.010_b1495 article-title: An immunogenic personal neoantigen vaccine for patients with melanoma publication-title: Nature doi: 10.1038/nature22991 contributor: fullname: Ott – volume: 5 start-page: 15 year: 2015 ident: 10.1016/j.ejpb.2021.03.010_b0985 article-title: Calreticulin as cancer treatment adjuvant: combination with photodynamic therapy and photodynamic therapy-generated vaccines publication-title: Front. Oncol. doi: 10.3389/fonc.2015.00015 contributor: fullname: Korbelik – volume: 119 start-page: 725 year: 1991 ident: 10.1016/j.ejpb.2021.03.010_b0010 article-title: Interval between Symptom Onset and Diagnosis of Pediatric Solid Tumors publication-title: J. Pediatr.-Us doi: 10.1016/S0022-3476(05)80287-2 contributor: fullname: Pollock – volume: 9 start-page: 180 year: 2014 ident: 10.1016/j.ejpb.2021.03.010_b1145 article-title: mRNA-based vaccines synergize with radiation therapy to eradicate established tumors publication-title: Radiat. Oncol. (London, England) doi: 10.1186/1748-717X-9-180 contributor: fullname: Fotin-Mleczek – volume: 213 start-page: 1133 year: 2016 ident: 10.1016/j.ejpb.2021.03.010_b0095 article-title: Combined IL-21-primed polyclonal CTL plus CTLA4 blockade controls refractory metastatic melanoma in a patient publication-title: J. Exp. Med. doi: 10.1084/jem.20152021 contributor: fullname: Chapuis |
| SSID | ssj0004758 |
| Score | 2.4361613 |
| SecondaryResourceType | review_article |
| Snippet | [Display omitted]
Novel strategies modulating the immune system yielded enhanced anticancer responses and improved cancer survival. Nevertheless, the success... Novel strategies modulating the immune system yielded enhanced anticancer responses and improved cancer survival. Nevertheless, the success rate of... |
| SourceID | crossref pubmed elsevier |
| SourceType | Aggregation Database Index Database Publisher |
| StartPage | 72 |
| SubjectTerms | Adjuvants Biomaterials Cancer treatment Imaging Immunotherapy Nanoparticles Theranostic Tumor Vaccines |
| Title | Nanotechnology synergized immunoengineering for cancer |
| URI | https://dx.doi.org/10.1016/j.ejpb.2021.03.010 https://www.ncbi.nlm.nih.gov/pubmed/33774162 |
| Volume | 163 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV07b8IwELYQXbpUfZc-kIeKpaTEjmMnI0JFtJUQUkFis5zYkcIACNKBDv3tPedB2oWhoxPnocv57rvovs8IPYYkZl5MhaMEgQJFJ7DmQgZD4itiKPdJkqt9jvloxt7m_ryBBhUXxrZVlrG_iOl5tC6P9Epr9tZp2vuAWjzkjFgFLCtKkzPYIRmBTz9_120eTOR7dNrJjp1dEmeKHi-zWEdQI1KSC51aFu3B5PQr8wxP0UkJGXG_eKsz1DDLc9SZFJrTuy6e1hSqbRd38KRWo95dIA7xc5Xtf6Dj7c6y_dIvo3FquSErUysSYkCwOLZ-sLlEs-HLdDByys0SnBiWYeYoqj1KYkJ1AEmfRVDm-DqirjGuEr5ggQYk4MI57ZmAR9QQq2mkFcBDwSOAeVeouVwtzY3tdoKVqokiWijGE8jpmscBMz43IqGhaaGnykpyXWhiyKpZbCGtTaW1qXQ9CTZtIb8ypPzzZSUE7YPXXRdW3z_D84TFj_T2n3e8Q8d2VDR63aNmtvk0DwApsqid-0wbHfVf30fjH-chyF0 |
| link.rule.ids | 315,786,790,4521,24144,27957,27958,45620,45714 |
| linkProvider | Elsevier |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV05b8IwGLUQDO1S9S49M1QsJSJ2fCQjQq1CoQipILFZSexIMACCdKC_vp9zkHZh6Jg4TqIXf1f0vWeEnn0cUzcmwg4FhgJFJWBzPoVDzEKsCWc4ydQ-RzyY0vcZm9VQr-TCmLbKwvfnPj3z1sWZToFmZz2fdz6hFvc5xUYBy4jSQAnUoExgWkeNbn8QjCp6pMi26TTX22ZCwZ3J27z0Yh1BmUhwpnVqiLQH49Ov4PN2ik6KrNHq5i92hmp6eY5a41x2ete2JhWLatu2Wta4EqTeXSAOLnSV7v-hW9udIfzNv7Wy5oYestKVKKEFSawVm6WwuUTTt9dJL7CL_RLsGCwxtUOiXIJjTJQHcZ9GUOkwFRFHaycUTFBPQTLgwJhytccjorGRNVIhZIiCR5DpXaH6crXUN6bhCYxV4RArEVKeQFhXPPaoZlyLhPi6iV5KlOQ6l8WQZb_YQhpMpcFUOq4ETJuIlUDKPx9Xgt8-OO86R33_DNcVJoUkt_-84xM6CiYfQznsjwZ36NiM5H1f96iebr70A2QYafRYrKAf6YrLEw |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Nanotechnology+synergized+immunoengineering+for+cancer&rft.jtitle=European+journal+of+pharmaceutics+and+biopharmaceutics&rft.au=Chauhan%2C+Deepak+S.&rft.au=Dhasmana%2C+Anupam&rft.au=Laskar%2C+Partha&rft.au=Prasad%2C+Rajendra&rft.date=2021-06-01&rft.issn=0939-6411&rft.volume=163&rft.spage=72&rft.epage=101&rft_id=info:doi/10.1016%2Fj.ejpb.2021.03.010&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_ejpb_2021_03_010 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0939-6411&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0939-6411&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0939-6411&client=summon |